<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmacol Res Perspect</journal-id><journal-id journal-id-type="iso-abbrev">Pharmacol Res Perspect</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2052-1707</journal-id><journal-id journal-id-type="publisher-id">PRP2</journal-id><journal-title-group><journal-title>Pharmacology Research &#x00026; Perspectives</journal-title></journal-title-group><issn pub-type="epub">2052-1707</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7916527</article-id><article-id pub-id-type="doi">10.1002/prp2.721</article-id><article-id pub-id-type="publisher-id">PRP2721</article-id><article-categories><subj-group subj-group-type="overline"><subject>Invited Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Invited Reviews</subject></subj-group></article-categories><title-group><article-title>Drug discovery: Insights from the invertebrate <italic>Caenorhabditis elegans</italic>
</article-title><alt-title alt-title-type="left-running-head">GIUNTI et al.</alt-title></title-group><contrib-group><contrib id="prp2721-cr-0001" contrib-type="author"><name><surname>Giunti</surname><given-names>Sebasti&#x000e1;n</given-names></name><xref ref-type="aff" rid="prp2721-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="prp2721-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="prp2721-cr-0002" contrib-type="author"><name><surname>Andersen</surname><given-names>Natalia</given-names></name><xref ref-type="aff" rid="prp2721-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="prp2721-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="prp2721-cr-0003" contrib-type="author" corresp="yes"><name><surname>Rayes</surname><given-names>Diego</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5448-1431</contrib-id><xref ref-type="aff" rid="prp2721-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="prp2721-aff-0002">
<sup>2</sup>
</xref><address><email>drayes@criba.edu.ar</email></address></contrib><contrib id="prp2721-cr-0004" contrib-type="author" corresp="yes"><name><surname>De Rosa</surname><given-names>Mar&#x000ed;a Jos&#x000e9;</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2149-6127</contrib-id><xref ref-type="aff" rid="prp2721-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="prp2721-aff-0002">
<sup>2</sup>
</xref><address><email>mjderosa@criba.edu.ar</email></address></contrib></contrib-group><aff id="prp2721-aff-0001">
<label><sup>1</sup></label>
<institution>Instituto de Investigaciones Bioqu&#x000ed;micas de Bah&#x000ed;a Blanca (INIBIBB) CCT UNS&#x02010;CONICET</institution>
<city>Bah&#x000ed;a Blanca</city>
<country country="AR">Argentina</country>
</aff><aff id="prp2721-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Dpto de Biolog&#x000ed;a, Bioqu&#x000ed;mica y Farmacia</named-content>
<institution>Universidad Nacional del Sur</institution>
<city>Bah&#x000ed;a Blanca</city>
<country country="AR">Argentina</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Diego Rayes and Mar&#x000ed;a Jos&#x000e9; De Rosa, Instituto de Investigaciones Bioqu&#x000ed;micas de Bah&#x000ed;a Blanca (INIBIBB) CCT UNS&#x02010;CONICET, Camino La Carrindanga Km 7, Bah&#x000ed;a Blanca, Argentina.<break/>
Email: <email>drayes@criba.edu.ar</email> (D. R.);<email>mjderosa@criba.edu.ar</email> (M. J. R.)<break/></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2021</year></pub-date><volume>9</volume><issue>2</issue><issue-id pub-id-type="doi">10.1002/prp2.v9.2</issue-id><elocation-id>e00721</elocation-id><history><date date-type="received"><day>16</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>06</day><month>1</month><year>2021</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright">&#x000a9; 2021 John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics<copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2021 The Authors. <italic>Pharmacology Research &#x00026; Perspectives</italic> published by John Wiley &#x00026; Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:PRP2-9-e00721.pdf"/><abstract id="prp2721-abs-0001"><title>Abstract</title><p>Therapeutic drug development is a long, expensive, and complex process that usually takes 12&#x02013;15&#x000a0;years. In the early phases of drug discovery, in particular, there is a growing need for animal models that ensure the reduction in both cost and time. <italic>Caenorhabditis elegans</italic> has been traditionally used to address fundamental aspects of key biological processes, such as apoptosis, aging, and gene expression regulation. During the last decade, with the advent of large&#x02010;scale platforms for screenings, this invertebrate has also emerged as an essential tool in the pharmaceutical research industry to identify novel drugs and drug targets. In this review, we discuss the reasons why <italic>C.&#x000a0;elegans</italic> has been positioned as an outstanding cost&#x02010;effective option for drug discovery, highlighting both the advantages and drawbacks of this model. Particular attention is paid to the suitability of this nematode in large&#x02010;scale genetic and pharmacological screenings. High&#x02010;throughput screenings in <italic>C.&#x000a0;elegans</italic> have indeed contributed to the breakthrough of a wide variety of candidate compounds involved in extensive fields including neurodegeneration, pathogen infections and metabolic disorders. The versatility of this nematode, which enables its instrumentation as a model of human diseases, is another attribute also herein underscored. As illustrative examples, we discuss the utility of <italic>C.&#x000a0;elegans</italic> models of both human neurodegenerative diseases and parasitic nematodes in the drug discovery industry. Summing up, this review aims to demonstrate the impact of <italic>C.&#x000a0;elegans</italic> models on the drug discovery pipeline.</p></abstract><kwd-group><kwd id="prp2721-kwd-0001"><italic>C. elegans</italic></kwd><kwd id="prp2721-kwd-0002">drug discovery</kwd><kwd id="prp2721-kwd-0003">genetic screenings</kwd><kwd id="prp2721-kwd-0004">human disease models</kwd><kwd id="prp2721-kwd-0005">pharmacological screenings</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Consejo Nacional de Investigaciones Cient&#x000ed;ficas y T&#x000e9;cnicas </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100002923</institution-id></institution-wrap></funding-source><award-id>PIP 2015&#x02013;2017 CO 11220150100182CO</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Agencia Nacional de Promoci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100003074</institution-id></institution-wrap></funding-source><award-id>PICT 2017 0566</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>Universidad Nacional del Sur </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100005740</institution-id></institution-wrap></funding-source><award-id>PGI 2016 24/B261</award-id><award-id>PGI 2018 24/B291</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="3"/><page-count count="18"/><word-count count="13371"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2021</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.9 mode:remove_FC converted:28.02.2021</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="prp2721-ntgp-0001"><fn fn-type="funding" id="prp2721-note-0001"><p>
<bold>Funding information</bold>
</p><p>This work was supported by Consejo Nacional de Investigaciones Cient&#x000ed;ficas y T&#x000e9;cnicas (PIP 2015&#x02013;2017 CO 11220150100182CO to DR), Agencia Nacional de Promoci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica (PICT 2017 0566 to MJDR), Universidad Nacional del Sur (PGI 2016 24/B261 to MJDR and PGI 2018 24/B291 to DR).</p></fn></fn-group></notes></front><body id="prp2721-body-0001"><def-list list-content="abbreviations" id="prp2721-lp-0001"><title>Abbreviations</title><def-item><term>AChR</term><def><p>muscle nicotinic receptor</p></def></def-item><def-item><term>AT</term><def><p>&#x003b1;1&#x02010;antitrypsin</p></def></def-item><def-item><term>A&#x003b2;</term><def><p>&#x003b2;&#x02010;amyloid</p></def></def-item><def-item><term>CACNA1A</term><def><p>calcium voltage&#x02010;gated channel subunit alpha 1A</p></def></def-item><def-item><term>CGC</term><def><p>
<italic>Caenorhabditis</italic> Genetics Center</p></def></def-item><def-item><term>HTS</term><def><p>high&#x02010;throughput screening</p></def></def-item><def-item><term>MOA</term><def><p>Mechanism of action</p></def></def-item><def-item><term>NGM</term><def><p>Nematode Growth Medium</p></def></def-item><def-item><term>PBS</term><def><p>phenotypic&#x02010;based drug screens</p></def></def-item><def-item><term>TBS</term><def><p>target&#x02010;based drug screens</p></def></def-item></def-list><sec id="prp2721-sec-0001"><label>1</label><title>INTRODUCTION: THE NEMATODE <italic>Caenorhabditis elegans</italic>
</title><p>Since its introduction into research by Sydney Brenner in the early 60s, the nematode <italic>Caenorhabditis elegans</italic> has played a pivotal role in different areas of biomedical investigation.<xref rid="prp2721-bib-0001" ref-type="ref">
<sup>1</sup>
</xref>, <xref rid="prp2721-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="prp2721-bib-0003" ref-type="ref">
<sup>3</sup>
</xref>, <xref rid="prp2721-bib-0004" ref-type="ref">
<sup>4</sup>
</xref>, <xref rid="prp2721-bib-0005" ref-type="ref">
<sup>5</sup>
</xref>, <xref rid="prp2721-bib-0006" ref-type="ref">
<sup>6</sup>
</xref>, <xref rid="prp2721-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>, <xref rid="prp2721-bib-0008" ref-type="ref">
<sup>8</sup>
</xref>, <xref rid="prp2721-bib-0009" ref-type="ref">
<sup>9</sup>
</xref> Studies on <italic>C.&#x000a0;elegans</italic> have contributed to fundamental breakthroughs in life science, such as the discovery of genetic regulators of programmed cell death, the use of the green fluorescent protein (GFP) as a protein marker, and the discovery of RNA interference (RNAi).<xref rid="prp2721-bib-0010" ref-type="ref">
<sup>10</sup>
</xref>, <xref rid="prp2721-bib-0011" ref-type="ref">
<sup>11</sup>
</xref>, <xref rid="prp2721-bib-0012" ref-type="ref">
<sup>12</sup>
</xref>
</p><p>
<italic>C.&#x000a0;elegans</italic> is a tiny (~1&#x000a0;mm in length), soil, free&#x02010;living, and bacteria&#x02010;eating nematode<xref rid="prp2721-bib-0013" ref-type="ref">
<sup>13</sup>
</xref>, <xref rid="prp2721-bib-0014" ref-type="ref">
<sup>14</sup>
</xref> which can develop as either of two sexes, self&#x02010;fertilizing hermaphrodites or males. Males represent a minor population (~0.2% of population).<xref rid="prp2721-bib-0014" ref-type="ref">
<sup>14</sup>
</xref>, <xref rid="prp2721-bib-0015" ref-type="ref">
<sup>15</sup>
</xref> Healthy hermaphrodites produce up to 300 self&#x02010;progeny although they are capable of giving approximately 1000 offspring if they are mated with males.</p><p>This nematode typically lives for about 3&#x000a0;weeks at 20&#x000b0;C in the laboratory. Unlike other members of the Nematoda phylum, <italic>C.&#x000a0;elegans</italic> is a nonhazardous and nonpathogenic animal that can be manipulated with standard safety rules. A unique benefit of using <italic>C.&#x000a0;elegans</italic> in the laboratory is that it can be frozen and stored in liquid nitrogen or &#x02212;80&#x000b0;C ultra&#x02010;freezers until needed.<xref rid="prp2721-bib-0014" ref-type="ref">
<sup>14</sup>
</xref> Moreover, its use does not raise the ethical issues associated with the use of vertebrates (Figure&#x000a0;<xref rid="prp2721-fig-0001" ref-type="fig">1</xref>).</p><fig fig-type="FIGURE" xml:lang="en" id="prp2721-fig-0001" orientation="portrait" position="float"><label>FIGURE 1</label><caption><p>
<italic>Caenorhabditis elegans</italic> as a versatile platform for drug discovery. Its genetic amenability and ease of transgenesis allows elucidation of MOAs by forward and reverse genetic screens and generation of "humanized worms" to emulate conditions seen in humans. All this combined with the feasibility for HTS and automation of easily scored phenotypes converts <italic>C.&#x000a0;elegans</italic> into a powerful model for pharmacological research. For more detailed anatomy and other <italic>C.&#x000a0;elegans</italic> resources visit: Wormatlas (<ext-link ext-link-type="uri" xlink:href="http://www.wormatlas.org">www.wormatlas.org</ext-link>), Wormbase (<ext-link ext-link-type="uri" xlink:href="http://www.wormbase.org">www.wormbase.org</ext-link>), Wormbook (<ext-link ext-link-type="uri" xlink:href="http://www.wormbook.org">www.wormbook.org</ext-link>)</p></caption><graphic id="nlm-graphic-1" xlink:href="PRP2-9-e00721-g001"/></fig><p>
<italic>C.&#x000a0;elegans &#x000b4;</italic> life cycle, which is very short, takes approximately 2.5&#x02013;3&#x000a0;days and is divided into embryogenesis (~16&#x000a0;h), four larval stages (L1&#x02013;L4, ~28&#x000a0;h) and the adult molt, from L4 to adult (~12&#x000a0;h). Adverse environmental conditions (starvation, high population density, high temperature) in the late L1 larval stage trigger entry into a developmental arrest phase called dauer.<xref rid="prp2721-bib-0016" ref-type="ref">
<sup>16</sup>
</xref>, <xref rid="prp2721-bib-0017" ref-type="ref">
<sup>17</sup>
</xref> Dauer larvae can survive stressful conditions for months until encountering favorable conditions that permit resuming reproductive development. The presence of separate sexes and the short life cycle permit rapid genetic crosses in the laboratory. It has an invariant number of somatic cells: 959 in hermaphrodites and 1031 in males. <italic>C.&#x000a0;elegans</italic> cellular genealogies have been traced from embryo to newly hatched larva. Unlike mammals, the pattern of cell lineages is invariant among individuals, which has been key to understand the roles of developmental control genes.<xref rid="prp2721-bib-0018" ref-type="ref">
<sup>18</sup>
</xref>, <xref rid="prp2721-bib-0019" ref-type="ref">
<sup>19</sup>
</xref>, <xref rid="prp2721-bib-0020" ref-type="ref">
<sup>20</sup>
</xref>
</p><p>Despite its apparent simplicity, <italic>C.&#x000a0;elegans</italic> contains organs and tissues present in more complex organisms, such as muscles, hypodermis, intestine, reproductive and excretory system, and a well&#x02010;described nervous system (Figure&#x000a0;<xref rid="prp2721-fig-0001" ref-type="fig">1</xref>). It is also the only organism where the complete neural wiring diagram has been established.<xref rid="prp2721-bib-0021" ref-type="ref">
<sup>21</sup>
</xref>, <xref rid="prp2721-bib-0022" ref-type="ref">
<sup>22</sup>
</xref> Its transparency allows the easy visualization of specific cells and subcellular structures through Nomarski (differential interference contrast, DIC) optics using whole&#x02010;live animals. The visualization of protein expression patterns, protein subcellular localization, and activity of specific cells using transgenic reporters and genetically encoded calcium indicators is feasible in living animals at any point in their lives (Figure&#x000a0;<xref rid="prp2721-fig-0001" ref-type="fig">1</xref>).<xref rid="prp2721-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>, <xref rid="prp2721-bib-0024" ref-type="ref">
<sup>24</sup>
</xref>, <xref rid="prp2721-bib-0025" ref-type="ref">
<sup>25</sup>
</xref>
</p><p>The fact that <italic>C.&#x000a0;elegans</italic> was the first multicellular organism to have its complete genome sequenced (<italic>C.&#x000a0;elegans</italic> Sequencing Consortium 1998) as well as its amenable genetic manipulation helped to turn this worm into a powerful organism for genetic screens.<xref rid="prp2721-bib-0026" ref-type="ref">
<sup>26</sup>
</xref>, <xref rid="prp2721-bib-0027" ref-type="ref">
<sup>27</sup>
</xref> 83% of <italic>C.&#x000a0;elegans</italic> proteome is predicted to have human homolog genes <xref rid="prp2721-bib-0028" ref-type="ref">
<sup>28</sup>
</xref> and it has been estimated that ~50% of <italic>C.&#x000a0;elegans</italic> protein&#x02010;coding genes have a functional ortholog in humans.<xref rid="prp2721-bib-0029" ref-type="ref">
<sup>29</sup>
</xref> Essential biological molecules and cell signaling pathways, such as the insulin&#x02010;signaling pathway, innate immunity regulatory pathways, synaptic machinery, and systems involved in protein homeostasis are highly conserved between worms and mammals.<xref rid="prp2721-bib-0030" ref-type="ref">
<sup>30</sup>
</xref>, <xref rid="prp2721-bib-0031" ref-type="ref">
<sup>31</sup>
</xref>, <xref rid="prp2721-bib-0032" ref-type="ref">
<sup>32</sup>
</xref>, <xref rid="prp2721-bib-0033" ref-type="ref">
<sup>33</sup>
</xref>, <xref rid="prp2721-bib-0034" ref-type="ref">
<sup>34</sup>
</xref>
</p><p>Taken together, all these features make <italic>C.&#x000a0;elegans</italic> an excellent model organism that bridges the gap between the simplicity of cultured cells and the complexity of multicellular organisms.</p></sec><sec id="prp2721-sec-0002"><label>2</label><title>
<italic>C.&#x000a0;elegans</italic> IN DRUG DISCOVERY</title><p>The advances in molecular biology techniques and genome knowledge allowed drug screening to be carried out directly on target proteins. Therefore, target&#x02010;based drug screens (TBS) have become the most commonly used approach for drug discovery. In this type of approach, compounds are screened for their capacity to bind or alter the activity of specific target proteins using cell extracts or cell cultures. However, as targets are previously identified and validated, TBS does not permit the discovery of novel targets and the elucidation of mechanisms of action (MOAs) is frequently limited to agonism or antagonism of known receptors/pathways. Moreover, once hits are detected they need to be tested in the context of a whole organism to further analyze its biological efficacy and toxicity. In contrast to TBS, phenotypic&#x02010;based drug screens (PBS) use cells or animal disease models to identify compounds that rescue or ameliorate the disease phenotype. This animal&#x02010;based approach includes the effects of cell communications and tissue interactions in the effect of a given compound. This unbiased strategy allows the identification of compounds with novel MOAs. One of the main caveats of PBS is that the identification of targets and MOAs could be complicated, particularly when mammalian animal models are used. This drawback can be significantly mitigated using invertebrates, such as the nematode <italic>C.&#x000a0;elegans</italic>, which has lately gained consideration as an excellent platform for the identification of new drug targets and drug discovery.</p><p>Automation of worm transfer, image acquisition, and data analysis allows the use of <italic>C.&#x000a0;elegans</italic> for high&#x02010;throughput screening (HTS) assays.<xref rid="prp2721-bib-0035" ref-type="ref">
<sup>35</sup>
</xref>, <xref rid="prp2721-bib-0036" ref-type="ref">
<sup>36</sup>
</xref>, <xref rid="prp2721-bib-0037" ref-type="ref">
<sup>37</sup>
</xref>, <xref rid="prp2721-bib-0038" ref-type="ref">
<sup>38</sup>
</xref>, <xref rid="prp2721-bib-0039" ref-type="ref">
<sup>39</sup>
</xref> Several companies (Celescreen, Sunnybiotech, Nagi Biosciences) offer these types of assays to the pharmaceutical industry for the identification of new potential compounds and validation of pharmacological targets. In the last 10&#x000a0;years, HTS in <italic>C.&#x000a0;elegans</italic> has become&#x02014;in fact&#x02014;a useful tool to identify candidate compounds as potential treatments for several pathological conditions (Table&#x000a0;<xref rid="prp2721-tbl-0001" ref-type="table">1</xref>).</p><table-wrap id="prp2721-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>
<italic>Caenorhabditis elegans</italic> phenotypic&#x02010;based drug screenings. The table shows relevant drug screenings assays performed during the last decade in <italic>C.&#x000a0;elegans</italic> models for human and animal diseases</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Biological activity</th><th align="left" valign="top" rowspan="1" colspan="1">Initial screening set</th><th align="left" valign="top" rowspan="1" colspan="1">Identified hits</th><th align="left" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="8" colspan="1">
<p>Anti&#x02010;proteotoxicity</p>
<p>Neuroprotection</p>
</td><td align="left" rowspan="1" colspan="1">10 positive modulators of healthspan</td><td align="left" rowspan="1" colspan="1">Metformin, lithium, and curcumin</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0040" ref-type="ref">40</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">18 compounds</td><td align="left" rowspan="1" colspan="1">&#x003b1;&#x02010;methyl&#x02010;&#x003b1;&#x02010;phenylsuccinimide</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0041" ref-type="ref">41</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">87 flavonoids and 13 neurosteroids</td><td align="left" rowspan="1" colspan="1">12 flavonoids (e.g., isoquercitrin) and 2 steroids (3&#x003b2;&#x02010;Methoxy&#x02010;Pregnenolone and 17&#x003b2;&#x02010;estradiol)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0042" ref-type="ref">42</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">3 850 compounds</td><td align="left" rowspan="1" colspan="1">13 hits (e.g., pimozide)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0043" ref-type="ref">43</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">983 FDA&#x02010;approved drugs</td><td align="left" rowspan="1" colspan="1">4 hits (dronedarone, tofranil, bendrofluazide, buspar)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0044" ref-type="ref">44</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">4 polyphenolic compounds</td><td align="left" rowspan="1" colspan="1">Ferulic acid</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0045" ref-type="ref">45</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">30 FDA&#x02010;approved drugs</td><td align="left" rowspan="1" colspan="1">Tannic acid, bacitracin</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0046" ref-type="ref">46</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">115&#x000a0;000 compounds</td><td align="left" rowspan="1" colspan="1">Four tetrahydroquinolinones</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0047" ref-type="ref">47</xref>
</td></tr><tr><td align="left" rowspan="8" colspan="1">Anti&#x02010;aging</td><td align="left" rowspan="1" colspan="1">1386 FDA&#x02010;approved drugs</td><td align="left" rowspan="1" colspan="1">Verapamil</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0048" ref-type="ref">48</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">32 compounds</td><td align="left" rowspan="1" colspan="1">1 hit (chalcone like&#x02010;compound)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0049" ref-type="ref">49</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">~100 serine hydrolase inhibitors</td><td align="left" rowspan="1" colspan="1">JZL184</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0050" ref-type="ref">50</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">107 FDA&#x02010;approved drugs</td><td align="left" rowspan="1" colspan="1">Tiagabine</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0051" ref-type="ref">51</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">15 FDA&#x02010;approved drugs</td><td align="left" rowspan="1" colspan="1">Captopril</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0052" ref-type="ref">52</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">33&#x000a0;000 compounds</td><td align="left" rowspan="1" colspan="1">57 hits (e.g., nitrophenyl piperazine&#x02010;containing compounds)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0053" ref-type="ref">53</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">1280 compounds</td><td align="left" rowspan="1" colspan="1">57 hits (e.g., minocycline)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0054" ref-type="ref">54</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">normal and disease&#x02010;associated endogenous metabolites</td><td align="left" rowspan="1" colspan="1">&#x003b1;&#x02010;ketoglutarate</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0055" ref-type="ref">55</xref>
</td></tr><tr><td align="left" rowspan="8" colspan="1">Anti&#x02010;microbial</td><td align="left" rowspan="1" colspan="1">69 compounds</td><td align="left" rowspan="1" colspan="1">5 hits (phenyl triazine compounds)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0056" ref-type="ref">56</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">82&#x000a0;000 compounds</td><td align="left" rowspan="1" colspan="1">185 hits (e.g., synthetic retinoid CD437)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0057" ref-type="ref">57</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">86&#x000a0;000 compounds</td><td align="left" rowspan="1" colspan="1">195 hits (e.g., 5&#x02010;fluorouracil)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0058" ref-type="ref">58</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">21 500 compounds</td><td align="left" rowspan="1" colspan="1">318 hits (e.g., phenylsulfonyl pyrazinecarbonitrile)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0059" ref-type="ref">59</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">640 FDA&#x02010;approved drugs</td><td align="left" rowspan="1" colspan="1">42 hits (e.g., closantel)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0060" ref-type="ref">60</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">1600 compounds</td><td align="left" rowspan="1" colspan="1">18 hits (e.g., iron&#x02010;chelator ciclopirox olamine)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0061" ref-type="ref">61</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">1300 extracts (from endophytic fungi)</td><td align="left" rowspan="1" colspan="1">4 hits</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0062" ref-type="ref">62</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2560</td><td align="left" rowspan="1" colspan="1">12 hits (e.g., natural saponins)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0063" ref-type="ref">63</xref>
</td></tr><tr><td align="left" rowspan="6" colspan="1">Anthelmintic</td><td align="left" rowspan="1" colspan="1">12 benzopyrano pyrazol compounds</td><td align="left" rowspan="1" colspan="1">4 hits</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0064" ref-type="ref">64</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">575 compounds</td><td align="left" rowspan="1" colspan="1">29 hits (e.g., arylidene ketones)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0065" ref-type="ref">65</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">11 imidazole&#x02010;derivatives</td><td align="left" rowspan="1" colspan="1">2 hits (e.g., diisopropylphenyl&#x02010;imidazole)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0066" ref-type="ref">66</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">400 compounds (Pathogen Box library)</td><td align="left" rowspan="1" colspan="1">18 hits (e.g., isoxazole compounds)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0039" ref-type="ref">39</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">480 compounds</td><td align="left" rowspan="1" colspan="1">20 hits (e.g., dihydrobenzoxazepinones)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0067" ref-type="ref">67</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">67&#x000a0;012 compounds</td><td align="left" rowspan="1" colspan="1">30 hits (e.g., ethyl benzamide moiety compounds</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0068" ref-type="ref">68</xref>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Anti&#x02010;tumoral</td><td align="left" rowspan="1" colspan="1">4 in vitro anticancer compounds</td><td align="left" rowspan="1" colspan="1">4 hits</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0069" ref-type="ref">69</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">30 plant extracts</td><td align="left" rowspan="1" colspan="1">Harmine (from the plant <italic>Peganum harmala</italic>)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0070" ref-type="ref">70</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">~9000 compounds</td><td align="left" rowspan="1" colspan="1">2 hits (an EGFR inhibitor and a MEK inhibitor)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0071" ref-type="ref">71</xref>
</td></tr><tr><td align="left" rowspan="3" colspan="1">
<p>Anti&#x02010;metabolic disorders</p>
<p>(obesity, insulin resistance, type II diabetes)</p>
</td><td align="left" rowspan="1" colspan="1">24 plants and fungal extracts</td><td align="left" rowspan="1" colspan="1">2 hits (extracts of Inonotus obliquus and Gardenia jasminoides)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0072" ref-type="ref">72</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">350 natural products</td><td align="left" rowspan="1" colspan="1">1 hit (swertiamarin)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0073" ref-type="ref">73</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">8 natural plant compounds</td><td align="left" rowspan="1" colspan="1">2 hits (isoquinoline alkaloids)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0074" ref-type="ref">74</xref>
</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>The fact that <italic>C.&#x000a0;elegans</italic> shares the nematode phylum with several parasitic roundworms makes it a straightforward model to be used for the development of anthelmintic drugs. Its use has allowed the MOA elucidation of several nematocidal drugs<xref rid="prp2721-bib-0075" ref-type="ref">
<sup>75</sup>
</xref>, <xref rid="prp2721-bib-0076" ref-type="ref">
<sup>76</sup>
</xref>, <xref rid="prp2721-bib-0077" ref-type="ref">
<sup>77</sup>
</xref>, <xref rid="prp2721-bib-0078" ref-type="ref">
<sup>78</sup>
</xref> (Table&#x000a0;<xref rid="prp2721-tbl-0002" ref-type="table">2</xref>). However, its use goes far beyond than merely applying <italic>C.&#x000a0;elegans</italic> to the discovery of drugs with anthelmintic potential. <italic>C.&#x000a0;elegans</italic> is also exploited as an accessible platform to recapitulate distinctive phenotypes of human diseases, such as cancer, diabetes, neurodegenerative disorders, and pathogen infection.<xref rid="prp2721-bib-0079" ref-type="ref">
<sup>79</sup>
</xref>, <xref rid="prp2721-bib-0080" ref-type="ref">
<sup>80</sup>
</xref>, <xref rid="prp2721-bib-0081" ref-type="ref">
<sup>81</sup>
</xref>, <xref rid="prp2721-bib-0082" ref-type="ref">
<sup>82</sup>
</xref>, <xref rid="prp2721-bib-0083" ref-type="ref">
<sup>83</sup>
</xref>, <xref rid="prp2721-bib-0084" ref-type="ref">
<sup>84</sup>
</xref>, <xref rid="prp2721-bib-0085" ref-type="ref">
<sup>85</sup>
</xref>, <xref rid="prp2721-bib-0086" ref-type="ref">
<sup>86</sup>
</xref>, <xref rid="prp2721-bib-0087" ref-type="ref">
<sup>87</sup>
</xref>, <xref rid="prp2721-bib-0088" ref-type="ref">
<sup>88</sup>
</xref>, <xref rid="prp2721-bib-0089" ref-type="ref">
<sup>89</sup>
</xref> The molecular pathways underlying a biological process that, when altered, could lead to physiological diseases are usually conserved throughout the animal kingdom. The alteration of these conserved pathways in <italic>C.&#x000a0;elegans</italic> often leads to specific phenotypes and behaviors, such as modifications in lifespan, stress resistance, or locomotion. All these phenotypes are easily measurable using automated protocols and devices, making the screening of drugs that ameliorate or rescue these defects a relatively simple procedure.</p><table-wrap id="prp2721-tbl-0002" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 2</label><caption><p>Recent contributions in deciphering drug&#x02010;targets and mechanism of action. Representative compounds for which the use of <italic>C.&#x000a0;elegans</italic> has been useful in elucidating their mechanisms of action</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Compound</th><th align="left" valign="top" rowspan="1" colspan="1">Field</th><th align="left" valign="top" rowspan="1" colspan="1">Identified target/Mechanism of action</th><th align="left" valign="top" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Resveratrol</td><td align="left" rowspan="1" colspan="1">Neurodegeneration</td><td align="left" rowspan="1" colspan="1">Reduces &#x003b2;&#x02010;amyloid by targeting UBL&#x02010;5 and XBP&#x02010;1, proteins implicated in UPR<sup>mt</sup> and UPR<sup>ER</sup>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0090" ref-type="ref">90</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Minocycline</td><td align="left" rowspan="1" colspan="1">Aging</td><td align="left" rowspan="1" colspan="1">Increases lifespan by decreasing mARN translation</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0091" ref-type="ref">91</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">RPW&#x02010;24</td><td align="left" rowspan="1" colspan="1">Microbial infection</td><td align="left" rowspan="1" colspan="1">Stimulates innate immune response through pmk&#x02010;1/p38 MAPK pathway, and the transcription factor, <italic>atf</italic>&#x02010;<italic>7</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0092" ref-type="ref">92</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Monepantel</td><td align="left" rowspan="1" colspan="1">Helminth infection</td><td align="left" rowspan="1" colspan="1">Targets ACR&#x02010;20 and ACR&#x02010;23 from the DEG&#x02010;3 subgroup of nAChR subunits</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0093" ref-type="ref">93</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Metformin</td><td align="left" rowspan="1" colspan="1">Cancer</td><td align="left" rowspan="1" colspan="1">Induces tumor growth inhibition and lifespan extension by targeting nuclear pore complex (NPC) and acyl&#x02010;CoA dehydrogenase family member&#x02010;10 (ACAD10)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0094" ref-type="ref">94</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Hesperidin</td><td align="left" rowspan="1" colspan="1">Metabolic disorders</td><td align="left" rowspan="1" colspan="1">Inhibits lipid accumulation by downregulating lipid metabolism genes (<italic>fat</italic>&#x02010;<italic>6 and fat</italic>&#x02010;<italic>7</italic>)</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2721-bib-0095" ref-type="ref">95</xref>
</td></tr></tbody></table><table-wrap-foot id="prp2721-ntgp-0002"><fn id="prp2721-note-0002"><p>Abbreviations: ACR, acetylcholine receptor subunit; atf&#x02010;7, Cyclic AMP&#x02010;dependent transcription factor 7; MAPK, mitogen&#x02010;activated protein kinase; pmk&#x02010;1, p38 MAPK; UBL&#x02010;5, Ubiquitin&#x02010;like protein 5; UPR<sup>ER</sup>, unfolded protein response of the endoplasmic reticulum; UPR<sup>mt</sup>, mitochondrial unfolded protein response; XBP&#x02010;1, X&#x02010;Box Binding Protein 1.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Several genetic tools for the manipulation of single genes or groups of genes are readily available in <italic>C.&#x000a0;elegans</italic> (chemical mutagenesis, transgenesis, RNAi, and CRISPR/Cas9) (Figure&#x000a0;<xref rid="prp2721-fig-0001" ref-type="fig">1</xref>). Animals carrying mutations of highly conserved biochemical pathways or expressing exogenous pathognomonic protein of a specific disease can be engineered in few weeks. Mutant strains and animals expressing human transgenes are available at a very low cost at the <italic>Caenorhabditis</italic> Genetics Center (CGC). Moreover, the rapid life&#x02010;cycle and the high brood size of <italic>C.&#x000a0;elegans</italic> permit the analysis of the effects of compounds not only in the exposed animal but also in the progeny in a very short time&#x02010;frame.</p><p>Cell cultures or cell extracts are typically the initial step in drug development. Using invertebrate animal models in these early steps is ideal to reduce research costs and time as they help to identify compounds that, apart from being effective in interacting with the active target, maintain their efficacy even after absorption, distribution, metabolism, and excretion (ADME) processes. They also provide information about potential systemic toxicity and biocompatibility.<xref rid="prp2721-bib-0096" ref-type="ref">
<sup>96</sup>
</xref>
</p><p>Although ADME processes are important sources of information compared with cell cultures, in <italic>C.&#x000a0;elegans</italic> they have certain limitations that should be taken into account at the moment of processing results from drug&#x02010;screening assays. In particular, the thick cuticle, which forms a strong barrier that limits drug absorption, can usually render false&#x02010;negative results.<xref rid="prp2721-bib-0097" ref-type="ref">
<sup>97</sup>
</xref>
</p><p>
<italic>C.&#x000a0;elegans&#x000b4;</italic> low&#x02010;cost maintenance, small size, genetic amenability, and conservation of key molecular pathways with mammalian animals convert this worm into an excellent alternative to significantly reduce drug development costs. Although the use of <italic>C.&#x000a0;elegans</italic> as a platform for drug screening is recent, there are compounds that have been identified in this nematode and which, once validated on vertebrate models, are currently being evaluated in human patients. For example, hits obtained in a drug screening performed in a <italic>C.&#x000a0;elegans</italic> model of amyotrophic lateral sclerosis were validated in zebrafish and mice. One of these hits, the neuroleptic Pimozide, a Ca<sup>2+</sup> channel blocker that stabilizes neuromuscular transmission in <italic>C.&#x000a0;elegans</italic>, has also shown efficiency in a short randomized controlled trial of sporadic ALS subjects.<xref rid="prp2721-bib-0043" ref-type="ref">
<sup>43</sup>
</xref> Another report evaluated the pearl powder (a Chinese medicine) by combining <italic>C.&#x000a0;elegans</italic> studies with a clinical trial. The authors have correlated the lifespan extension found in <italic>C.&#x000a0;elegans</italic> with the higher antioxidant capacity in blood samples of patients treated with pearl powder.<xref rid="prp2721-bib-0098" ref-type="ref">
<sup>98</sup>
</xref> These two examples serve as proofs of concept for the translational potential of drug screenings in the invertebrate <italic>C.&#x000a0;elegans</italic>. Since the number of drug screenings in this nematode is increasing year after year (Table&#x000a0;<xref rid="prp2721-tbl-0001" ref-type="table">1</xref>), more clinical trials for hits identified in <italic>C.&#x000a0;elegans</italic> are expected in the near future.</p><sec id="prp2721-sec-0003"><label>2.1</label><title>Genetic screening assays</title><p>One of the greatest advantages of using <italic>C.&#x000a0;elegans</italic> for biomedical research is undoubtedly its amenability for genetic manipulation. Genetic screens are widely used in <italic>C.&#x000a0;elegans</italic> to either discover gene function or find genes involved in relevant biological pathways. Furthermore, the feasibility of rapid genetic crossing permits epistatic analyses to find new players in known genetic pathways.<xref rid="prp2721-bib-0099" ref-type="ref">
<sup>99</sup>
</xref>
</p><p>To date, two strategies to perform screenings in <italic>C.&#x000a0;elegans</italic> have been developed: forward genetics and reverse genetics. Whereas the former uses mutagens to randomly generate mutations that induce or reverse a given phenotype, the latter analyzes the phenotype obtained after altering or knocking down a specific known gene. Forward genetics therefore goes from phenotype to gene, whereas reverse genetics works the other way around, that is, from gene to phenotype.</p><sec id="prp2721-sec-0004"><label>2.1.1</label><title>Forward genetics</title><p>Mutations are important tools for gene function discovery. Mutagenesis can be accomplished using a variety of chemical agents, such as ethyl methanesulfonate (EMS), N&#x02010;ethyl&#x02010;N&#x02010;nitrosourea (ENU), trimethylpsoralen (TMP), among others. Hermaphrodites (P0) are randomly mutagenized at the late L4/early adult stages and then distributed in Petri dishes. F1 hermaphrodite progeny that are heterozygous for these mutations can be allowed to self&#x02010;fertilize. The F2 animals, which bring mutations to homozygosis, are isolated based on the phenotype of interest.<xref rid="prp2721-bib-0027" ref-type="ref">
<sup>27</sup>
</xref> Several mutations generate clearly altered phenotypes, such as changes in development, lifespan, stress resistance, uncoordinated movement (unc), or dumpy&#x02010;shaped animals (dpy). Today, mutated genes underlying a given phenotype can be identified by whole&#x02010;genome sequencing.<xref rid="prp2721-bib-0100" ref-type="ref">
<sup>100</sup>
</xref>, <xref rid="prp2721-bib-0101" ref-type="ref">
<sup>101</sup>
</xref>
</p><p>Another approach, which has proven to be very useful for identifying novel gene interactions, consists in performing mutagenesis directly in strains already carrying mutations that induce a strong phenotype.<xref rid="prp2721-bib-0102" ref-type="ref">
<sup>102</sup>
</xref>, <xref rid="prp2721-bib-0103" ref-type="ref">
<sup>103</sup>
</xref>, <xref rid="prp2721-bib-0104" ref-type="ref">
<sup>104</sup>
</xref> Mutant animals are then mutagenized allowing enhancer or suppressor genes to be detected. For example, a suppressor screening recently performed on a hyperactive mutant in UNC&#x02010;2, the worm ortholog for calcium voltage&#x02010;gated channel subunit alpha 1A (CACNA1A) channel, has led to the identification of key modulators of channel function.<xref rid="prp2721-bib-0104" ref-type="ref">
<sup>104</sup>
</xref>
</p><p>Chemical genetic screening is another strategy which involves the use of drugs that induce a strong phenotype. After mutagenesis, which may affect the drug target gene or other genes involved in the same pathway, either resistant or hypersensitive mutants can be identified.<xref rid="prp2721-bib-0075" ref-type="ref">
<sup>75</sup>
</xref>, <xref rid="prp2721-bib-0105" ref-type="ref">
<sup>105</sup>
</xref>, <xref rid="prp2721-bib-0106" ref-type="ref">
<sup>106</sup>
</xref>, <xref rid="prp2721-bib-0107" ref-type="ref">
<sup>107</sup>
</xref>
</p><p>In <italic>C.&#x000a0;elegans</italic>, forward genetic screens have been traditionally used to identify molecular targets and MOAs for anthelmintic agents.<xref rid="prp2721-bib-0075" ref-type="ref">
<sup>75</sup>
</xref>, <xref rid="prp2721-bib-0076" ref-type="ref">
<sup>76</sup>
</xref>, <xref rid="prp2721-bib-0077" ref-type="ref">
<sup>77</sup>
</xref>, <xref rid="prp2721-bib-0108" ref-type="ref">
<sup>108</sup>
</xref> However, more recently, this approach has also proved to be useful for discovering targets and MOAs for drugs with potential relevance in metabolic, neurological, and oncological disorders.<xref rid="prp2721-bib-0068" ref-type="ref">
<sup>68</sup>
</xref>, <xref rid="prp2721-bib-0094" ref-type="ref">
<sup>94</sup>
</xref>, <xref rid="prp2721-bib-0109" ref-type="ref">
<sup>109</sup>
</xref>, <xref rid="prp2721-bib-0110" ref-type="ref">
<sup>110</sup>
</xref>, <xref rid="prp2721-bib-0111" ref-type="ref">
<sup>111</sup>
</xref>, <xref rid="prp2721-bib-0112" ref-type="ref">
<sup>112</sup>
</xref>
</p></sec><sec id="prp2721-sec-0005"><label>2.1.2</label><title>Reverse genetics</title><p>In 1998, Fire and Mello found that injection of double&#x02010;stranded RNA (dsRNA) into worm gonads allows gene knocking down in the progeny.<xref rid="prp2721-bib-0012" ref-type="ref">
<sup>12</sup>
</xref> Since then, RNAi knockdown has become a powerful tool in other animals and cultured cells.<xref rid="prp2721-bib-0113" ref-type="ref">
<sup>113</sup>
</xref>, <xref rid="prp2721-bib-0114" ref-type="ref">
<sup>114</sup>
</xref>, <xref rid="prp2721-bib-0115" ref-type="ref">
<sup>115</sup>
</xref> However, in <italic>C.&#x000a0;elegans</italic> it can be easily achieved by feeding worms with bacteria expressing dsRNA or just soaking worms in dsRNA solution. Therefore, this technique has served for functional analyses of a plethora of genes in worms.</p><p>Genomic RNAi bacterial feeding libraries that cover most of the <italic>C.&#x000a0;elegans</italic> genome have been generated,<xref rid="prp2721-bib-0116" ref-type="ref">
<sup>116</sup>
</xref>, <xref rid="prp2721-bib-0117" ref-type="ref">
<sup>117</sup>
</xref> avoiding the requirement of in vitro synthesis of dsRNA. <italic>C.&#x000a0;elegans</italic>, one of the few organisms for which genome&#x02010;wide RNAi screens are feasible, has been found to be a useful tool to identify genes involved in essential biological processes<xref rid="prp2721-bib-0002" ref-type="ref">
<sup>2</sup>
</xref>, <xref rid="prp2721-bib-0118" ref-type="ref">
<sup>118</sup>
</xref>, <xref rid="prp2721-bib-0119" ref-type="ref">
<sup>119</sup>
</xref>, <xref rid="prp2721-bib-0120" ref-type="ref">
<sup>120</sup>
</xref> and pathological conditions.<xref rid="prp2721-bib-0107" ref-type="ref">
<sup>107</sup>
</xref>, <xref rid="prp2721-bib-0121" ref-type="ref">
<sup>121</sup>
</xref>, <xref rid="prp2721-bib-0122" ref-type="ref">
<sup>122</sup>
</xref>
</p><p>A historical limitation of RNAi knock&#x02010;down in <italic>C.&#x000a0;elegans</italic> has been the poor penetrance of RNAi in neurons. However, several strategies have been developed to solve this caveat, namely strains expressing the transmembrane proteins required for RNAi transportation SID&#x02010;1 pan&#x02010;neuronally,<xref rid="prp2721-bib-0123" ref-type="ref">
<sup>123</sup>
</xref> strains deficient in genes coding for ribonuclease enzymes,<xref rid="prp2721-bib-0124" ref-type="ref">
<sup>124</sup>
</xref> neurons transformed to an immature and more permeable stage<xref rid="prp2721-bib-0125" ref-type="ref">
<sup>125</sup>
</xref> or even a combination of them.<xref rid="prp2721-bib-0126" ref-type="ref">
<sup>126</sup>
</xref>
</p><p>In the last decade, several customized endonucleases, such as zinc&#x02010;finger nucleases (ZFNs) and transcription activator&#x02010;like effector nucleases (TALENs),<xref rid="prp2721-bib-0127" ref-type="ref">
<sup>127</sup>
</xref>, <xref rid="prp2721-bib-0128" ref-type="ref">
<sup>128</sup>
</xref> have been used in genome editing. Other techniques, such as CRISPR/Cas9 and Mos&#x02010;1 single copy insertion that allow the introduction of almost any change in any gene, have also been developed, further widening the tool repertoire to perform reverse genetics in the nematode.<xref rid="prp2721-bib-0129" ref-type="ref">
<sup>129</sup>
</xref>, <xref rid="prp2721-bib-0130" ref-type="ref">
<sup>130</sup>
</xref>, <xref rid="prp2721-bib-0131" ref-type="ref">
<sup>131</sup>
</xref>
</p></sec></sec><sec id="prp2721-sec-0006"><label>2.2</label><title>Drug screening assays</title><p>Drug ingestion is probably the main way through which xenobiotic molecules can gain access to target tissues in wild&#x02010;type <italic>C.&#x000a0;elegans</italic>.<xref rid="prp2721-bib-0132" ref-type="ref">
<sup>132</sup>
</xref>, <xref rid="prp2721-bib-0133" ref-type="ref">
<sup>133</sup>
</xref> However, the amphids, a pair of anterior sensory structures opened to the outside environment, and the vulva are also involved in drug and nanoparticles intake, respectively.<xref rid="prp2721-bib-0134" ref-type="ref">
<sup>134</sup>
</xref>, <xref rid="prp2721-bib-0135" ref-type="ref">
<sup>135</sup>
</xref> Moreover, the use of animals that have a compromised cuticle can significantly increase drug absorption.<xref rid="prp2721-bib-0097" ref-type="ref">
<sup>97</sup>
</xref>
<italic>C.&#x000a0;elegans</italic> is typically grown in the laboratory on petri&#x02010;dishes containing NGM agar and <italic>E. coli</italic> as a food source. In the past, during the first drug screens, compounds were generally dissolved in the agar.<xref rid="prp2721-bib-0014" ref-type="ref">
<sup>14</sup>
</xref>, <xref rid="prp2721-bib-0136" ref-type="ref">
<sup>136</sup>
</xref> Although this method has contributed to the elucidation of MOAs for several compounds previously proven to be biologically active,<xref rid="prp2721-bib-0137" ref-type="ref">
<sup>137</sup>
</xref>, <xref rid="prp2721-bib-0138" ref-type="ref">
<sup>138</sup>
</xref> the agar&#x02010;based technique does not permit large scale screenings because it is labor&#x02010; and time&#x02010;consuming and needs large quantities of drugs.<xref rid="prp2721-bib-0014" ref-type="ref">
<sup>14</sup>
</xref> Even with limitations, these assays are still very valuable for assessing small compound libraries.<xref rid="prp2721-bib-0066" ref-type="ref">
<sup>66</sup>
</xref>
</p><p>The introduction of <italic>C.&#x000a0;elegans</italic> liquid cultures in multi&#x02010;well format together with workflow automation from worm transfer to data analysis enabled the development of HTS assays.<xref rid="prp2721-bib-0139" ref-type="ref">
<sup>139</sup>
</xref>, <xref rid="prp2721-bib-0140" ref-type="ref">
<sup>140</sup>
</xref> Moreover, the breakthrough of microfluidic devices for <italic>C.&#x000a0;elegans</italic> have improved the strength of HTS mainly thanks to the small amounts of compound (microscale) that are required and to the possibility of observing worms in parallel or in a serial manner.<xref rid="prp2721-bib-0141" ref-type="ref">
<sup>141</sup>
</xref>
</p></sec><sec id="prp2721-sec-0007"><label>2.3</label><title>Challenges of using <italic>C.&#x000a0;elegans</italic> model in drug discovery</title><p>In spite of the obvious advantages of using <italic>C.&#x000a0;elegans</italic> for drug screening, some caveats need to be considered. First, <italic>C.&#x000a0;elegans</italic> cultures require bacterial co&#x02010;culture as a food source. Many drugs and compounds are metabolized by bacteria and could alter drug efficacy. These limitations can be circumvented using killed bacteria as a food source.<xref rid="prp2721-bib-0142" ref-type="ref">
<sup>142</sup>
</xref>, <xref rid="prp2721-bib-0143" ref-type="ref">
<sup>143</sup>
</xref> However, feeding worms with dead bacteria can also affect some phenotypes (e.g., it slows worm development).<xref rid="prp2721-bib-0144" ref-type="ref">
<sup>144</sup>
</xref> Therefore, the chosen food source will depend on the phenotype to be assessed, the compounds to be tested, and the bacteria species to be used for worm feeding.<xref rid="prp2721-bib-0142" ref-type="ref">
<sup>142</sup>
</xref>, <xref rid="prp2721-bib-0145" ref-type="ref">
<sup>145</sup>
</xref>
</p><p>A second disadvantage is related to the thick <italic>C.&#x000a0;elegans</italic> cuticle that usually affects drug uptake. Some studies revealed that internal tested&#x02010;drug concentration could be less than half of that applied externally.<xref rid="prp2721-bib-0146" ref-type="ref">
<sup>146</sup>
</xref> This implies that some drugs are discarded as hits due to their inefficacy to pass through the cuticle barrier and that some compounds need very high drug concentrations to produce a biological effect. To reduce these limitations, mutant strains with compromised cuticles have been used to enhance drug uptake.<xref rid="prp2721-bib-0097" ref-type="ref">
<sup>97</sup>
</xref> The selection of these mutants depends on the trade&#x02010;off between enhanced cuticle permeability and animal fitness.<xref rid="prp2721-bib-0097" ref-type="ref">
<sup>97</sup>
</xref> Although <italic>C.&#x000a0;elegans</italic> cuticle impermeability is indeed a limitation, it increases the potential significance of a positive hit in specific drug screening assays. In line with this, hits in anthelmintic search assays that induce death in <italic>C.&#x000a0;elegans</italic> are extremely likely to kill parasitic nematodes (which in general have thinner cuticles) at lower concentrations.<xref rid="prp2721-bib-0068" ref-type="ref">
<sup>68</sup>
</xref>
</p><p>Finally, <italic>C.&#x000a0;elegans</italic> lacks a circulatory system and many vital organs present in mammals. It has an innate immune system but lacks an adaptive immune system or a myelination system. This is the reason why it is difficult to model diseases affecting these organs/systems in <italic>C.&#x000a0;elegans</italic>. In some cases, it is nonetheless possible to study a disease affecting a particular mammal organ nonexistent in the worm using phenologues. The latter are described as a group of overlapping genes defining a pathway that, when disrupted, cause different phenotypes in different species. For example, osteogenesis imperfecta (known as brittle bone disease) is caused by mutations in the human collagen COL1A1 and COL1A2 genes.<xref rid="prp2721-bib-0147" ref-type="ref">
<sup>147</sup>
</xref> Although <italic>C.&#x000a0;elegans</italic> lacks bones, it expresses collagen genes. When worm collagen genes are mutated, they lead to cuticle defects, easily showing recognized dumpy phenotypes.<xref rid="prp2721-bib-0148" ref-type="ref">
<sup>148</sup>
</xref> Thus, the dumpy phenotype can be used to perform screenings to study collagen&#x02010;associated diseases even in the absence of the affected tissue.</p><p>Additionally, even if a disease gene ortholog is not present in the worm, a disease model can be artificially generated by expressing human transgenes.<xref rid="prp2721-bib-0149" ref-type="ref">
<sup>149</sup>
</xref>, <xref rid="prp2721-bib-0150" ref-type="ref">
<sup>150</sup>
</xref> Transgenic animals are then used as tools to screen drugs or new genes involved in the disease phenotype with the goal of finding new therapeutic options. For example, mutations in &#x003b1;1&#x02010;antitrypsin (AT) lead to lung and liver diseases.<xref rid="prp2721-bib-0151" ref-type="ref">
<sup>151</sup>
</xref>, <xref rid="prp2721-bib-0152" ref-type="ref">
<sup>152</sup>
</xref> Although <italic>C.&#x000a0;elegans</italic> has no orthologs for AT, transgenic expression of human AT gene in worms can replicate in the animal intestine the abnormal misfolded protein accumulation observed in patients&#x000b4; livers. A drug screen performed using this model allowed to detect drugs capable of decreasing misfolded protein accumulation.<xref rid="prp2721-bib-0035" ref-type="ref">
<sup>35</sup>
</xref>
</p></sec></sec><sec id="prp2721-sec-0008"><label>3</label><title>RELEVANT <italic>C.&#x000a0;elegans</italic> APPLICATIONS FOR DRUG TARGET DISCOVERIES</title><p>As illustrative examples of the use of <italic>C.&#x000a0;elegans</italic> model in pharmacology research, we will discuss findings that show the advantages of using this nematode in the drug discovery field.</p><sec id="prp2721-sec-0009"><label>3.1</label><title>Neurodegenerative diseases</title><p>As a result of the continuous increase in the proportion of the elderly population, age&#x02010;related disorders have become a major health concern. Neurodegenerative diseases (NDs), in particular, such as Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD), are considered as top ten lethal illnesses (G7 Academies&#x000b4;Joint Statements 2017). Despite their growing incidence worldwide and decades of intense research, there is still neither a cure nor a set of effect&#x02010;mitigation strategies for these diseases. Research efforts are currently aimed at precluding or&#x02014;at least&#x02014;delaying their progression. The discovery of curative treatments for the majority of these NDs remains elusive due to several factors. NDs are heterogeneous in etiology (while some of them have a genetic or hereditary origin, others have no related cause). They are also heterogeneous in the collection of neurons affected, leading to an assortment of clinical manifestations ranging from cognitive to progressive motor dysfunction.<xref rid="prp2721-bib-0153" ref-type="ref">
<sup>153</sup>
</xref> They nonetheless share some pathological hallmarks. For example, aging is a strong risk factor related to their development.<xref rid="prp2721-bib-0154" ref-type="ref">
<sup>154</sup>
</xref> Moreover, the abnormal formation and deposition of misfolded protein aggregates in specific neurons is a trademark of most NDs. Because of this attribute, these disorders are generally referred to as &#x0201c;proteinopathies.&#x0201d; Therefore, current research is focused on the above&#x02010;mentioned common features by targeting pathological aggregation or by delaying physiological aging.<xref rid="prp2721-bib-0155" ref-type="ref">
<sup>155</sup>
</xref>
</p><p>In this respect, <italic>C.&#x000a0;elegans</italic> is a powerful in vivo model for the development of targeted therapeutics. Most of the advantages that convert this animal into a superb candidate for drug discovery have already been mentioned in this review and are also applicable to the neurodegeneration research field. Still, there are some topics that deserve special attention. Features that confer <italic>C.&#x000a0;elegans</italic> an extra value as a model for age&#x02010;related proteinopathies research include, among others: (i) the remarkable similarities at the molecular and cellular levels between nematode and vertebrate neurons, (ii) the continuous design of mutant and transgenic <italic>C.&#x000a0;elegans</italic> models of human NDs,<xref rid="prp2721-bib-0082" ref-type="ref">
<sup>82</sup>
</xref>, <xref rid="prp2721-bib-0156" ref-type="ref">
<sup>156</sup>
</xref>, <xref rid="prp2721-bib-0157" ref-type="ref">
<sup>157</sup>
</xref>, <xref rid="prp2721-bib-0158" ref-type="ref">
<sup>158</sup>
</xref>, <xref rid="prp2721-bib-0159" ref-type="ref">
<sup>159</sup>
</xref>, <xref rid="prp2721-bib-0160" ref-type="ref">
<sup>160</sup>
</xref>, <xref rid="prp2721-bib-0161" ref-type="ref">
<sup>161</sup>
</xref> (iii) the thoroughly studied whole&#x02010;animal neuronal connectome which can be individually visualized using fluorescent reporters in the living transparent worm,<xref rid="prp2721-bib-0011" ref-type="ref">
<sup>11</sup>
</xref>, <xref rid="prp2721-bib-0021" ref-type="ref">
<sup>21</sup>
</xref>, <xref rid="prp2721-bib-0022" ref-type="ref">
<sup>22</sup>
</xref>, <xref rid="prp2721-bib-0162" ref-type="ref">
<sup>162</sup>
</xref> (iv) its short and genetically tractable lifespan,<xref rid="prp2721-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>, <xref rid="prp2721-bib-0163" ref-type="ref">
<sup>163</sup>
</xref>, <xref rid="prp2721-bib-0164" ref-type="ref">
<sup>164</sup>
</xref>, <xref rid="prp2721-bib-0165" ref-type="ref">
<sup>165</sup>
</xref>, <xref rid="prp2721-bib-0166" ref-type="ref">
<sup>166</sup>
</xref> and (v) the recently developed high&#x02010;throughput (even automatized) drug screening platforms.<xref rid="prp2721-bib-0035" ref-type="ref">
<sup>35</sup>
</xref>, <xref rid="prp2721-bib-0054" ref-type="ref">
<sup>54</sup>
</xref>, <xref rid="prp2721-bib-0167" ref-type="ref">
<sup>167</sup>
</xref>, <xref rid="prp2721-bib-0168" ref-type="ref">
<sup>168</sup>
</xref>, <xref rid="prp2721-bib-0169" ref-type="ref">
<sup>169</sup>
</xref>, <xref rid="prp2721-bib-0170" ref-type="ref">
<sup>170</sup>
</xref>, <xref rid="prp2721-bib-0171" ref-type="ref">
<sup>171</sup>
</xref>, <xref rid="prp2721-bib-0172" ref-type="ref">
<sup>172</sup>
</xref>, <xref rid="prp2721-bib-0173" ref-type="ref">
<sup>173</sup>
</xref> However, the limitations on using a &#x0201c;humanized&#x0201d; worm model for neurodegenerative proteinopathies should be taken into account, particularly its simple nervous system, glia and lack of myelin. Furthermore, genes encoding for voltage&#x02010;gated sodium channels are absent in the <italic>C.&#x000a0;elegans</italic> genome.<xref rid="prp2721-bib-0174" ref-type="ref">
<sup>174</sup>
</xref> Unlike vertebrates, the action potentials detected in muscles and neurons of <italic>C.&#x000a0;elegans</italic> depend on voltage&#x02010;gated calcium channels.<xref rid="prp2721-bib-0175" ref-type="ref">
<sup>175</sup>
</xref>, <xref rid="prp2721-bib-0176" ref-type="ref">
<sup>176</sup>
</xref>, <xref rid="prp2721-bib-0177" ref-type="ref">
<sup>177</sup>
</xref> Despite these caveats, <italic>C.&#x000a0;elegans</italic> is an excellent whole&#x02010;animal platform to identify genes, drug targets, and compounds with neuroprotective roles in human NDs.</p><sec id="prp2721-sec-0010"><label>3.1.1</label><title>
<italic>C.&#x000a0;elegans</italic> models for ND</title><p>The first <italic>C.&#x000a0;elegans</italic> model of a human ND was built 25&#x000a0;years ago,<xref rid="prp2721-bib-0178" ref-type="ref">
<sup>178</sup>
</xref> and, since then, an extensive list of animal models for most of the NDs have been generated (Table&#x000a0;<xref rid="prp2721-tbl-0003" ref-type="table">3</xref>). The methods that are regularly used include knocking&#x02010;down or &#x02010;out the homologous gene involved in the human disease if it is present in the worm genome or, if there is no orthologous, the method of choice involves the transgenic expression of the human gene to mimic a disease&#x02010;related phenotype. Most of the <italic>C.&#x000a0;elegans</italic> models of human NDs are transgenic strains developed by overexpression of human wild&#x02010;type or disease&#x02010;associated mutant genes. However, overexpressing genes, even as wild&#x02010;type, sometimes results in an artificial condition that can be pathogenic. CRISP/Cas9 technology has been fortunately established in <italic>C.&#x000a0;elegans</italic>
<xref rid="prp2721-bib-0179" ref-type="ref">
<sup>179</sup>
</xref> and recent single&#x02010;copy knock&#x02010;in models of some NDs have been developed (Table&#x000a0;<xref rid="prp2721-tbl-0003" ref-type="table">3</xref>).<xref rid="prp2721-bib-0180" ref-type="ref">
<sup>180</sup>
</xref>, <xref rid="prp2721-bib-0181" ref-type="ref">
<sup>181</sup>
</xref>, <xref rid="prp2721-bib-0182" ref-type="ref">
<sup>182</sup>
</xref>
</p><table-wrap id="prp2721-tbl-0003" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 3</label><caption><p>List of the main <italic>C.&#x000a0;elegans</italic> models of ND, employed for the understanding of disease molecular mechanisms and for performing genetic and pharmacologic screenings</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Model of</th><th align="left" valign="top" rowspan="1" colspan="1">Strategy</th><th align="left" valign="top" rowspan="1" colspan="1">Expression</th><th align="left" valign="top" rowspan="1" colspan="1">Transgene</th><th align="left" valign="top" rowspan="1" colspan="1">Phenotype</th></tr></thead><tbody><tr><td align="left" rowspan="5" colspan="1">HD</td><td align="left" rowspan="2" colspan="1">polyQ expression</td><td align="left" rowspan="1" colspan="1">Constitutive muscle</td><td align="left" rowspan="1" colspan="1">P<italic>unc</italic>&#x02010;<italic>54</italic>::<italic>polyQ</italic>&#x02010;<italic>yfp</italic>
</td><td align="left" rowspan="1" colspan="1">Age&#x02010;dependent aggregation and motility defects<xref rid="prp2721-bib-0082" ref-type="ref">
<sup>82</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Constitutive pan&#x02010;neuronal</td><td align="left" rowspan="1" colspan="1">P<italic>rgef</italic>&#x02010;<italic>1</italic>::<italic>polyQ</italic>&#x02010;<italic>yfp</italic>
</td><td align="left" rowspan="1" colspan="1">Age&#x02010;dependent aggregation and neuronal dysfunction like trashing and pharyngeal pumping<xref rid="prp2721-bib-0083" ref-type="ref">
<sup>83</sup>
</xref>
</td></tr><tr><td align="left" rowspan="3" colspan="1">polyQ&#x02010;HTT expression</td><td align="left" rowspan="1" colspan="1">Constitutive muscle</td><td align="left" rowspan="1" colspan="1">
<italic>Punc&#x02010;54::htt513Q128::yfp</italic>
</td><td align="left" rowspan="1" colspan="1">Age&#x02010;dependent aggregation and motility defects<xref rid="prp2721-bib-0183" ref-type="ref">
<sup>183</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Chemosensory neurons</td><td align="left" rowspan="1" colspan="1">P<italic>osm</italic>&#x02010;<italic>10</italic>::<italic>gfp</italic>+P<italic>osm</italic>&#x02010;<italic>10</italic>::<italic>httQ150</italic>+<italic>dpy</italic>&#x02212;<italic>20(</italic>+<italic>)</italic>
</td><td align="left" rowspan="1" colspan="1">Accelerated ASH neuronal degeneration<xref rid="prp2721-bib-0184" ref-type="ref">
<sup>184</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mechanosensory neurons</td><td align="left" rowspan="1" colspan="1">P<italic>mec</italic>&#x02010;<italic>3</italic>::<italic>htt57Q128</italic>::<italic>cfp</italic>+<italic>Pmec3</italic>::<italic>yfp</italic>
</td><td align="left" rowspan="1" colspan="1">Aggregated polyQ, morphological abnormalities and dysfunction of mechanosensory neurons<xref rid="prp2721-bib-0185" ref-type="ref">
<sup>185</sup>
</xref>
</td></tr><tr><td align="left" rowspan="6" colspan="1">AD</td><td align="left" rowspan="4" colspan="1">human A&#x003b2; expression</td><td align="left" rowspan="1" colspan="1">Constitutive muscle</td><td align="left" rowspan="1" colspan="1">P<italic>unc</italic>&#x02010;<italic>54</italic>::<italic>A&#x003b2;<sub>1</sub></italic>
<sub>&#x02010;</sub>
<italic><sub>42</sub></italic>
</td><td align="left" rowspan="1" colspan="1">Age&#x02010;dependent aggregation and paralysis<xref rid="prp2721-bib-0178" ref-type="ref">
<sup>178</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Temperature&#x02010;induced muscle</td><td align="left" rowspan="1" colspan="1">
<italic>smg</italic>&#x02010;<italic>1(cc546)</italic>;<italic>Is[</italic>Pmyo&#x02010;3::<italic>A&#x003b2;<sub>1</sub></italic>
<sub>&#x02010;</sub>
<italic><sub>42</sub></italic>::<italic>letUTR</italic>+<italic>rol6(su1006)]</italic>
</td><td align="left" rowspan="1" colspan="1">Rapid paralysis by temperature upshift<xref rid="prp2721-bib-0186" ref-type="ref">
<sup>186</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Constitutive pan&#x02010;neuronal</td><td align="left" rowspan="1" colspan="1">P<italic>myo</italic>&#x02010;<italic>2</italic>::<italic>yfp</italic>+P<italic>unc</italic>&#x02010;<italic>119</italic>::<italic>A&#x003b2;<sub>1</sub></italic>
<sub>&#x02010;</sub>
<italic><sub>42</sub></italic>
</td><td align="left" rowspan="1" colspan="1">Impaired locomotion and chemotaxis behavior<xref rid="prp2721-bib-0187" ref-type="ref">
<sup>187</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Temperature&#x02010;induced pan&#x02010;neuronal</td><td align="left" rowspan="1" colspan="1">
<italic>smg&#x02010;1(cc546);Is[snb&#x02010;1::A&#x003b2;<sub>1&#x02010;42</sub>+mtl&#x02010;2::gfp]</italic>
</td><td align="left" rowspan="1" colspan="1">Defective chemotaxis, formation of amyloid deposits, and serotonin hypersensitivity<xref rid="prp2721-bib-0188" ref-type="ref">
<sup>188</sup>
</xref>
</td></tr><tr><td align="left" rowspan="2" colspan="1">human Tau expression</td><td align="left" rowspan="1" colspan="1">Constitutive pan&#x02010;neuronal</td><td align="left" rowspan="1" colspan="1">P<italic>aex&#x02010;3::h4R1NTau WT, V337M and P301L</italic>
</td><td align="left" rowspan="1" colspan="1">Insoluble tau accumulation, neurodegeneration and uncoordinated movement (Unc)<xref rid="prp2721-bib-0189" ref-type="ref">
<sup>189</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Single copy knock&#x02010;in in mechanosensory neurons</td><td align="left" rowspan="1" colspan="1">Single copy human Tau mutants (T231E and K274/281Q)</td><td align="left" rowspan="1" colspan="1">Diminished touch response and neuronal morphological abnormalities<xref rid="prp2721-bib-0190" ref-type="ref">
<sup>190</sup>
</xref>
</td></tr><tr><td align="left" rowspan="4" colspan="1">PD</td><td align="left" rowspan="3" colspan="1">&#x003b1;&#x02010;synuclein expression</td><td align="left" rowspan="1" colspan="1">Constitutive muscle</td><td align="left" rowspan="1" colspan="1">P<italic>unc&#x02010;54::&#x003b1;&#x02010;syn::yfp+unc&#x02010;119(+)</italic>
</td><td align="left" rowspan="1" colspan="1">Motility deficits and &#x003b1;&#x02010;syn aggregation<xref rid="prp2721-bib-0005" ref-type="ref">
<sup>5</sup>
</xref>, <xref rid="prp2721-bib-0159" ref-type="ref">
<sup>159</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Constitutive pan&#x02010;neuronal</td><td align="left" rowspan="1" colspan="1">P<italic>aex&#x02010;3::&#x003b1;&#x02010;syn (WT, A53T)+Paex&#x02010;3::gfp/Pdat&#x02010;1::gfp</italic>
</td><td align="left" rowspan="1" colspan="1">Motility deficits, significant dopaminergic neuron loss<xref rid="prp2721-bib-0158" ref-type="ref">
<sup>158</sup>
</xref>, <xref rid="prp2721-bib-0191" ref-type="ref">
<sup>191</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Constitutive dopaminergic neurons</td><td align="left" rowspan="1" colspan="1">P<italic>dat&#x02010;1::&#x003b1;&#x02010;syn (WT, A53T)+Pdat&#x02010;1::gfp</italic>
</td><td align="left" rowspan="1" colspan="1">Dopaminergic neuronal loss and dendritic breaks, &#x003b1;&#x02010;syn accumulation<xref rid="prp2721-bib-0158" ref-type="ref">
<sup>158</sup>
</xref>, <xref rid="prp2721-bib-0192" ref-type="ref">
<sup>192</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurotoxin&#x02010;induced</td><td align="left" rowspan="1" colspan="1">Dopaminergic neurons</td><td align="left" rowspan="1" colspan="1">[P<italic>dat&#x02010;1::gfp</italic>] subject to 6&#x02010;OHDA or MPTP</td><td align="left" rowspan="1" colspan="1">Morphological dopaminergic neuronal defects<xref rid="prp2721-bib-0193" ref-type="ref">
<sup>193</sup>
</xref>
</td></tr><tr><td align="left" rowspan="8" colspan="1">ALS</td><td align="left" rowspan="4" colspan="1">SOD&#x02010;1 models</td><td align="left" rowspan="1" colspan="1">Temperature&#x02010;induced muscle</td><td align="left" rowspan="1" colspan="1">P<italic>hsp&#x02010;16.2::sod&#x02010;1</italic> (WT, A4V, G37R, G93A)&#x000a0;+&#x000a0;P<italic>myo&#x02010;3::sod&#x02010;1</italic> (WT, A4V)::GFP +rol&#x02010;6(su1006)</td><td align="left" rowspan="1" colspan="1">Increased sensitivity to oxidative stress, and oxidative stress induced&#x02010; SOD&#x02010;1 aggregation<xref rid="prp2721-bib-0194" ref-type="ref">
<sup>194</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Constitutive muscle</td><td align="left" rowspan="1" colspan="1">P<italic>unc&#x02010;54::sod=1</italic>(WT, G85R, G93A, G127insTGGGstop)::<italic>yfp</italic>
</td><td align="left" rowspan="1" colspan="1">Aggregation of mutant SOD&#x02010;1 and motility defects<xref rid="prp2721-bib-0195" ref-type="ref">
<sup>195</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Constitutive pan&#x02010;neuronal</td><td align="left" rowspan="1" colspan="1">P<italic>snb&#x02010;1::sod&#x02010;1</italic>(WT, G85R)::<italic>yfp)</italic>
</td><td align="left" rowspan="1" colspan="1">Aggregation of mutant SOD&#x02010;1 and motility defects<xref rid="prp2721-bib-0196" ref-type="ref">
<sup>196</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Single copy knock&#x02010;in</td><td align="left" rowspan="1" colspan="1">Single copy knock&#x02010;in expression of mutants forms of <italic>sod&#x02010;1</italic> (A4V, H71Y, L84V, G85R, G93A)</td><td align="left" rowspan="1" colspan="1">Aggregation of mutant SOD&#x02010;1 and oxidative stress induced neurodegeneration<xref rid="prp2721-bib-0180" ref-type="ref">
<sup>180</sup>
</xref>
</td></tr><tr><td align="left" rowspan="2" colspan="1">TPD&#x02010;43 models</td><td align="left" rowspan="1" colspan="1">Constitutive pan&#x02010;neuronal</td><td align="left" rowspan="1" colspan="1">P<italic>snb&#x02010;1::tdp&#x02010;43</italic> (WT, G290A, A315T, M337V)+<italic>snb&#x02010;1::gfp</italic>
</td><td align="left" rowspan="1" colspan="1">Uncoordinated movement and GABAergic motor neuron degeneration<xref rid="prp2721-bib-0197" ref-type="ref">
<sup>197</sup>
</xref>, <xref rid="prp2721-bib-0198" ref-type="ref">
<sup>198</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Constitutive GABAergic motor neurons</td><td align="left" rowspan="1" colspan="1">P<italic>unc&#x02010;47::tpd&#x02010;43</italic> (WT, A315T)</td><td align="left" rowspan="1" colspan="1">Age&#x02010;dependent motility defects and neuronal degeneration<xref rid="prp2721-bib-0199" ref-type="ref">
<sup>199</sup>
</xref>
</td></tr><tr><td align="left" rowspan="2" colspan="1">FUS models</td><td align="left" rowspan="1" colspan="1">Constitutive pan&#x02010;neuronal</td><td align="left" rowspan="1" colspan="1">P<italic>rgef&#x02010;1::fus</italic> (WT, R514G, R521G, R522G, R524S, P525L)</td><td align="left" rowspan="1" colspan="1">Aggregation and paralysis<xref rid="prp2721-bib-0200" ref-type="ref">
<sup>200</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Single copy knock&#x02010;in</td><td align="left" rowspan="1" colspan="1">Single&#x02010;copy knock&#x02010;in of R524S and P525L equivalent mutations into fust&#x02010;1 (FUS orthologous gene)</td><td align="left" rowspan="1" colspan="1">Impaired neuronal and muscular autophagy<xref rid="prp2721-bib-0181" ref-type="ref">
<sup>181</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot id="prp2721-ntgp-0003"><fn id="prp2721-note-0003"><p>Abbreviations: ALS, Amyotrophic lateral sclerosis; a&#x02010;syn, a&#x02010;synuclein; FUS, RNA&#x02010;binding protein Fused in Sarcoma; HTT, huntingtin; MPTP, 1&#x02010;methyl&#x02010;4&#x02010;phenyl&#x02010;1,2,3,6&#x02010;tetrahydropyridine;6&#x02010;OHDA, 6&#x02010;hydroxydopamine; polyQ, polyglutamine; SOD&#x02010;1, superoxide dismutase 1; TPD&#x02010;43, Transactive response DNA&#x02010;binding protein&#x02010;43.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Since <italic>C.&#x000a0;elegans</italic> has no orthologous gene for &#x003b2;&#x02010;amyloid (A&#x003b2;), &#x003b1;&#x02010;synuclein, or huntingtin, models of NDs have been essentially produced by transgenic overexpression of the disease causing&#x02010;protein in either body&#x02010;wall muscle cells, in all neurons or in a specific subset of neurons.<xref rid="prp2721-bib-0082" ref-type="ref">
<sup>82</sup>
</xref>, <xref rid="prp2721-bib-0083" ref-type="ref">
<sup>83</sup>
</xref>, <xref rid="prp2721-bib-0150" ref-type="ref">
<sup>150</sup>
</xref>, <xref rid="prp2721-bib-0158" ref-type="ref">
<sup>158</sup>
</xref>, <xref rid="prp2721-bib-0178" ref-type="ref">
<sup>178</sup>
</xref>, <xref rid="prp2721-bib-0195" ref-type="ref">
<sup>195</sup>
</xref>, <xref rid="prp2721-bib-0197" ref-type="ref">
<sup>197</sup>
</xref>, <xref rid="prp2721-bib-0201" ref-type="ref">
<sup>201</sup>
</xref> In most cases, the protein is tagged with GFP, which permits monitoring protein aggregation in whole live animals. Furthermore, according to the promoter used, that is, either muscle or neuronal promoters, toxic protein aggregation is reflected by specific pronounced phenotypes which are indispensable for high&#x02010;throughput screenings. For instance, muscle&#x02010;expressing strains usually manifest proteotoxicity as age&#x02010;dependent locomotion defects. In addition, muscle cells are large, allowing the visualization of protein aggregation more easily than in neurons. Moreover, RNAi is more efficient in muscles than in neurons, making these models more amenable for RNAi screens. On the other hand, transgenic strains with neuronal expression of protein aggregates are more accurate models of NDs. In the latter, proteotoxicity can be assessed by means of indirect phenotypes, such as neurodegeneration or specific morphological and/or behavioral neuronal defects. Thus, according to the selected strain, different read&#x02010;outs have been described, which can be used in HTS with the aim to evaluate genes and drug modifiers as potential therapeutic interventions.</p><p>Genetic and pharmacological screenings have been performed in these models by tracking protein aggregation and assessing a simple phenotype (such as locomotion or neuronal behavior defects) in whole&#x02010;live animals. In fact, large RNAi&#x02010;mediated reverse screens, performed in <italic>C.&#x000a0;elegans</italic> models of NDs, have identified gene modifiers of protein homeostasis, including genes with roles in protein synthesis, folding, degradation, and vesicle trafficking.<xref rid="prp2721-bib-0003" ref-type="ref">
<sup>3</sup>
</xref>, <xref rid="prp2721-bib-0005" ref-type="ref">
<sup>5</sup>
</xref>, <xref rid="prp2721-bib-0159" ref-type="ref">
<sup>159</sup>
</xref>, <xref rid="prp2721-bib-0202" ref-type="ref">
<sup>202</sup>
</xref>, <xref rid="prp2721-bib-0203" ref-type="ref">
<sup>203</sup>
</xref>, <xref rid="prp2721-bib-0204" ref-type="ref">
<sup>204</sup>
</xref>, <xref rid="prp2721-bib-0205" ref-type="ref">
<sup>205</sup>
</xref> Forward mutagenesis genetic screens have also been developed in these models. For example, a study using a <italic>C.&#x000a0;elegans</italic> model of HD identified a novel gene, called modifier of aggregation 4 (<italic>moag</italic>&#x02010;<italic>4</italic>) as an enhancer of protein aggregation.<xref rid="prp2721-bib-0206" ref-type="ref">
<sup>206</sup>
</xref> Pharmacological screenings have also contributed with hundreds of neuroprotective compounds, classified in a wide range of categories, including natural and synthetic products, herbal medicines, and also FDA&#x02010;approved drugs (Table&#x000a0;<xref rid="prp2721-tbl-0001" ref-type="table">1</xref>). These findings highlight the strength of <italic>C.&#x000a0;elegans</italic> in finding novel genetic and drug modifiers for human NDs, reinforcing its potential in preclinical drug discovery.</p><p>Despite the complexity of the pathology underlying NDs, most of the pathways involved are conserved or they can be mimicked in the worm. The aim of using <italic>C.&#x000a0;elegans</italic> as a platform of NDs is to dig inside molecular mechanisms to unravel pathological features and to develop effective strategies to treat these diseases.</p></sec></sec><sec id="prp2721-sec-0011"><label>3.2</label><title>
<italic>C.&#x000a0;elegans</italic> as model of parasite nematodes</title><p>Parasitic nematodes infect a wide range of species, including humans, companion animals, livestock, and crops producing a devastating impact on human life quality and economy. The World Health Organization (WHO) claims that helminth infections are the most common neglected tropical diseases and estimates that 30% of the human world population is infected with at least one parasite (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/neglected_diseases/en/">https://www.who.int/neglected_diseases/en/</ext-link>). This prevalence could be even higher in rural areas and in low&#x02010;income countries. Although helminth infections are, in general, not lethal, human helminthiases are associated with morbidity. The consequences are particularly serious in children, impairing growth, nutrition, cognition, and school performance.</p><p>Several issues are of concern in relation to helminthiasis management and treatment, namely (i) the loss of effectiveness caused by parasite resistance, (ii) the environmental impact of drugs used for crop protection, and (iii) the lack of interest in this field by the pharmaceutical industry.</p><p>The development of novel pharmacological agents for helminthiasis treatment has been delayed for decades and the repertoire of available anthelmintics is limited.<xref rid="prp2721-bib-0077" ref-type="ref">
<sup>77</sup>
</xref>, <xref rid="prp2721-bib-0207" ref-type="ref">
<sup>207</sup>
</xref>, <xref rid="prp2721-bib-0208" ref-type="ref">
<sup>208</sup>
</xref> Since drug&#x02010;resistant parasitic nematodes have been reported for all classes of currently used anthelmintics,<xref rid="prp2721-bib-0209" ref-type="ref">
<sup>209</sup>
</xref>, <xref rid="prp2721-bib-0210" ref-type="ref">
<sup>210</sup>
</xref>, <xref rid="prp2721-bib-0211" ref-type="ref">
<sup>211</sup>
</xref>, <xref rid="prp2721-bib-0212" ref-type="ref">
<sup>212</sup>
</xref>, <xref rid="prp2721-bib-0213" ref-type="ref">
<sup>213</sup>
</xref> there is an urgent need to advance in pharmacological research to develop new antiparasitic drugs.</p><p>Due to their complex life cycles, growing and maintaining parasitic nematodes under standard laboratory conditions are both challenging. The limited molecular genetic tools available for these nematodes hampers the study of molecular mechanisms.<xref rid="prp2721-bib-0214" ref-type="ref">
<sup>214</sup>
</xref> It has been shown that compounds that induce <italic>C.&#x000a0;elegans</italic> death likely also kill parasitic nematodes,<xref rid="prp2721-bib-0068" ref-type="ref">
<sup>68</sup>
</xref> highlighting the potential of this worm as an anthelmintic screening platform (Table&#x000a0;<xref rid="prp2721-tbl-0001" ref-type="table">1</xref>).<xref rid="prp2721-bib-0039" ref-type="ref">
<sup>39</sup>
</xref>, <xref rid="prp2721-bib-0215" ref-type="ref">
<sup>215</sup>
</xref>, <xref rid="prp2721-bib-0216" ref-type="ref">
<sup>216</sup>
</xref>
</p><sec id="prp2721-sec-0012"><label>3.2.1</label><title>Current use of <italic>C.&#x000a0;elegans</italic> in anthelmintic drug discovery</title><p>In the past, <italic>C.&#x000a0;elegans</italic> was used to dissect the target pathways and molecular mechanisms of known anthelmintics, such as levamisole, ivermectin, benzimidazoles, nitazoxanide, and amino&#x02010;acetonitrile derivatives.<xref rid="prp2721-bib-0075" ref-type="ref">
<sup>75</sup>
</xref>, <xref rid="prp2721-bib-0077" ref-type="ref">
<sup>77</sup>
</xref>, <xref rid="prp2721-bib-0078" ref-type="ref">
<sup>78</sup>
</xref>, <xref rid="prp2721-bib-0108" ref-type="ref">
<sup>108</sup>
</xref>, <xref rid="prp2721-bib-0217" ref-type="ref">
<sup>217</sup>
</xref>, <xref rid="prp2721-bib-0218" ref-type="ref">
<sup>218</sup>
</xref>, <xref rid="prp2721-bib-0219" ref-type="ref">
<sup>219</sup>
</xref> Nowadays, it is a recognized platform to screen new compounds and drug repurposing<xref rid="prp2721-bib-0220" ref-type="ref">
<sup>220</sup>
</xref> that must be subsequently tested in parasites. Many of the currently used anthelmintics are imidazole derivatives.<xref rid="prp2721-bib-0221" ref-type="ref">
<sup>221</sup>
</xref> In general, the mechanisms underlying the anthelmintic effect can induce worm death or generate paralysis to facilitate parasite expulsion. The anthelmintic mechanisms of imidazole&#x02010;derivatives are diverse. For example, levamisole causes nematode spastic paralysis through the potent activation of a muscle nicotinic receptor (AChR)<xref rid="prp2721-bib-0218" ref-type="ref">
<sup>218</sup>
</xref>, <xref rid="prp2721-bib-0222" ref-type="ref">
<sup>222</sup>
</xref>, <xref rid="prp2721-bib-0223" ref-type="ref">
<sup>223</sup>
</xref>, <xref rid="prp2721-bib-0224" ref-type="ref">
<sup>224</sup>
</xref>, <xref rid="prp2721-bib-0225" ref-type="ref">
<sup>225</sup>
</xref> whereas the anthelmintic action of benzimidazoles (e.g., albendazole and mebendazole) arises from their capacity to block tubulin polymerization in nematode cells.<xref rid="prp2721-bib-0078" ref-type="ref">
<sup>78</sup>
</xref> Thus, while the presence of the imidazole ring appears to be important for bioactivity, it does not restrict the molecular targets where imidazole&#x02010;containing anthelmintics can act. Recently, taking advantage of <italic>C.&#x000a0;elegans</italic> as an established model for parasitic nematodes, we screened the nematicidal potential of novel imidazolium and imidazole derivatives.<xref rid="prp2721-bib-0066" ref-type="ref">
<sup>66</sup>
</xref> We identified a new compound, diisopropylphenyl&#x02010;imidazole (DII), that is lethal to <italic>C.&#x000a0;elegans</italic> through a novel mode of action that includes differential targeting in larvae and adult nematodes. This lethal effect appears to be specific for nematodes because at DII concentrations, proven to be toxic to <italic>C.&#x000a0;elegans</italic>, no significant lethality on bacteria, <italic>Drosophila melanogaster</italic> and HEK&#x02010;293 cells has been detected. Using <italic>C.&#x000a0;elegans</italic> mutant and transgenic strains, we found that DII effects on adult nematodes rely on a previously unidentified UNC&#x02010;29&#x02010;containing muscle AChR, different from the classical Levamisole&#x02010;sensitive AChR. Interestingly, DII targets appear to be different between larvae and adults as <italic>unc</italic>&#x02010;<italic>29</italic> null mutant larvae are sensitive to the drug.<xref rid="prp2721-bib-0066" ref-type="ref">
<sup>66</sup>
</xref> Summing up, using the model <italic>C.&#x000a0;elegans</italic> we demonstrated that DII fulfills the major criteria necessary for the development of a novel anthelmintic, namely phylogenetic specificity and a novel biochemical mode of action. The next step will be to expose parasite worms to this already characterized drug.</p><p>Other researchers performed a screen of a small&#x02010;molecule library using <italic>C.&#x000a0;elegans</italic> to test the anthelmintic activity of FDA&#x02010;approved drugs with the aim of repurposing their clinical activity.<xref rid="prp2721-bib-0226" ref-type="ref">
<sup>226</sup>
</xref> The availability of data on their toxicity and pharmacokinetic characteristics will expedite its potential use for new therapeutic indications. From this screen, they found that the neuromodulatory drugs sertraline, paroxetine, and chlorpromazine kill <italic>C.&#x000a0;elegans</italic> at multiple life stages and inhibit worm feeding. <italic>C.&#x000a0;elegans</italic> mutants with resistance to known anthelmintic drugs are as sensitive as wild&#x02010;type worms to these three drugs, suggesting that they may act through novel targets. They also demonstrated that these drugs affect divergent parasitic helminth species, such as <italic>Trichuris muris</italic> and <italic>Ancylostoma caninum</italic> and the trematode <italic>Schistosoma mansoni</italic>. These researchers therefore conclude that these drugs may represent a new class of anthelmintic drugs that could be used in combination with classic anthelmintics to boost effectiveness as well as to avoid parasite drug resistance.</p><p>As a result of the limited repertoire of available anthelmintics and the alarming emergence of anthelmintic resistance, there is an urgent need to develop novel anthelmintics. <italic>C.&#x000a0;elegans</italic> becomes a useful platform to accelerate the screening process for anthelmintic drug discovery. The use of <italic>C.&#x000a0;elegans</italic> can permit the development of new parasite control strategies by identifying new drugs with better and broad&#x02010;spectrum, repurpose already approved drugs, and combine different therapeutic options.</p></sec></sec></sec><sec sec-type="conclusions" id="prp2721-sec-0013"><label>4</label><title>CONCLUSIONS</title><p>Traditional preclinical drug discovery is a complex process that takes more than 10&#x000a0;years. Today, innovative strategies are required to satisfy both the increasing demand for better and more efficient therapies and the need to save resources and time for drug development. Under this scenario, the use of invertebrate animals, such as the nematode <italic>C.&#x000a0;elegans</italic>, during the early phases of drug development becomes a very convenient strategy to achieve these two aims. Since the introduction of <italic>C.&#x000a0;elegans</italic> into research studies, this nematode has been extensively used to understand fundamental biological processes. During the last years, <italic>C.&#x000a0;elegans</italic> has also become an invaluable tool for the screening of compounds with potential therapeutic uses. This nematode is probably the best cost&#x02010;effective choice for early target validation scheme among animal models. Primary hits could be identified in <italic>C elegans</italic> as an initial filter. The efficacy and safety information gathered by the use of this nematode, significantly reduce costs, time, and the number of vertebrate animals required.</p><p>In this review, we have outlined several attributes that highlight the strength of <italic>C.&#x000a0;elegans</italic> as a model for drug screening, drug repurposing, drug target identification, drug combination, and molecular drug mechanism unraveling. The advances in massive and automated high&#x02010;throughput drug discovery assays for <italic>C.&#x000a0;elegans</italic>, the amenability of genetic manipulation, and the extended information available on gene structures, mutant and RNAi phenotypes, microarray data and protein&#x02013;protein interactions (Wormbase) should be further exploited to facilitate the development of new drugs. The variety of <italic>C.&#x000a0;elegans</italic> disease models now available in the drug discovery pipeline does secure a significant boost to our understanding of human diseases and accelerates the reach of effective disease treatments.</p></sec><sec sec-type="COI-statement" id="prp2721-sec-0014"><title>CONFLICT OF INTEREST</title><p>The authors have no conflict of interest to declare.</p></sec><sec id="prp2721-sec-0015"><title>AUTHOR CONTRIBUTIONS</title><p>All authors were involved in manuscript preparation for this project.</p></sec></body><back><sec sec-type="data-availability" id="prp2721-sec-0017"><title>DATA AVAILABILITY STATEMENT</title><p>Data sharing is not applicable to this article as no new data were created or analyzed in this study.</p></sec><ref-list content-type="cited-references" id="prp2721-bibl-0001"><title>REFERENCES</title><ref id="prp2721-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="prp2721-cit-0001">
<string-name>
<surname>Dillin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Arantes&#x02010;Oliveira</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Rates of behavior and aging specified by mitochondrial function during development</article-title>. <source xml:lang="en">Science</source>. <year>2002</year>;<volume>298</volume>(<issue>5602</issue>):<fpage>2398</fpage>&#x02010;<lpage>2401</lpage>. <pub-id pub-id-type="doi">10.1126/science.1077780</pub-id>
<pub-id pub-id-type="pmid">12471266</pub-id></mixed-citation></ref><ref id="prp2721-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="prp2721-cit-0002">
<string-name>
<surname>Lee</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tolonen</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Ruvkun</surname>
<given-names>G</given-names>
</string-name>. <article-title>DAF&#x02010;16 target genes that control <italic>C. elegans</italic> life&#x02010;span and metabolism</article-title>. <source xml:lang="en">Science</source>. <year>2003</year>;<volume>300</volume>(<issue>5619</issue>):<fpage>644</fpage>&#x02010;<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1126/science.1083614</pub-id>
<pub-id pub-id-type="pmid">12690206</pub-id></mixed-citation></ref><ref id="prp2721-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="prp2721-cit-0003">
<string-name>
<surname>Nollen</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Garcia</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>van Haaften</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Genome&#x02010;wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2004</year>;<volume>101</volume>(<issue>17</issue>):<fpage>6403</fpage>&#x02010;<lpage>6408</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0307697101</pub-id>
<pub-id pub-id-type="pmid">15084750</pub-id></mixed-citation></ref><ref id="prp2721-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="prp2721-cit-0004">
<string-name>
<surname>Kim</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>H</given-names>
</string-name>. <article-title>Functional genomic approach to identify novel genes involved in the regulation of oxidative stress resistance and animal lifespan</article-title>. <source xml:lang="en">Aging Cell</source>. <year>2007</year>;<volume>6</volume>(<issue>4</issue>):<fpage>489</fpage>&#x02010;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2007.00302.x</pub-id>
<pub-id pub-id-type="pmid">17608836</pub-id></mixed-citation></ref><ref id="prp2721-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="prp2721-cit-0005">
<string-name>
<surname>van Ham</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Thijssen</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Breitling</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hofstra</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Plasterk</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Nollen</surname>
<given-names>EA</given-names>
</string-name>. <article-title>
<italic>C. elegans</italic> model identifies genetic modifiers of alpha&#x02010;synuclein inclusion formation during aging</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2008</year>;<volume>4</volume>(<issue>3</issue>):<elocation-id>e1000027</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000027</pub-id>
<pub-id pub-id-type="pmid">18369446</pub-id></mixed-citation></ref><ref id="prp2721-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="prp2721-cit-0006">
<string-name>
<surname>Habchi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Arosio</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Perni</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Abeta42 aggregates linked with Alzheimer's disease</article-title>. <source xml:lang="en">Sci Adv</source>. <year>2016</year>;<volume>2</volume>(<issue>2</issue>):<elocation-id>e1501244</elocation-id>. <pub-id pub-id-type="doi">10.1126/sciadv.1501244</pub-id>
<pub-id pub-id-type="pmid">26933687</pub-id></mixed-citation></ref><ref id="prp2721-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="prp2721-cit-0007">
<string-name>
<surname>De Rosa</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Veuthey</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Florman</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>The flight response impairs cytoprotective mechanisms by activating the insulin pathway</article-title>. <source xml:lang="en">Nature</source>. <year>2019</year>;<volume>573</volume>(<issue>7772</issue>):<fpage>135</fpage>&#x02010;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1524-5</pub-id>
<pub-id pub-id-type="pmid">31462774</pub-id></mixed-citation></ref><ref id="prp2721-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="prp2721-cit-0008">
<string-name>
<surname>Pirri</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Rayes</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Alkema</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>A change in the ion selectivity of ligand&#x02010;gated ion channels provides a mechanism to switch behavior</article-title>. <source xml:lang="en">PLOS Biol</source>. <year>2015</year>;<volume>13</volume>(<issue>9</issue>):<fpage>15</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1002238</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="prp2721-cit-0009">
<string-name>
<surname>Jones</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Rayes</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Diwani</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>A Cys&#x02010;loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC&#x02010;63 impairs but does not abolish channel function</article-title>. <source xml:lang="en">J Biol Chem</source>. <year>2011</year>;<volume>286</volume>(<issue>4</issue>):<fpage>2550</fpage>&#x02010;<lpage>2558</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.177238</pub-id>
<pub-id pub-id-type="pmid">20966081</pub-id></mixed-citation></ref><ref id="prp2721-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="prp2721-cit-0010">
<string-name>
<surname>Hengartner</surname>
<given-names>MO</given-names>
</string-name>, <string-name>
<surname>Horvitz</surname>
<given-names>HR</given-names>
</string-name>. <article-title>Programmed cell death in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Curr Opin Genet Dev</source>. <year>1994</year>;<volume>4</volume>(<issue>4</issue>):<fpage>581</fpage>&#x02010;<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1016/0959-437X(94)90076-F</pub-id>
<pub-id pub-id-type="pmid">7950327</pub-id></mixed-citation></ref><ref id="prp2721-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="prp2721-cit-0011">
<string-name>
<surname>Chalfie</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Euskirchen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ward</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Prasher</surname>
<given-names>DC</given-names>
</string-name>. <article-title>Green fluorescent protein as a marker for gene expression</article-title>. <source xml:lang="en">Science</source>. <year>1994</year>;<volume>263</volume>(<issue>5148</issue>):<fpage>802</fpage>&#x02010;<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1126/science.8303295</pub-id>
<pub-id pub-id-type="pmid">8303295</pub-id></mixed-citation></ref><ref id="prp2721-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="prp2721-cit-0012">
<string-name>
<surname>Fire</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Montgomery</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Kostas</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Driver</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Mello</surname>
<given-names>CC</given-names>
</string-name>. <article-title>Potent and specific genetic interference by double&#x02010;stranded RNA in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Nature</source>. <year>1998</year>;<volume>391</volume>(<issue>6669</issue>):<fpage>806</fpage>&#x02010;<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1038/35888</pub-id>
<pub-id pub-id-type="pmid">9486653</pub-id></mixed-citation></ref><ref id="prp2721-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="prp2721-cit-0013">
<string-name>
<surname>Samuel</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Rowedder</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Braendle</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>F&#x000e9;lix</surname>
<given-names>M&#x02010;A</given-names>
</string-name>, <string-name>
<surname>Ruvkun</surname>
<given-names>G</given-names>
</string-name>. <article-title>
<italic>Caenorhabditis elegans</italic>; responses to bacteria from its natural habitats</article-title>. <source xml:lang="en">Proc Natl Acad Sci</source>. <year>2016</year>;<volume>113</volume>(<issue>27</issue>):<fpage>E3941</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.1607183113</pub-id>
<pub-id pub-id-type="pmid">27317746</pub-id></mixed-citation></ref><ref id="prp2721-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="prp2721-cit-0014">
<string-name>
<surname>Brenner</surname>
<given-names>S</given-names>
</string-name>. <article-title>The genetics of <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Genetics</source>. <year>1974</year>;<volume>77</volume>(<issue>1</issue>):<fpage>71</fpage>&#x02010;<lpage>94</lpage>.<pub-id pub-id-type="pmid">4366476</pub-id></mixed-citation></ref><ref id="prp2721-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="prp2721-cit-0015">
<string-name>
<surname>Girard</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Fiedler</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>TW</given-names>
</string-name>, et al. <article-title>WormBook: The online review of <italic>Caenorhabditis elegans</italic> biology</article-title>. <source xml:lang="en">Nucleic Acids Res</source>. <year>2007</year>;<volume>35</volume>(<issue>Database</issue>):<fpage>D472</fpage>&#x02010;<lpage>D475</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl894</pub-id>
<pub-id pub-id-type="pmid">17099225</pub-id></mixed-citation></ref><ref id="prp2721-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="prp2721-cit-0016">
<string-name>
<surname>Cassada</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Russell</surname>
<given-names>RL</given-names>
</string-name>. <article-title>The dauerlarva, a post&#x02010;embryonic developmental variant of the nematode <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Dev Biol</source>. <year>1975</year>;<volume>46</volume>(<issue>2</issue>):<fpage>326</fpage>&#x02010;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(75)90109-8</pub-id>
<pub-id pub-id-type="pmid">1183723</pub-id></mixed-citation></ref><ref id="prp2721-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="prp2721-cit-0017">
<string-name>
<surname>Golden</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Riddle</surname>
<given-names>DL</given-names>
</string-name>. <article-title>A pheromone influences larval development in the nematode <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Science</source>. <year>1982</year>;<volume>218</volume>(<issue>4572</issue>):<fpage>578</fpage>&#x02010;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1126/science.6896933</pub-id>
<pub-id pub-id-type="pmid">6896933</pub-id></mixed-citation></ref><ref id="prp2721-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="prp2721-cit-0018">
<string-name>
<surname>Sulston</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Horvitz</surname>
<given-names>HR</given-names>
</string-name>. <article-title>Post&#x02010;embryonic cell lineages of the nematode, <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Dev Biol</source>. <year>1977</year>;<volume>56</volume>(<issue>1</issue>):<fpage>110</fpage>&#x02010;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(77)90158-0</pub-id>
<pub-id pub-id-type="pmid">838129</pub-id></mixed-citation></ref><ref id="prp2721-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="prp2721-cit-0019">
<string-name>
<surname>Kimble</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hirsh</surname>
<given-names>D</given-names>
</string-name>. <article-title>The postembryonic cell lineages of the hermaphrodite and male gonads in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Dev Biol</source>. <year>1979</year>;<volume>70</volume>(<issue>2</issue>):<fpage>396</fpage>&#x02010;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(79)90035-6</pub-id>
<pub-id pub-id-type="pmid">478167</pub-id></mixed-citation></ref><ref id="prp2721-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="prp2721-cit-0020">
<string-name>
<surname>Sulston</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Schierenberg</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Thomson</surname>
<given-names>JN</given-names>
</string-name>. <article-title>The embryonic cell lineage of the nematode <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Dev Biol</source>. <year>1983</year>;<volume>100</volume>(<issue>1</issue>):<fpage>64</fpage>&#x02010;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(83)90201-4</pub-id>
<pub-id pub-id-type="pmid">6684600</pub-id></mixed-citation></ref><ref id="prp2721-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="prp2721-cit-0021">
<string-name>
<surname>White</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Southgate</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Thomson</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Brenner</surname>
<given-names>S</given-names>
</string-name>. <article-title>The structure of the nervous system of the nematode <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Philos Trans R Soc Lond B Biol Sci</source>. <year>1986</year>;<volume>314</volume>(<issue>1165</issue>):<fpage>1</fpage>&#x02010;<lpage>340</lpage>.<pub-id pub-id-type="pmid">22462104</pub-id></mixed-citation></ref><ref id="prp2721-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="prp2721-cit-0022">
<string-name>
<surname>Cook</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Jarrell</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Brittin</surname>
<given-names>CA</given-names>
</string-name>, et al. <article-title>Whole&#x02010;animal connectomes of both <italic>Caenorhabditis elegans</italic> sexes</article-title>. <source xml:lang="en">Nature</source>. <year>2019</year>;<volume>571</volume>(<issue>7763</issue>):<fpage>63</fpage>&#x02010;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1352-7</pub-id>
<pub-id pub-id-type="pmid">31270481</pub-id></mixed-citation></ref><ref id="prp2721-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="prp2721-cit-0023">
<string-name>
<surname>Kerr</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lev&#x02010;Ram</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Baird</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Vincent</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tsien</surname>
<given-names>RY</given-names>
</string-name>, <string-name>
<surname>Schafer</surname>
<given-names>WR</given-names>
</string-name>. <article-title>Optical imaging of calcium transients in neurons and pharyngeal muscle of <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Neuron</source>. <year>2000</year>;<volume>26</volume>(<issue>3</issue>):<fpage>583</fpage>&#x02010;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)81196-4</pub-id>
<pub-id pub-id-type="pmid">10896155</pub-id></mixed-citation></ref><ref id="prp2721-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="prp2721-cit-0024">
<string-name>
<surname>Nagel</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Brauner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Liewald</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Adeishvili</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bamberg</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gottschalk</surname>
<given-names>A</given-names>
</string-name>. <article-title>Light activation of channelrhodopsin&#x02010;2 in excitable cells of <italic>Caenorhabditis elegans</italic> triggers rapid behavioral responses</article-title>. <source xml:lang="en">Current Biol</source>. <year>2005</year>;<volume>15</volume>(<issue>24</issue>):<fpage>2279</fpage>&#x02010;<lpage>2284</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2005.11.032</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="prp2721-cit-0025">
<string-name>
<surname>Nguyen</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Shipley</surname>
<given-names>FB</given-names>
</string-name>, <string-name>
<surname>Linder</surname>
<given-names>AN</given-names>
</string-name>, et al. <article-title>Whole&#x02010;brain calcium imaging with cellular resolution in freely behaving <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2016</year>;<volume>113</volume>(<issue>8</issue>):<fpage>E1074</fpage>&#x02010;<lpage>E1081</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1507110112</pub-id>
<pub-id pub-id-type="pmid">26712014</pub-id></mixed-citation></ref><ref id="prp2721-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="prp2721-cit-0026">
<string-name>
<surname>Singh</surname>
<given-names>J</given-names>
</string-name>. <article-title>Harnessing the power of genetics: Fast forward genetics in <italic>Caenorhabditis elegans</italic>
</article-title> [published online ahead of print, 2020 Sep 4]. <source xml:lang="en">Mol Genet Genomics</source>. <year>2020</year>. <pub-id pub-id-type="doi">10.1007/s00438-020-01721-6</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="prp2721-cit-0027">
<string-name>
<surname>Jorgensen</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Mango</surname>
<given-names>SE</given-names>
</string-name>. <article-title>The art and design of genetic screens: <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Nat Rev Genet</source>. <year>2002</year>;<volume>3</volume>(<issue>5</issue>):<fpage>356</fpage>&#x02010;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1038/nrg794</pub-id>
<pub-id pub-id-type="pmid">11988761</pub-id></mixed-citation></ref><ref id="prp2721-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="prp2721-cit-0028">
<string-name>
<surname>Lai</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Ch'ang</surname>
<given-names>LY</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>W</given-names>
</string-name>. <article-title>Identification of novel human genes evolutionarily conserved in <italic>Caenorhabditis elegans</italic> by comparative proteomics</article-title>. <source xml:lang="en">Genome Res</source>. <year>2000</year>;<volume>10</volume>(<issue>5</issue>):<fpage>703</fpage>&#x02010;<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1101/gr.10.5.703</pub-id>
<pub-id pub-id-type="pmid">10810093</pub-id></mixed-citation></ref><ref id="prp2721-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="prp2721-cit-0029">
<string-name>
<surname>Kim</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Underwood</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Greenwald</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Shaye</surname>
<given-names>DD</given-names>
</string-name>. <article-title>OrthoList 2: A new comparative genomic analysis of human and <italic>Caenorhabditis elegans</italic> genes</article-title>. <source xml:lang="en">Genetics</source>. <year>2018</year>;<volume>210</volume>(<issue>2</issue>):<fpage>445</fpage>&#x02010;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.118.301307</pub-id>
<pub-id pub-id-type="pmid">30120140</pub-id></mixed-citation></ref><ref id="prp2721-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="prp2721-cit-0030">
<string-name>
<surname>Bargmann</surname>
<given-names>CI</given-names>
</string-name>. <article-title>Neurobiology of the <italic>Caenorhabditis elegans</italic> genome</article-title>. <source xml:lang="en">Science</source>. <year>1998</year>;<volume>282</volume>(<issue>5396</issue>):<fpage>2028</fpage>&#x02010;<lpage>2033</lpage>. <pub-id pub-id-type="doi">10.1126/science.282.5396.2028</pub-id>
<pub-id pub-id-type="pmid">9851919</pub-id></mixed-citation></ref><ref id="prp2721-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="prp2721-cit-0031">
<string-name>
<surname>Das</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Arur</surname>
<given-names>S</given-names>
</string-name>. <article-title>Conserved insulin signaling in the regulation of oocyte growth, development, and maturation</article-title>. <source xml:lang="en">Mol Reprod Dev</source>. <year>2017</year>;<volume>84</volume>(<issue>6</issue>):<fpage>444</fpage>&#x02010;<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1002/mrd.22806</pub-id>
<pub-id pub-id-type="pmid">28379636</pub-id></mixed-citation></ref><ref id="prp2721-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="prp2721-cit-0032">
<string-name>
<surname>Jia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>B</given-names>
</string-name>. <article-title>Autophagy is required for dietary restriction&#x02010;mediated life span extension in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Autophagy</source>. <year>2007</year>;<volume>3</volume>(<issue>6</issue>):<fpage>597</fpage>&#x02010;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.4161/auto.4989</pub-id>
<pub-id pub-id-type="pmid">17912023</pub-id></mixed-citation></ref><ref id="prp2721-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="prp2721-cit-0033">
<string-name>
<surname>Kim</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Feinbaum</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Alloing</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>A conserved p38 MAP kinase pathway in <italic>Caenorhabditis elegans</italic> innate immunity</article-title>. <source xml:lang="en">Science</source>. <year>2002</year>;<volume>297</volume>(<issue>5581</issue>):<fpage>623</fpage>&#x02010;<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1126/science.1073759</pub-id>
<pub-id pub-id-type="pmid">12142542</pub-id></mixed-citation></ref><ref id="prp2721-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="prp2721-cit-0034">
<string-name>
<surname>Jia</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Riddle</surname>
<given-names>DL</given-names>
</string-name>. <article-title>The TOR pathway interacts with the insulin signaling pathway to regulate <italic>C. elegans</italic> larval development, metabolism and life span</article-title>. <source xml:lang="en">Development</source>. <year>2004</year>;<volume>131</volume>(<issue>16</issue>):<fpage>3897</fpage>&#x02010;<lpage>3906</lpage>. <pub-id pub-id-type="doi">10.1242/dev.01255</pub-id>
<pub-id pub-id-type="pmid">15253933</pub-id></mixed-citation></ref><ref id="prp2721-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="prp2721-cit-0035">
<string-name>
<surname>Gosai</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Kwak</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Luke</surname>
<given-names>CJ</given-names>
</string-name>, et al. <article-title>Automated high&#x02010;content live animal drug screening using <italic>C. elegans</italic> expressing the aggregation prone serpin &#x003b1;1&#x02010;antitrypsin Z</article-title>. <source xml:lang="en">PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>11</issue>):<elocation-id>e15460</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015460</pub-id>
<pub-id pub-id-type="pmid">21103396</pub-id></mixed-citation></ref><ref id="prp2721-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="prp2721-cit-0036">
<string-name>
<surname>Mathew</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Mathew</surname>
<given-names>ND</given-names>
</string-name>, <string-name>
<surname>Ebert</surname>
<given-names>PR</given-names>
</string-name>. <article-title>WormScan: A technique for high&#x02010;throughput phenotypic analysis of <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>3</issue>):<elocation-id>e33483</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033483</pub-id>
<pub-id pub-id-type="pmid">22457766</pub-id></mixed-citation></ref><ref id="prp2721-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="prp2721-cit-0037">
<string-name>
<surname>Swierczek</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Giles</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Rankin</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Kerr</surname>
<given-names>RA</given-names>
</string-name>. <article-title>High&#x02010;throughput behavioral analysis in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Nat Methods</source>. <year>2011</year>;<volume>8</volume>(<issue>7</issue>):<fpage>592</fpage>&#x02010;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1625</pub-id>
<pub-id pub-id-type="pmid">21642964</pub-id></mixed-citation></ref><ref id="prp2721-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="prp2721-cit-0038">
<string-name>
<surname>Xian</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>WormFarm: A quantitative control and measurement device toward automated <italic>Caenorhabditis elegans</italic> aging analysis</article-title>. <source xml:lang="en">Aging Cell</source>. <year>2013</year>;<volume>12</volume>(<issue>3</issue>):<fpage>398</fpage>&#x02010;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12063</pub-id>
<pub-id pub-id-type="pmid">23442149</pub-id></mixed-citation></ref><ref id="prp2721-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="prp2721-cit-0039">
<string-name>
<surname>Partridge</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Buckingham</surname>
<given-names>SD</given-names>
</string-name>, et al. <article-title>An automated high&#x02010;throughput system for phenotypic screening of chemical libraries on <italic>C. elegans</italic> and parasitic nematodes</article-title>. <source xml:lang="en">Int J Parasitol Drugs Drug Resist</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>8</fpage>&#x02010;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2017.11.004</pub-id>
<pub-id pub-id-type="pmid">29223747</pub-id></mixed-citation></ref><ref id="prp2721-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="prp2721-cit-0040">
<string-name>
<surname>Teo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Fong</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tolwinski</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Gruber</surname>
<given-names>J</given-names>
</string-name>. <article-title>Drug synergy as a strategy for compression of morbidity in a <italic>Caenorhabditis elegans</italic> model of Alzheimer's disease</article-title>. <source xml:lang="en">GeroScience</source>. <year>2020</year>;<volume>42</volume>(<issue>3</issue>):<fpage>849</fpage>&#x02010;<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-020-00169-1</pub-id>
<pub-id pub-id-type="pmid">32088829</pub-id></mixed-citation></ref><ref id="prp2721-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="prp2721-cit-0041">
<string-name>
<surname>Wong</surname>
<given-names>SQ</given-names>
</string-name>, <string-name>
<surname>Pontifex</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Phelan</surname>
<given-names>MM</given-names>
</string-name>, et al. <article-title>&#x003b1;&#x02010;Methyl&#x02010;&#x003b1;&#x02010;phenylsuccinimide ameliorates neurodegeneration in a <italic>C. elegans</italic> model of TDP&#x02010;43 proteinopathy</article-title>. <source xml:lang="en">Neurobiol Dis</source>. <year>2018</year>;<volume>118</volume>:<fpage>40</fpage>&#x02010;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2018.06.013</pub-id>
<pub-id pub-id-type="pmid">29940336</pub-id></mixed-citation></ref><ref id="prp2721-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="prp2721-cit-0042">
<string-name>
<surname>Farina</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Lambert</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Commeau</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>The stress response factor daf&#x02010;16/FOXO is required for multiple compound families to prolong the function of neurons with Huntington&#x02019;s disease</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>4014</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-04256-w</pub-id>
<pub-id pub-id-type="pmid">28638078</pub-id></mixed-citation></ref><ref id="prp2721-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="prp2721-cit-0043">
<string-name>
<surname>Patten</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Aggad</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Martinez</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis</article-title>. <source xml:lang="en">JCI Insight</source>. <year>2017</year>;<volume>2</volume>(<issue>22</issue>):<elocation-id>e97152</elocation-id>. <pub-id pub-id-type="doi">10.1172/jci.insight.97152</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="prp2721-cit-0044">
<string-name>
<surname>Mondal</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hegarty</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>G&#x000f6;k&#x000e7;e</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Ghorashian</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ben&#x02010;Yakar</surname>
<given-names>A</given-names>
</string-name>. <article-title>Large&#x02010;scale microfluidics providing high&#x02010;resolution and high&#x02010;throughput screening of Caenorhabditis elegans poly&#x02010;glutamine aggregation model</article-title>. <source xml:lang="en">Nat Commun</source>. <year>2016</year>;<volume>7</volume>:<fpage>13023</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms13023</pub-id>
<pub-id pub-id-type="pmid">27725672</pub-id></mixed-citation></ref><ref id="prp2721-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="prp2721-cit-0045">
<string-name>
<surname>Jagota</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rajadas</surname>
<given-names>J</given-names>
</string-name>. <article-title>Effect of phenolic compounds against A&#x003b2; aggregation and A&#x003b2;&#x02010;induced toxicity in transgenic <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Neurochem Res</source>. <year>2012</year>;<volume>37</volume>(<issue>1</issue>):<fpage>40</fpage>&#x02010;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-011-0580-5</pub-id>
<pub-id pub-id-type="pmid">21858698</pub-id></mixed-citation></ref><ref id="prp2721-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="prp2721-cit-0046">
<string-name>
<surname>Lublin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Isoda</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>FDA&#x02010;approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on Cbp and protect against proteotoxicity</article-title>. <source xml:lang="en">PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>11</issue>):<elocation-id>e27762</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0027762</pub-id>
<pub-id pub-id-type="pmid">22114686</pub-id></mixed-citation></ref><ref id="prp2721-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="prp2721-cit-0047">
<string-name>
<surname>Su</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Auluck</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Outeiro</surname>
<given-names>TF</given-names>
</string-name>, et al. <article-title>Compounds from an unbiased chemical screen reverse both ER&#x02010;to&#x02010;Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models</article-title>. <source xml:lang="en">Dis Models Mech</source>. <year>2010</year>;<volume>3</volume>(<issue>3&#x02010;4</issue>):<fpage>194</fpage>&#x02010;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.004267</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="prp2721-cit-0048">
<string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Verapamil extends lifespan in <italic>Caenorhabditis elegans</italic> by inhibiting calcineurin activity and promoting autophagy</article-title>. <source xml:lang="en">Aging</source>. <year>2020</year>;<volume>12</volume>(<issue>6</issue>):<fpage>5300</fpage>&#x02010;<lpage>5317</lpage>. <pub-id pub-id-type="doi">10.18632/aging.102951</pub-id>
<pub-id pub-id-type="pmid">32208362</pub-id></mixed-citation></ref><ref id="prp2721-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="prp2721-cit-0049">
<string-name>
<surname>Zhang</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Zhai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cregg</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ang</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Arkin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kenyon</surname>
<given-names>C</given-names>
</string-name>. <article-title>Stress resistance screen in a human primary cell line identifies small molecules that affect aging pathways and extend <italic>Caenorhabditis elegans</italic>&#x02019; lifespan</article-title>. <source xml:lang="en">G3 (Bethesda, MD)</source>. <year>2020</year>;<volume>10</volume>(<issue>2</issue>):<fpage>849</fpage>&#x02010;<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1534/g3.119.400618</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="prp2721-cit-0050">
<string-name>
<surname>Chen</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Lum</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Lara&#x02010;Gonzalez</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Pharmacological convergence reveals a lipid pathway that regulates <italic>C. elegans</italic> lifespan</article-title>. <source xml:lang="en">Nat Chem Biol</source>. <year>2019</year>;<volume>15</volume>(<issue>5</issue>):<fpage>453</fpage>&#x02010;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-019-0243-4</pub-id>
<pub-id pub-id-type="pmid">30911178</pub-id></mixed-citation></ref><ref id="prp2721-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="prp2721-cit-0051">
<string-name>
<surname>Bazopoulou</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chaudhury</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Pantazis</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chronis</surname>
<given-names>N</given-names>
</string-name>. <article-title>An automated compound screening for anti&#x02010;aging effects on the function of <italic>C. elegans</italic> sensory neurons</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>9403</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-09651-x</pub-id>
<pub-id pub-id-type="pmid">28839194</pub-id></mixed-citation></ref><ref id="prp2721-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="prp2721-cit-0052">
<string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dietrich</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kornfeld</surname>
<given-names>K</given-names>
</string-name>. <article-title>Angiotensin Converting Enzyme (ACE) inhibitor extends <italic>Caenorhabditis elegans</italic> life span</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2016</year>;<volume>12</volume>(<issue>2</issue>):<elocation-id>e1005866</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1005866</pub-id>
<pub-id pub-id-type="pmid">26918946</pub-id></mixed-citation></ref><ref id="prp2721-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="prp2721-cit-0053">
<string-name>
<surname>Lucanic</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Garrett</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Chemical activation of a food deprivation signal extends lifespan</article-title>. <source xml:lang="en">Aging Cell</source>. <year>2016</year>;<volume>15</volume>(<issue>5</issue>):<fpage>832</fpage>&#x02010;<lpage>841</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12492</pub-id>
<pub-id pub-id-type="pmid">27220516</pub-id></mixed-citation></ref><ref id="prp2721-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="prp2721-cit-0054">
<string-name>
<surname>Ye</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Linton</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Schork</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Buck</surname>
<given-names>LB</given-names>
</string-name>, <string-name>
<surname>Petrascheck</surname>
<given-names>M</given-names>
</string-name>. <article-title>A pharmacological network for lifespan extension in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Aging Cell</source>. <year>2014</year>;<volume>13</volume>(<issue>2</issue>):<fpage>206</fpage>
<lpage>&#x02010;215</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12163</pub-id>
<pub-id pub-id-type="pmid">24134630</pub-id></mixed-citation></ref><ref id="prp2721-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="prp2721-cit-0055">
<string-name>
<surname>Chin</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Pai</surname>
<given-names>MY</given-names>
</string-name>, et al. <article-title>The metabolite &#x003b1;&#x02010;ketoglutarate extends lifespan by inhibiting ATP synthase and TOR</article-title>. <source xml:lang="en">Nature</source>. <year>2014</year>;<volume>510</volume>(<issue>7505</issue>):<fpage>397</fpage>&#x02010;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1038/nature13264</pub-id>
<pub-id pub-id-type="pmid">24828042</pub-id></mixed-citation></ref><ref id="prp2721-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="prp2721-cit-0056">
<string-name>
<surname>Hummell</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Revtovich</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Kirienko</surname>
<given-names>NV</given-names>
</string-name>. <article-title>Novel immune modulators enhance <italic>Caenorhabditis elegans</italic> resistance to multiple pathogens</article-title>. <source xml:lang="en">mSphere</source>. <year>2021</year>;<volume>6</volume>(<issue>1</issue>):<elocation-id>e00950&#x02010;20</elocation-id>. <pub-id pub-id-type="doi">10.1101/2020.10.23.352229</pub-id>
<pub-id pub-id-type="pmid">33408224</pub-id></mixed-citation></ref><ref id="prp2721-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="prp2721-cit-0057">
<string-name>
<surname>Kim</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Hendricks</surname>
<given-names>GL</given-names>
</string-name>, et al. <article-title>A new class of synthetic retinoid antibiotics effective against bacterial persisters</article-title>. <source xml:lang="en">Nature</source>. <year>2018</year>;<volume>556</volume>(<issue>7699</issue>):<fpage>103</fpage>&#x02010;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1038/nature26157</pub-id>
<pub-id pub-id-type="pmid">29590091</pub-id></mixed-citation></ref><ref id="prp2721-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="prp2721-cit-0058">
<string-name>
<surname>Kirienko</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Revtovich</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>High&#x02010;Content</surname>
<given-names>KNVA</given-names>
</string-name>. <article-title>Phenotypic screen identifies fluorouridine as an inhibitor of pyoverdine biosynthesis and <italic>Pseudomonas aeruginosa</italic> virulence</article-title>. <source xml:lang="en">mSphere</source>. <year>2016</year>;<volume>1</volume>(<issue>4</issue>):e00217&#x02010;e316. <pub-id pub-id-type="doi">10.1128/mSphere.00217-16</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="prp2721-cit-0059">
<string-name>
<surname>Rajamuthiah</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jayamani</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Majed</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Antibacterial properties of 3&#x02010;(phenylsulfonyl)&#x02010;2&#x02010;pyrazinecarbonitrile</article-title>. <source xml:lang="en">Bioorg Med Chem Lett</source>. <year>2015</year>;<volume>25</volume>(<issue>22</issue>):<fpage>5203</fpage>&#x02010;<lpage>5207</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2015.09.066</pub-id>
<pub-id pub-id-type="pmid">26459212</pub-id></mixed-citation></ref><ref id="prp2721-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="prp2721-cit-0060">
<string-name>
<surname>Rajamuthiah</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fuchs</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Jayamani</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Whole animal automated platform for drug discovery against multi&#x02010;drug resistant <italic>Staphylococcus aureus</italic>
</article-title>. <source xml:lang="en">PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>2</issue>):<elocation-id>e89189</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0089189</pub-id>
<pub-id pub-id-type="pmid">24586584</pub-id></mixed-citation></ref><ref id="prp2721-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="prp2721-cit-0061">
<string-name>
<surname>Kirienko</surname>
<given-names>NV</given-names>
</string-name>, <string-name>
<surname>Kirienko</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Larkins&#x02010;Ford</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>W&#x000e4;hlby</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ruvkun</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ausubel</surname>
<given-names>FM</given-names>
</string-name>. <article-title>Pseudomonas aeruginosa disrupts <italic>Caenorhabditis elegans</italic> iron homeostasis, causing a hypoxic response and death</article-title>. <source xml:lang="en">Cell Host Microbe</source>. <year>2013</year>;<volume>13</volume>(<issue>4</issue>):<fpage>406</fpage>&#x02010;<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2013.03.003</pub-id>
<pub-id pub-id-type="pmid">23601103</pub-id></mixed-citation></ref><ref id="prp2721-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="prp2721-cit-0062">
<string-name>
<surname>Zhou</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Shao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>JA</given-names>
</string-name>, et al. <article-title>An efficient and novel screening model for assessing the bioactivity of extracts against multidrug&#x02010;resistant <italic>Pseudomonas aeruginosa</italic> using <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Biosci Biotechnol Biochem</source>. <year>2011</year>;<volume>75</volume>(<issue>9</issue>):<fpage>1746</fpage>&#x02010;<lpage>1751</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.110290</pub-id>
<pub-id pub-id-type="pmid">21897025</pub-id></mixed-citation></ref><ref id="prp2721-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="prp2721-cit-0063">
<string-name>
<surname>Coleman</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Okoli</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Tegos</surname>
<given-names>GP</given-names>
</string-name>, et al. <article-title>Characterization of plant&#x02010;derived saponin natural products against <italic>Candida albicans</italic>
</article-title>. <source xml:lang="en">ACS Chem Biol</source>. <year>2010</year>;<volume>5</volume>(<issue>3</issue>):<fpage>321</fpage>&#x02010;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1021/cb900243b</pub-id>
<pub-id pub-id-type="pmid">20099897</pub-id></mixed-citation></ref><ref id="prp2721-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="prp2721-cit-0064">
<string-name>
<surname>Mili&#x00161;i&#x0016b;nait&#x00117;</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kadlecov&#x000e1;</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>&#x0017d;ukauskait&#x00117;</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Synthesis and anthelmintic activity of benzopyrano[2,3&#x02010;c]pyrazol&#x02010;4(2H)&#x02010;one derivatives</article-title>. <source xml:lang="en">Mol Diversity</source>. <year>2020</year>;<volume>24</volume>(<issue>4</issue>):<fpage>1025</fpage>&#x02010;<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1007/s11030-019-10010-3</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="prp2721-cit-0065">
<string-name>
<surname>Risi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Aguilera</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Lad&#x000f3;s</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>
<italic>Caenorhabditis elegans</italic> infrared&#x02010;based motility assay identified new hits for nematicide drug development</article-title>. <source xml:lang="en">Vet Sci</source>. <year>2019</year>;<volume>6</volume>(<issue>1</issue>):<fpage>29</fpage>. <pub-id pub-id-type="doi">10.3390/vetsci6010029</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="prp2721-cit-0066">
<string-name>
<surname>Blanco</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Vela Gurovic</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Silbestri</surname>
<given-names>GF</given-names>
</string-name>, et al. <article-title>Diisopropylphenyl&#x02010;imidazole (DII): A new compound that exerts anthelmintic activity through novel molecular mechanisms</article-title>. <source xml:lang="en">PLoS Negl Trop Dis</source>. <year>2018</year>;<volume>12</volume>(<issue>12</issue>):<elocation-id>e0007021</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0007021</pub-id>
<pub-id pub-id-type="pmid">30557347</pub-id></mixed-citation></ref><ref id="prp2721-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="prp2721-cit-0067">
<string-name>
<surname>Partridge</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Willis</surname>
<given-names>NJ</given-names>
</string-name>, et al. <article-title>Dihydrobenz[e][1,4]oxazepin&#x02010;2(3H)&#x02010;ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo</article-title>. <source xml:lang="en">PLoS Negl Trop Dis</source>. <year>2017</year>;<volume>11</volume>(<issue>2</issue>):<elocation-id>e0005359</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0005359</pub-id>
<pub-id pub-id-type="pmid">28182663</pub-id></mixed-citation></ref><ref id="prp2721-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="prp2721-cit-0068">
<string-name>
<surname>Burns</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Luciani</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Musso</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>
<italic>Caenorhabditis elegans</italic> is a useful model for anthelmintic discovery</article-title>. <source xml:lang="en">Nat Commun</source>. <year>2015</year>;<volume>6</volume>:<fpage>7485</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8485</pub-id>
<pub-id pub-id-type="pmid">26108372</pub-id></mixed-citation></ref><ref id="prp2721-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="prp2721-cit-0069">
<string-name>
<surname>Medina</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Ponce</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Cruz</surname>
<given-names>CA</given-names>
</string-name>. <article-title>Revealing the anticancer potential of candidate drugs in vivo using <italic>Caenorhabditis elegans</italic> mutant strains</article-title>. <source xml:lang="en">Transl Oncol</source>. <year>2020</year>;<volume>14</volume>(<issue>1</issue>):<fpage>100940</fpage>. <pub-id pub-id-type="doi">10.1016/j.tranon.2020.100940</pub-id>
<pub-id pub-id-type="pmid">33221682</pub-id></mixed-citation></ref><ref id="prp2721-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="prp2721-cit-0070">
<string-name>
<surname>Ji</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Harmine suppresses hyper&#x02010;activated Ras&#x02010;MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Cancer Cell Int</source>. <year>2019</year>;<volume>19</volume>:<fpage>159</fpage>. <pub-id pub-id-type="doi">10.1186/s12935-019-0880-4</pub-id>
<pub-id pub-id-type="pmid">31198408</pub-id></mixed-citation></ref><ref id="prp2721-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="prp2721-cit-0071">
<string-name>
<surname>Bae</surname>
<given-names>YK</given-names>
</string-name>, <string-name>
<surname>Sung</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YN</given-names>
</string-name>, et al. <article-title>An in vivo <italic>C. elegans</italic> model system for screening EGFR&#x02010;inhibiting anti&#x02010;cancer drugs</article-title>. <source xml:lang="en">PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>9</issue>):<elocation-id>e42441</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0042441</pub-id>
<pub-id pub-id-type="pmid">22957020</pub-id></mixed-citation></ref><ref id="prp2721-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="prp2721-cit-0072">
<string-name>
<surname>Zwirchmayr</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kirchweger</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lehner</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tahir</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pretsch</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rollinger</surname>
<given-names>JM</given-names>
</string-name>. <article-title>A robust and miniaturized screening platform to study natural products affecting metabolism and survival in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>12323</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-69186-6</pub-id>
<pub-id pub-id-type="pmid">32704017</pub-id></mixed-citation></ref><ref id="prp2721-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="prp2721-cit-0073">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>J</given-names>
</string-name>. <article-title>Swertiamarin decreases lipid accumulation dependent on 3&#x02010;ketoacyl&#x02010;coA thiolase</article-title>. <source xml:lang="en">Biomed Pharmacother</source>. <year>2019</year>;<volume>112</volume>:<fpage>108668</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2019.108668</pub-id>
<pub-id pub-id-type="pmid">30784937</pub-id></mixed-citation></ref><ref id="prp2721-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="prp2721-cit-0074">
<string-name>
<surname>Chow</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>F</given-names>
</string-name>. <article-title>Screening of isoquinoline alkaloids for potent lipid metabolism modulation with <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Biosci Biotechnol Biochem</source>. <year>2013</year>;<volume>77</volume>(<issue>12</issue>):<fpage>2405</fpage>&#x02010;<lpage>2412</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.130523</pub-id>
<pub-id pub-id-type="pmid">24317056</pub-id></mixed-citation></ref><ref id="prp2721-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="prp2721-cit-0075">
<string-name>
<surname>Lewis</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Berg</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>JH</given-names>
</string-name>. <article-title>The genetics of levamisole resistance in the nematode <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Genetics</source>. <year>1980</year>;<volume>95</volume>(<issue>4</issue>):<fpage>905</fpage>&#x02010;<lpage>928</lpage>.<pub-id pub-id-type="pmid">7203008</pub-id></mixed-citation></ref><ref id="prp2721-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="prp2721-cit-0076">
<string-name>
<surname>Lewis</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Berg</surname>
<given-names>H</given-names>
</string-name>. <article-title>Levamisole&#x02010;resistant mutants of the nematode <italic>Caenorhabditis elegans</italic> appear to lack pharmacological acetylcholine receptors</article-title>. <source xml:lang="en">Neuroscience</source>. <year>1980</year>;<volume>5</volume>(<issue>6</issue>):<fpage>967</fpage>&#x02010;<lpage>989</lpage>.<pub-id pub-id-type="pmid">7402460</pub-id></mixed-citation></ref><ref id="prp2721-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="prp2721-cit-0077">
<string-name>
<surname>Kaminsky</surname>
<given-names>R</given-names>
</string-name>. <article-title>A new class of anthelmintics effective against drug&#x02010;resistant nematodes</article-title>. <source xml:lang="en">Nature</source>. <year>2008</year>;<volume>452</volume>(<issue>7184</issue>):<fpage>176</fpage>&#x02010;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1038/nature06722</pub-id>
<pub-id pub-id-type="pmid">18337814</pub-id></mixed-citation></ref><ref id="prp2721-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="prp2721-cit-0078">
<string-name>
<surname>Driscoll</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dean</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Reilly</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bergholz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Chalfie</surname>
<given-names>M</given-names>
</string-name>. <article-title>Genetic and molecular analysis of a <italic>Caenorhabditis elegans</italic> beta&#x02010;tubulin that conveys benzimidazole sensitivity</article-title>. <source xml:lang="en">J Cell Biol</source>. <year>1989</year>;<volume>109</volume>(<issue>6 Pt 1</issue>):<fpage>2993</fpage>&#x02010;<lpage>3003</lpage>.<pub-id pub-id-type="pmid">2592410</pub-id></mixed-citation></ref><ref id="prp2721-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="prp2721-cit-0079">
<string-name>
<surname>Apfeld</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Alper</surname>
<given-names>S</given-names>
</string-name>. <article-title>What can we learn about human disease from the nematode <italic>C. elegans</italic>?</article-title>
<source xml:lang="en">Methods Mol Biol</source>. <year>2018</year>;<volume>1706</volume>:<fpage>53</fpage>&#x02010;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-7471-9_4</pub-id>
<pub-id pub-id-type="pmid">29423793</pub-id></mixed-citation></ref><ref id="prp2721-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="prp2721-cit-0080">
<string-name>
<surname>Gao</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Uit de Bos</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sterken</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Kammenga</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Houtkooper</surname>
<given-names>RH</given-names>
</string-name>. <article-title>Forward and reverse genetics approaches to uncover metabolic aging pathways in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Biochim Biophys Acta</source>. <year>2018</year>;<volume>1864</volume>(<issue>9 Pt A</issue>):<fpage>2697</fpage>&#x02010;<lpage>2706</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2017.09.006</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="prp2721-cit-0081">
<string-name>
<surname>Serrat</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Kukhtar</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Cornes</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>CRISPR editing of sftb&#x02010;1/SF3B1 in <italic>Caenorhabditis elegans</italic> allows the identification of synthetic interactions with cancer&#x02010;related mutations and the chemical inhibition of splicing</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2019</year>;<volume>15</volume>(<issue>10</issue>):<elocation-id>e1008464</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1008464</pub-id>
<pub-id pub-id-type="pmid">31634348</pub-id></mixed-citation></ref><ref id="prp2721-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="prp2721-cit-0082">
<string-name>
<surname>Morley</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Brignull</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Weyers</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Morimoto</surname>
<given-names>RI</given-names>
</string-name>. <article-title>The threshold for polyglutamine&#x02010;expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2002</year>;<volume>99</volume>(<issue>16</issue>):<fpage>10417</fpage>&#x02010;<lpage>10422</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.152161099</pub-id>
<pub-id pub-id-type="pmid">12122205</pub-id></mixed-citation></ref><ref id="prp2721-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="prp2721-cit-0083">
<string-name>
<surname>Brignull</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>FE</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Morimoto</surname>
<given-names>RI</given-names>
</string-name>. <article-title>Polyglutamine proteins at the pathogenic threshold display neuron&#x02010;specific aggregation in a pan&#x02010;neuronal <italic>Caenorhabditis elegans</italic> model</article-title>. <source xml:lang="en">J Neurosci</source>. <year>2006</year>;<volume>26</volume>(<issue>29</issue>):<fpage>7597</fpage>&#x02010;<lpage>7606</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0990-06.2006</pub-id>
<pub-id pub-id-type="pmid">16855087</pub-id></mixed-citation></ref><ref id="prp2721-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="prp2721-cit-0084">
<string-name>
<surname>Teixeira&#x02010;Castro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ailion</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jalles</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Neuron&#x02010;specific proteotoxicity of mutant ataxin&#x02010;3 in <italic>C. elegans</italic>: Rescue by the DAF&#x02010;16 and HSF&#x02010;1 pathways</article-title>. <source xml:lang="en">Hum Mol Genet</source>. <year>2011</year>;<volume>20</volume>(<issue>15</issue>):<fpage>2996</fpage>&#x02010;<lpage>3009</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr203</pub-id>
<pub-id pub-id-type="pmid">21546381</pub-id></mixed-citation></ref><ref id="prp2721-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="prp2721-cit-0085">
<string-name>
<surname>Styer</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Macosko</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Steele</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Bargmann</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Aballay</surname>
<given-names>A</given-names>
</string-name>. <article-title>Innate immunity in <italic>Caenorhabditis elegans</italic> is regulated by neurons expressing NPR&#x02010;1/GPCR</article-title>. <source xml:lang="en">Science</source>. <year>2008</year>;<volume>322</volume>(<issue>5900</issue>):<fpage>460</fpage>&#x02010;<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1126/science.1163673</pub-id>
<pub-id pub-id-type="pmid">18801967</pub-id></mixed-citation></ref><ref id="prp2721-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="prp2721-cit-0086">
<string-name>
<surname>Singh</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Aballay</surname>
<given-names>A</given-names>
</string-name>. <article-title>Regulation of DAF&#x02010;16&#x02010;mediated Innate Immunity in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">J Biol Chem</source>. <year>2009</year>;<volume>284</volume>(<issue>51</issue>):<fpage>35580</fpage>&#x02010;<lpage>35587</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.060905</pub-id>
<pub-id pub-id-type="pmid">19858203</pub-id></mixed-citation></ref><ref id="prp2721-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="prp2721-cit-0087">
<string-name>
<surname>Singh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Aballay</surname>
<given-names>A</given-names>
</string-name>. <article-title>Intestinal infection regulates behavior and learning via neuroendocrine signaling</article-title>. <source xml:lang="en">Elife</source>. <year>2019</year>;<volume>8</volume>:<elocation-id>e50033</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.50033</pub-id>
<pub-id pub-id-type="pmid">31674907</pub-id></mixed-citation></ref><ref id="prp2721-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="prp2721-cit-0088">
<string-name>
<surname>Schlotterer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kukudov</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bozorgmehr</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>
<italic>C. elegans</italic> as model for the study of high glucose&#x02010; mediated life span reduction</article-title>. <source xml:lang="en">Diabetes</source>. <year>2009</year>;<volume>58</volume>(<issue>11</issue>):<fpage>2450</fpage>&#x02010;<lpage>2456</lpage>. <pub-id pub-id-type="doi">10.2337/db09-0567</pub-id>
<pub-id pub-id-type="pmid">19675139</pub-id></mixed-citation></ref><ref id="prp2721-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="prp2721-cit-0089">
<string-name>
<surname>Zhu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Qin</surname>
<given-names>J</given-names>
</string-name>. <article-title>Modeling type 2 diabetes&#x02010;like hyperglycemia in <italic>C. elegans</italic> on a microdevice</article-title>. <source xml:lang="en">Integr Biol</source>. <year>2016</year>;<volume>8</volume>(<issue>1</issue>):<fpage>30</fpage>&#x02010;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1039/C5IB00243E</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="prp2721-cit-0090">
<string-name>
<surname>Regitz</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Fitzenberger</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mahn</surname>
<given-names>FL</given-names>
</string-name>, <string-name>
<surname>Du&#x000df;ling</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Wenzel</surname>
<given-names>U</given-names>
</string-name>. <article-title>Resveratrol reduces amyloid&#x02010;beta (A&#x003b2;&#x02081;&#x0208b;&#x02084;&#x02082;)&#x02010;induced paralysis through targeting proteostasis in an Alzheimer model of <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Eur J Nutr</source>. <year>2016</year>;<volume>55</volume>(<issue>2</issue>):<fpage>741</fpage>&#x02010;<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1007/s00394-015-0894-1</pub-id>
<pub-id pub-id-type="pmid">25851110</pub-id></mixed-citation></ref><ref id="prp2721-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="prp2721-cit-0091">
<string-name>
<surname>Solis</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Kardakaris</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Valentine</surname>
<given-names>ER</given-names>
</string-name>, et al. <article-title>Translation attenuation by minocycline enhances longevity and proteostasis in old post&#x02010;stress&#x02010;responsive organisms</article-title>. <source xml:lang="en">Elife</source>. <year>2018</year>;<volume>7</volume>:<elocation-id>e40314</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.40314</pub-id>.<pub-id pub-id-type="pmid">30479271</pub-id></mixed-citation></ref><ref id="prp2721-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="prp2721-cit-0092">
<string-name>
<surname>Pukkila&#x02010;Worley</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ausubel</surname>
<given-names>FM</given-names>
</string-name>. <article-title>Immune defense mechanisms in the <italic>Caenorhabditis elegans</italic> intestinal epithelium</article-title>. <source xml:lang="en">Curr Opin Immunol</source>. <year>2012</year>;<volume>24</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02010;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2011.10.004</pub-id>
<pub-id pub-id-type="pmid">22236697</pub-id></mixed-citation></ref><ref id="prp2721-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="prp2721-cit-0093">
<string-name>
<surname>Baur</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Beech</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sigel</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rufener</surname>
<given-names>L</given-names>
</string-name>. <article-title>Monepantel irreversibly binds to and opens <italic>Haemonchus contortus</italic> MPTL&#x02010;1 and <italic>Caenorhabditis elegans</italic> ACR&#x02010;20 receptors</article-title>. <source xml:lang="en">Mol Pharmacol</source>. <year>2015</year>;<volume>87</volume>(<issue>1</issue>):<fpage>96</fpage>&#x02010;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1124/mol.114.095653</pub-id>
<pub-id pub-id-type="pmid">25352042</pub-id></mixed-citation></ref><ref id="prp2721-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="prp2721-cit-0094">
<string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Oshiro&#x02010;Rapley</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>An ancient, unified mechanism for metformin growth inhibition in <italic>C. elegans</italic> and cancer</article-title>. <source xml:lang="en">Cell</source>. <year>2016</year>;<volume>167</volume>(<issue>7</issue>):<fpage>1705</fpage>&#x02010;<lpage>1718.e13</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.11.055</pub-id>
<pub-id pub-id-type="pmid">27984722</pub-id></mixed-citation></ref><ref id="prp2721-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="prp2721-cit-0095">
<string-name>
<surname>Peng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Inhibition of fat accumulation by hesperidin in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">J Agr Food Chem</source>. <year>2016</year>;<volume>64</volume>(<issue>25</issue>):<fpage>5207</fpage>&#x02010;<lpage>5214</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.6b02183</pub-id>
<pub-id pub-id-type="pmid">27267939</pub-id></mixed-citation></ref><ref id="prp2721-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="prp2721-cit-0096">
<string-name>
<surname>Agotegaray</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Blanco</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Campelo</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>&#x003b2;&#x02010;cyclodextrin coating: Improving biocompatibility of magnetic nanocomposites for biomedical applications</article-title>. <source xml:lang="en">J Mater Sci &#x02010; Mater Med</source>. <year>2020</year>;<volume>31</volume>(<issue>2</issue>):<fpage>22</fpage>. <pub-id pub-id-type="doi">10.1007/s10856-020-6361-4</pub-id>
<pub-id pub-id-type="pmid">32002683</pub-id></mixed-citation></ref><ref id="prp2721-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="prp2721-cit-0097">
<string-name>
<surname>Xiong</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pears</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Woollard</surname>
<given-names>A</given-names>
</string-name>. <article-title>An enhanced <italic>C. elegans</italic> based platform for toxicity assessment</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>9839</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-10454-3</pub-id>
<pub-id pub-id-type="pmid">28852193</pub-id></mixed-citation></ref><ref id="prp2721-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="prp2721-cit-0098">
<string-name>
<surname>Chiu</surname>
<given-names>HF</given-names>
</string-name>, <string-name>
<surname>Hsiao</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>YY</given-names>
</string-name>, et al. <article-title>Efficacy of protein rich pearl powder on antioxidant status in a randomized placebo&#x02010;controlled trial</article-title>. <source xml:lang="en">J Food Drug Anal</source>. <year>2018</year>;<volume>26</volume>(<issue>1</issue>):<fpage>309</fpage>&#x02010;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.jfda.2017.05.010</pub-id>
<pub-id pub-id-type="pmid">29389568</pub-id></mixed-citation></ref><ref id="prp2721-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="prp2721-cit-0099">
<string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sherwood</surname>
<given-names>DR</given-names>
</string-name>. <article-title>Dissection of genetic pathways in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Methods Cell Biol</source>. <year>2011</year>;<volume>106</volume>:<fpage>113</fpage>&#x02010;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/b978-0-12-544172-8.00005-0</pub-id>
<pub-id pub-id-type="pmid">22118276</pub-id></mixed-citation></ref><ref id="prp2721-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="prp2721-cit-0100">
<string-name>
<surname>Lehrbach</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Ji</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sadreyev</surname>
<given-names>R</given-names>
</string-name>. <article-title>Next&#x02010;generation sequencing for identification of EMS&#x02010;induced mutations in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Curr Protoc Mol Biol</source>. <year>2017</year>;<volume>117</volume>(<issue>7</issue>):29.1&#x02010;7.29.12. <pub-id pub-id-type="doi">10.1002/cpmb.27</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="prp2721-cit-0101">
<string-name>
<surname>Doitsidou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jarriault</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Poole</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Next&#x02010;generation sequencing&#x02010;based approaches for mutation mapping and identification in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Genetics</source>. <year>2016</year>;<volume>204</volume>(<issue>2</issue>):<fpage>451</fpage>&#x02010;<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.115.186197</pub-id>
<pub-id pub-id-type="pmid">27729495</pub-id></mixed-citation></ref><ref id="prp2721-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="prp2721-cit-0102">
<string-name>
<surname>Anderson</surname>
<given-names>P</given-names>
</string-name>. <article-title>Mutagenesis</article-title>. <source xml:lang="en">Methods Cell Biol</source>. <year>1995</year>;<volume>48</volume>:<fpage>31</fpage>&#x02010;<lpage>58</lpage>.<pub-id pub-id-type="pmid">8531732</pub-id></mixed-citation></ref><ref id="prp2721-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="prp2721-cit-0103">
<string-name>
<surname>Kutscher</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Shaham</surname>
<given-names>S</given-names>
</string-name>. <article-title>Forward and reverse mutagenesis in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">WormBook</source>. <year>2014</year>:<fpage>1</fpage>&#x02010;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1895/wormbook.1.167.1</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="prp2721-cit-0104">
<string-name>
<surname>Huang</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Pirri</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Rayes</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Gain&#x02010;of&#x02010;function mutations in the UNC&#x02010;2/CaV2alpha channel lead to excitation&#x02010;dominant synaptic transmission in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Elife</source>. <year>2019</year>;<volume>8</volume>:<elocation-id>e45905</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.45905</pub-id>
<pub-id pub-id-type="pmid">31364988</pub-id></mixed-citation></ref><ref id="prp2721-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="prp2721-cit-0105">
<string-name>
<surname>Nass</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hahn</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Jessen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>McDonald</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Carvelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Blakely</surname>
<given-names>RD</given-names>
</string-name>. <article-title>A genetic screen in <italic>Caenorhabditis elegans</italic> for dopamine neuron insensitivity to 6&#x02010;hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking</article-title>. <source xml:lang="en">J Neurochem</source>. <year>2005</year>;<volume>94</volume>(<issue>3</issue>):<fpage>774</fpage>&#x02010;<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03205.x</pub-id>
<pub-id pub-id-type="pmid">15992384</pub-id></mixed-citation></ref><ref id="prp2721-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="prp2721-cit-0106">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Banskota</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Critchley</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Hafting</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Prithiviraj</surname>
<given-names>B</given-names>
</string-name>. <article-title>Neuroprotective effects of the cultivated <italic>Chondrus crispus</italic> in a <italic>C. elegans</italic> model of Parkinson&#x02019;s disease</article-title>. <source xml:lang="en">Marine Drugs</source>. <year>2015</year>;<volume>13</volume>(<issue>4</issue>):<fpage>2250</fpage>&#x02010;<lpage>2266</lpage>. <pub-id pub-id-type="doi">10.3390/md13042250</pub-id>
<pub-id pub-id-type="pmid">25874922</pub-id></mixed-citation></ref><ref id="prp2721-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="prp2721-cit-0107">
<string-name>
<surname>Mathew</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Mathew</surname>
<given-names>ND</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Using <italic>C. elegans</italic> forward and reverse genetics to identify new compounds with anthelmintic activity</article-title>. <source xml:lang="en">PLoS Negl Trop Dis</source>. <year>2016</year>;<volume>10</volume>(<issue>10</issue>):<elocation-id>e0005058</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0005058</pub-id>
<pub-id pub-id-type="pmid">27755544</pub-id></mixed-citation></ref><ref id="prp2721-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="prp2721-cit-0108">
<string-name>
<surname>Dent</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Vassilatis</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Avery</surname>
<given-names>L</given-names>
</string-name>. <article-title>The genetics of ivermectin resistance in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2000</year>;<volume>97</volume>(<issue>6</issue>):<fpage>2674</fpage>&#x02010;<lpage>2679</lpage>
<pub-id pub-id-type="pmid">10716995</pub-id></mixed-citation></ref><ref id="prp2721-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="prp2721-cit-0109">
<string-name>
<surname>Kwok</surname>
<given-names>TCY</given-names>
</string-name>, <string-name>
<surname>Hui</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kostelecki</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>A genetic screen for dihydropyridine (dhp)&#x02010;resistant worms reveals new residues required for DHP&#x02010;blockage of mammalian calcium channels</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2008</year>;<volume>4</volume>(<issue>5</issue>):<elocation-id>e1000067</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000067</pub-id>
<pub-id pub-id-type="pmid">18464914</pub-id></mixed-citation></ref><ref id="prp2721-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="prp2721-cit-0110">
<string-name>
<surname>Ung</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hall</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kikis</surname>
<given-names>E</given-names>
</string-name>. <article-title>Chemical mutagenesis of <italic>Caenorhabditis elegans</italic> uncovers genetic modifiers of huntingtin protein aggregation</article-title>. <source xml:lang="en">Micro Publ Biol</source>. <year>2020</year>;<volume>2020</volume>:<fpage>10.17912/micropub.biology.000202</fpage>. <pub-id pub-id-type="doi">10.17912/micropub.biology.000202</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="prp2721-cit-0111">
<string-name>
<surname>Kawamura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Maruyama</surname>
<given-names>IN</given-names>
</string-name>. <article-title>Forward genetic screen for <italic>Caenorhabditis elegans</italic> mutants with a shortened locomotor healthspan</article-title>. <source xml:lang="en">G3 (Bethesda, Md)</source>. <year>2019</year>;<volume>9</volume>(<issue>8</issue>):<fpage>2415</fpage>&#x02010;<lpage>2423</lpage>. <pub-id pub-id-type="doi">10.1534/g3.119.400241</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="prp2721-cit-0112">
<string-name>
<surname>Sheng</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hosseinzadeh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Muralidharan</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Gaur</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Selstam</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tuck</surname>
<given-names>S</given-names>
</string-name>. <article-title>Aberrant fat metabolism in <italic>Caenorhabditis elegans</italic> mutants with defects in the defecation motor program</article-title>. <source xml:lang="en">PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>4</issue>):<elocation-id>e0124515</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0124515</pub-id>
<pub-id pub-id-type="pmid">25849533</pub-id></mixed-citation></ref><ref id="prp2721-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="prp2721-cit-0113">
<string-name>
<surname>Heigwer</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Port</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Boutros</surname>
<given-names>M</given-names>
</string-name>. <article-title>RNA interference (RNAi) screening in Drosophila</article-title>. <source xml:lang="en">Genetics</source>. <year>2018</year>;<volume>208</volume>(<issue>3</issue>):<fpage>853</fpage>&#x02010;<lpage>874</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.117.300077</pub-id>
<pub-id pub-id-type="pmid">29487145</pub-id></mixed-citation></ref><ref id="prp2721-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="prp2721-cit-0114">
<string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Niu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Robust RNAi&#x02010;mediated resistance to infection of seven potyvirids in soybean expressing an intron hairpin NIb RNA</article-title>. <source xml:lang="en">Transgenic Res</source>. <year>2017</year>;<volume>26</volume>(<issue>5</issue>):<fpage>665</fpage>&#x02010;<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1007/s11248-017-0041-2</pub-id>
<pub-id pub-id-type="pmid">28840434</pub-id></mixed-citation></ref><ref id="prp2721-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="prp2721-cit-0115">
<string-name>
<surname>Rytlewski</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Beronja</surname>
<given-names>S</given-names>
</string-name>. <article-title>RNAi in the mouse: rapid and affordable gene function studies in a vertebrate system</article-title>. <source xml:lang="en">WIREs</source>. <year>2015</year>;<volume>4</volume>(<issue>1</issue>):<fpage>45</fpage>&#x02010;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1002/wdev.164</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="prp2721-cit-0116">
<string-name>
<surname>Kamath</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Ahringer</surname>
<given-names>J</given-names>
</string-name>. <article-title>Genome&#x02010;wide RNAi screening in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Methods</source>. <year>2003</year>;<volume>30</volume>(<issue>4</issue>):<fpage>313</fpage>&#x02010;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/s1046-2023(03)00050-1</pub-id>
<pub-id pub-id-type="pmid">12828945</pub-id></mixed-citation></ref><ref id="prp2721-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="prp2721-cit-0117">
<string-name>
<surname>Rual</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Ceron</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Koreth</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Toward improving <italic>Caenorhabditis elegans</italic> phenome mapping with an ORFeome&#x02010;based RNAi library</article-title>. <source xml:lang="en">Genome Res</source>. <year>2004</year>;<volume>14</volume>(<issue>10b</issue>):<fpage>2162</fpage>&#x02010;<lpage>2168</lpage>. <pub-id pub-id-type="doi">10.1101/gr.2505604</pub-id>
<pub-id pub-id-type="pmid">15489339</pub-id></mixed-citation></ref><ref id="prp2721-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="prp2721-cit-0118">
<string-name>
<surname>Ashrafi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>FY</given-names>
</string-name>, <string-name>
<surname>Watts</surname>
<given-names>JL</given-names>
</string-name>, et al. <article-title>Genome&#x02010;wide RNAi analysis of <italic>Caenorhabditis elegans</italic> fat regulatory genes</article-title>. <source xml:lang="en">Nature</source>. <year>2003</year>;<volume>421</volume>(<issue>6920</issue>):<fpage>268</fpage>&#x02010;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1038/nature01279</pub-id>
<pub-id pub-id-type="pmid">12529643</pub-id></mixed-citation></ref><ref id="prp2721-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="prp2721-cit-0119">
<string-name>
<surname>G&#x000f6;nczy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Echeverri</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Oegema</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Functional genomic analysis of cell division in <italic>C. elegans</italic> using RNAi of genes on chromosome III</article-title>. <source xml:lang="en">Nature</source>. <year>2000</year>;<volume>408</volume>(<issue>6810</issue>):<fpage>331</fpage>&#x02010;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1038/35042526</pub-id>
<pub-id pub-id-type="pmid">11099034</pub-id></mixed-citation></ref><ref id="prp2721-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="prp2721-cit-0120">
<string-name>
<surname>Zugasti</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Thakur</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Belougne</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>A quantitative genome&#x02010;wide RNAi screen in <italic>C. elegans</italic> for antifungal innate immunity genes</article-title>. <source xml:lang="en">BMC Biol</source>. <year>2016</year>;<volume>14</volume>:<fpage>35</fpage>. <pub-id pub-id-type="doi">10.1186/s12915-016-0256-3</pub-id>
<pub-id pub-id-type="pmid">27129311</pub-id></mixed-citation></ref><ref id="prp2721-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="prp2721-cit-0121">
<string-name>
<surname>Mao</surname>
<given-names>Y&#x02010;Q</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>S&#x02010;F</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>S&#x02010;L</given-names>
</string-name>, et al. <article-title>An approach using <italic>Caenorhabditis elegans</italic> screening novel targets to suppress tumour cell proliferation</article-title>. <source xml:lang="en">Cell Prolif</source>. <year>2020</year>;<volume>53</volume>(<issue>6</issue>):<elocation-id>e12832</elocation-id>. <pub-id pub-id-type="doi">10.1111/cpr.12832</pub-id>
<pub-id pub-id-type="pmid">32452127</pub-id></mixed-citation></ref><ref id="prp2721-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="prp2721-cit-0122">
<string-name>
<surname>Liachko</surname>
<given-names>NF</given-names>
</string-name>, <string-name>
<surname>Saxton</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>McMillan</surname>
<given-names>PJ</given-names>
</string-name>, et al. <article-title>Genome wide analysis reveals heparan sulfate epimerase modulates TDP&#x02010;43 proteinopathy</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2019</year>;<volume>15</volume>(<issue>12</issue>):<elocation-id>e1008526</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1008526</pub-id>
<pub-id pub-id-type="pmid">31834878</pub-id></mixed-citation></ref><ref id="prp2721-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="prp2721-cit-0123">
<string-name>
<surname>Calixto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chelur</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Topalidou</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Chalfie</surname>
<given-names>M</given-names>
</string-name>
<article-title>. Enhanced neuronal RNAi in <italic>C. elegans</italic> using SID&#x02010;1</article-title>. <source xml:lang="en">Nat Methods</source>. <year>2010</year>;<volume>7</volume>(<issue>7</issue>):<fpage>554</fpage>&#x02010;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1463</pub-id>
<pub-id pub-id-type="pmid">20512143</pub-id></mixed-citation></ref><ref id="prp2721-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="prp2721-cit-0124">
<string-name>
<surname>Kennedy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ruvkun</surname>
<given-names>G</given-names>
</string-name>. <article-title>A conserved siRNA&#x02010;degrading RNase negatively regulates RNA interference in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Nature</source>. <year>2004</year>;<volume>427</volume>(<issue>6975</issue>):<fpage>645</fpage>&#x02010;<lpage>649</lpage>. <pub-id pub-id-type="doi">10.1038/nature02302</pub-id>
<pub-id pub-id-type="pmid">14961122</pub-id></mixed-citation></ref><ref id="prp2721-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="prp2721-cit-0125">
<string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kennedy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Conte</surname>
<given-names>D</given-names>
<suffix>Jr</suffix>
</string-name>, et al. <article-title>Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants</article-title>. <source xml:lang="en">Nature</source>. <year>2005</year>;<volume>436</volume>(<issue>7050</issue>):<fpage>593</fpage>&#x02010;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1038/nature04010</pub-id>
<pub-id pub-id-type="pmid">16049496</pub-id></mixed-citation></ref><ref id="prp2721-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="prp2721-cit-0126">
<string-name>
<surname>Sieburth</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ch'ng</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Dybbs</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Systematic analysis of genes required for synapse structure and function</article-title>. <source xml:lang="en">Nature</source>. <year>2005</year>;<volume>436</volume>(<issue>7050</issue>):<fpage>510</fpage>&#x02010;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1038/nature03809</pub-id>
<pub-id pub-id-type="pmid">16049479</pub-id></mixed-citation></ref><ref id="prp2721-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="prp2721-cit-0127">
<string-name>
<surname>Hsu</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Lander</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>F</given-names>
</string-name>. <article-title>Development and applications of CRISPR&#x02010;Cas9 for genome engineering</article-title>. <source xml:lang="en">Cell</source>. <year>2014</year>;<volume>157</volume>(<issue>6</issue>):<fpage>1262</fpage>&#x02010;<lpage>1278</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.05.010</pub-id>
<pub-id pub-id-type="pmid">24906146</pub-id></mixed-citation></ref><ref id="prp2721-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="prp2721-cit-0128">
<string-name>
<surname>Maggio</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gon&#x000e7;alves</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Genome editing at the crossroads of delivery, specificity, and fidelity</article-title>. <source xml:lang="en">Trends Biotechnol</source>. <year>2015</year>;<volume>33</volume>(<issue>5</issue>):<fpage>280</fpage>&#x02010;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2015.02.011</pub-id>
<pub-id pub-id-type="pmid">25819765</pub-id></mixed-citation></ref><ref id="prp2721-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="prp2721-cit-0129">
<string-name>
<surname>Fr&#x000f8;kj&#x000e6;r&#x02010;Jensen</surname>
<given-names>C</given-names>
</string-name>. <article-title>Transposon&#x02010;assisted genetic engineering with Mos1&#x02010;Mediated Single&#x02010;Copy Insertion (MosSCI)</article-title>. <source xml:lang="en">Methods Mol Biol</source>. <year>2015</year>;<volume>1327</volume>:<fpage>49</fpage>&#x02010;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-2842-2_5</pub-id>
<pub-id pub-id-type="pmid">26423967</pub-id></mixed-citation></ref><ref id="prp2721-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="prp2721-cit-0130">
<string-name>
<surname>Dickinson</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>B</given-names>
</string-name>. <article-title>CRISPR&#x02010;based methods for <italic>Caenorhabditis elegans</italic> genome engineering</article-title>. <source xml:lang="en">Genetics</source>. <year>2016</year>;<volume>202</volume>(<issue>3</issue>):<fpage>885</fpage>&#x02010;<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.115.182162</pub-id>
<pub-id pub-id-type="pmid">26953268</pub-id></mixed-citation></ref><ref id="prp2721-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="prp2721-cit-0131">
<string-name>
<surname>Nance</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Frokjaer&#x02010;Jensen</surname>
<given-names>C</given-names>
</string-name>. <article-title>The <italic>Caenorhabditis elegans</italic> transgenic toolbox</article-title>. <source xml:lang="en">Genetics</source>. <year>2019</year>;<volume>212</volume>(<issue>4</issue>):<fpage>959</fpage>&#x02010;<lpage>990</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.119.301506</pub-id>
<pub-id pub-id-type="pmid">31405997</pub-id></mixed-citation></ref><ref id="prp2721-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="prp2721-cit-0132">
<string-name>
<surname>Baiga</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Metabolite induction of <italic>Caenorhabditis elegans</italic> dauer larvae arises via transport in the pharynx</article-title>. <source xml:lang="en">ACS Chem Biol</source>. <year>2008</year>;<volume>3</volume>(<issue>5</issue>):<fpage>294</fpage>&#x02010;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1021/cb700269e</pub-id>
<pub-id pub-id-type="pmid">18376812</pub-id></mixed-citation></ref><ref id="prp2721-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="prp2721-cit-0133">
<string-name>
<surname>Kamal</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Moshiri</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Magomedova</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>The marginal cells of the <italic>Caenorhabditis elegans</italic> pharynx scavenge cholesterol and other hydrophobic small molecules</article-title>. <source xml:lang="en">Nat Commun</source>. <year>2019</year>;<volume>10</volume>(<issue>1</issue>):<fpage>3938</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-11908-0</pub-id>
<pub-id pub-id-type="pmid">31477732</pub-id></mixed-citation></ref><ref id="prp2721-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="prp2721-cit-0134">
<string-name>
<surname>Scharf</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Piechulek</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>von Mikecz</surname>
<given-names>A</given-names>
</string-name>. <article-title>Effect of nanoparticles on the biochemical and behavioral aging phenotype of the nematode <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">ACS Nano</source>. <year>2013</year>;<volume>7</volume>(<issue>12</issue>):<fpage>10695</fpage>&#x02010;<lpage>10703</lpage>. <pub-id pub-id-type="doi">10.1021/nn403443r</pub-id>
<pub-id pub-id-type="pmid">24256469</pub-id></mixed-citation></ref><ref id="prp2721-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="prp2721-cit-0135">
<string-name>
<surname>Page</surname>
<given-names>AP</given-names>
</string-name>. <article-title>The sensory amphidial structures of <italic>Caenorhabditis elegans</italic> are involved in macrocyclic lactone uptake and anthelmintic resistance</article-title>. <source xml:lang="en">Int J Parasitol</source>. <year>2018</year>;<volume>48</volume>(<issue>13</issue>):<fpage>1035</fpage>&#x02010;<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpara.2018.06.003</pub-id>
<pub-id pub-id-type="pmid">30253131</pub-id></mixed-citation></ref><ref id="prp2721-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="prp2721-cit-0136">
<string-name>
<surname>Kwok</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Ricker</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Fraser</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>A small&#x02010;molecule screen in <italic>C. elegans</italic> yields a new calcium channel antagonist</article-title>. <source xml:lang="en">Nature</source>. <year>2006</year>;<volume>441</volume>(<issue>7089</issue>):<fpage>91</fpage>&#x02010;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1038/nature04657</pub-id>
<pub-id pub-id-type="pmid">16672971</pub-id></mixed-citation></ref><ref id="prp2721-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="prp2721-cit-0137">
<string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Aroian</surname>
<given-names>RV</given-names>
</string-name>. <article-title>The new anthelmintic tribendimidine is an L&#x02010;type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist</article-title>. <source xml:lang="en">PLoS Negl Trop Dis</source>. <year>2009</year>;<volume>3</volume>(<issue>8</issue>):<fpage>e499</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0000499</pub-id>
<pub-id pub-id-type="pmid">19668355</pub-id></mixed-citation></ref><ref id="prp2721-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="prp2721-cit-0138">
<string-name>
<surname>Tam</surname>
<given-names>ZY</given-names>
</string-name>, <string-name>
<surname>Gruber</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Halliwell</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Gunawan</surname>
<given-names>R</given-names>
</string-name>. <article-title>Effects of lithium on age&#x02010;related decline in mitochondrial turnover and function in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">J Gerontol: Series A</source>. <year>2014</year>;<volume>69</volume>(<issue>7</issue>):<fpage>810</fpage>&#x02010;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/glt210</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="prp2721-cit-0139">
<string-name>
<surname>van Haaften</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Vastenhouw</surname>
<given-names>NL</given-names>
</string-name>, <string-name>
<surname>Nollen</surname>
<given-names>EAA</given-names>
</string-name>, <string-name>
<surname>Plasterk</surname>
<given-names>RHA</given-names>
</string-name>, <string-name>
<surname>Tijsterman</surname>
<given-names>M</given-names>
</string-name>. <article-title>Gene interactions in the DNA damage&#x02010;response pathway identified by genome&#x02010;wide RNA&#x02010;interference analysis of synthetic lethality</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2004</year>;<volume>101</volume>(<issue>35</issue>):<fpage>12992</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.0403131101</pub-id>
<pub-id pub-id-type="pmid">15326288</pub-id></mixed-citation></ref><ref id="prp2721-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="prp2721-cit-0140">
<string-name>
<surname>Moy</surname>
<given-names>TI</given-names>
</string-name>, <string-name>
<surname>Ball</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Anklesaria</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Casadei</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ausubel</surname>
<given-names>FM</given-names>
</string-name>. <article-title>Identification of novel antimicrobials using a live&#x02010;animal infection model</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2006</year>;<volume>103</volume>(<issue>27</issue>):<fpage>10414</fpage>&#x02010;<lpage>10419</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0604055103</pub-id>
<pub-id pub-id-type="pmid">16801562</pub-id></mixed-citation></ref><ref id="prp2721-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="prp2721-cit-0141">
<string-name>
<surname>Ben&#x02010;Yakar</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bourgeois</surname>
<given-names>F</given-names>
</string-name>. <article-title>Ultrafast laser nanosurgery in microfluidics for genome&#x02010;wide screenings</article-title>. <source xml:lang="en">Curr Opin Biotechnol</source>. <year>2009</year>;<volume>20</volume>(<issue>1</issue>):<fpage>100</fpage>&#x02010;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2009.01.008</pub-id>
<pub-id pub-id-type="pmid">19278850</pub-id></mixed-citation></ref><ref id="prp2721-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="prp2721-cit-0142">
<string-name>
<surname>Zheng</surname>
<given-names>SQ</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>HR</given-names>
</string-name>. <article-title>Drug absorption efficiency in <italic>Caenorhbditis elegans</italic> delivered by different methods</article-title>. <source xml:lang="en">PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>2</issue>):<elocation-id>e56877</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0056877</pub-id>
<pub-id pub-id-type="pmid">23451103</pub-id></mixed-citation></ref><ref id="prp2721-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="prp2721-cit-0143">
<string-name>
<surname>Edwards</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Canfield</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Copes</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Rehan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lipps</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bradshaw</surname>
<given-names>PC</given-names>
</string-name>. <article-title>D&#x02010;beta&#x02010;hydroxybutyrate extends lifespan in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Aging</source>. <year>2014</year>;<volume>6</volume>(<issue>8</issue>):<fpage>621</fpage>&#x02010;<lpage>644</lpage>. <pub-id pub-id-type="doi">10.18632/aging.100683</pub-id>
<pub-id pub-id-type="pmid">25127866</pub-id></mixed-citation></ref><ref id="prp2721-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="prp2721-cit-0144">
<string-name>
<surname>Kim</surname>
<given-names>DH</given-names>
</string-name>. <article-title>Bacteria and the aging and longevity of <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Annu Rev Genet</source>. <year>2013</year>;<volume>47</volume>:<fpage>233</fpage>&#x02010;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-111212-133352</pub-id>
<pub-id pub-id-type="pmid">24274752</pub-id></mixed-citation></ref><ref id="prp2721-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="prp2721-cit-0145">
<string-name>
<surname>Cabreiro</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gems</surname>
<given-names>D</given-names>
</string-name>. <article-title>Worms need microbes too: Microbiota, health and aging in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">EMBO Mol Med</source>. <year>2013</year>;<volume>5</volume>(<issue>9</issue>):<fpage>1300</fpage>&#x02010;<lpage>1310</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201100972</pub-id>
<pub-id pub-id-type="pmid">23913848</pub-id></mixed-citation></ref><ref id="prp2721-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="prp2721-cit-0146">
<string-name>
<surname>Burns</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Wallace</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Wildenhain</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>A predictive model for drug bioaccumulation and bioactivity in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Nat Chem Biol</source>. <year>2010</year>;<volume>6</volume>(<issue>7</issue>):<fpage>549</fpage>&#x02010;<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.380</pub-id>
<pub-id pub-id-type="pmid">20512140</pub-id></mixed-citation></ref><ref id="prp2721-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="prp2721-cit-0147">
<string-name>
<surname>van Dijk</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Cobben</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Kariminejad</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Osteogenesis imperfecta: A review with clinical examples</article-title>. <source xml:lang="en">Molecular Syndromology</source>. <year>2011</year>;<volume>2</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1159/000332228</pub-id>
<pub-id pub-id-type="pmid">22570641</pub-id></mixed-citation></ref><ref id="prp2721-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="prp2721-cit-0148">
<string-name>
<surname>Johnstone</surname>
<given-names>IL</given-names>
</string-name>, <string-name>
<surname>Shafi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Barry</surname>
<given-names>JD</given-names>
</string-name>. <article-title>Molecular analysis of mutations in the <italic>Caenorhabditis elegans</italic> collagen gene dpy&#x02010;7</article-title>. <source xml:lang="en">Embo J</source>. <year>1992</year>;<volume>11</volume>(<issue>11</issue>):<fpage>3857</fpage>&#x02010;<lpage>3863</lpage>.<pub-id pub-id-type="pmid">1396579</pub-id></mixed-citation></ref><ref id="prp2721-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="prp2721-cit-0149">
<string-name>
<surname>McColl</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Pukala</surname>
<given-names>TL</given-names>
</string-name>, et al. <article-title>Utility of an improved model of amyloid&#x02010;beta (A&#x003b2;&#x02081;&#x0208b;&#x02084;&#x02082;) toxicity in <italic>Caenorhabditis elegans</italic> for drug screening for Alzheimer's disease.</article-title>
<source xml:lang="en">Mol Neurodegener</source>. <year>2012</year>;<volume>7</volume>:<fpage>57</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-7-57</pub-id>
<pub-id pub-id-type="pmid">23171715</pub-id></mixed-citation></ref><ref id="prp2721-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="prp2721-cit-0150">
<string-name>
<surname>Vartiainen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aarnio</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lakso</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>G</given-names>
</string-name>. <article-title>Increased lifespan in transgenic <italic>Caenorhabditis elegans</italic> overexpressing human alpha&#x02010;synuclein</article-title>. <source xml:lang="en">Exp Gerontol</source>. <year>2006</year>;<volume>41</volume>(<issue>9</issue>):<fpage>871</fpage>&#x02010;<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2006.05.005</pub-id>
<pub-id pub-id-type="pmid">16782295</pub-id></mixed-citation></ref><ref id="prp2721-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="prp2721-cit-0151">
<string-name>
<surname>Perlmutter</surname>
<given-names>DH</given-names>
</string-name>. <article-title>The role of autophagy in alpha&#x02010;1&#x02010;antitrypsin deficiency: A specific cellular response in genetic diseases associated with aggregation&#x02010;prone proteins</article-title>. <source xml:lang="en">Autophagy</source>. <year>2006</year>;<volume>2</volume>(<issue>4</issue>):<fpage>258</fpage>&#x02010;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.4161/auto.2882</pub-id>
<pub-id pub-id-type="pmid">16874089</pub-id></mixed-citation></ref><ref id="prp2721-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="prp2721-cit-0152">
<string-name>
<surname>Silverman</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pak</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Perlmutter</surname>
<given-names>D</given-names>
</string-name>. <article-title>Disorders of protein misfolding: Alpha&#x02010;1&#x02010;antitrypsin deficiency as prototype</article-title>. <source xml:lang="en">J Pediatr</source>. <year>2013</year>;<volume>163</volume>(<issue>2</issue>):<fpage>320</fpage>&#x02010;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2013.03.077</pub-id>
<pub-id pub-id-type="pmid">23664631</pub-id></mixed-citation></ref><ref id="prp2721-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="prp2721-cit-0153">
<string-name>
<surname>Gitler</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Dhillon</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Shorter</surname>
<given-names>J</given-names>
</string-name>. <article-title>Neurodegenerative disease: Models, mechanisms, and a new hope</article-title>. <source xml:lang="en">Dis Models Mech</source>. <year>2017</year>;<volume>10</volume>(<issue>5</issue>):<fpage>499</fpage>. <pub-id pub-id-type="doi">10.1242/dmm.030205</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="prp2721-cit-0154">
<string-name>
<surname>Mattson</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Magnus</surname>
<given-names>T</given-names>
</string-name>. <article-title>Ageing and neuronal vulnerability</article-title>. <source xml:lang="en">Nat Rev Neurosci</source>. <year>2006</year>;<volume>7</volume>(<issue>4</issue>):<fpage>278</fpage>&#x02010;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1886</pub-id>
<pub-id pub-id-type="pmid">16552414</pub-id></mixed-citation></ref><ref id="prp2721-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="prp2721-cit-0155">
<string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Barclay</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Burgoyne</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Morgan</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Using <italic>C. elegans</italic> to discover therapeutic compounds for ageing&#x02010;associated neurodegenerative diseases</article-title>. <source xml:lang="en">Chemistry Central Journal</source>. <year>2015</year>;<volume>9</volume>:<fpage>65</fpage>. <pub-id pub-id-type="doi">10.1534/genetics.115.177998</pub-id>
<pub-id pub-id-type="pmid">26617668</pub-id></mixed-citation></ref><ref id="prp2721-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="prp2721-cit-0156">
<string-name>
<surname>Ma</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>K</given-names>
</string-name>. <article-title>
<italic>Caenorhabditis elegans</italic> as a model system for target identification and drug screening against neurodegenerative diseases</article-title>. <source xml:lang="en">Eur J Pharmacol</source>. <year>2018</year>;<volume>819</volume>:<fpage>169</fpage>&#x02010;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2017.11.051</pub-id>
<pub-id pub-id-type="pmid">29208474</pub-id></mixed-citation></ref><ref id="prp2721-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="prp2721-cit-0157">
<string-name>
<surname>Brignull</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Morley</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Garcia</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Morimoto</surname>
<given-names>RI</given-names>
</string-name>. <article-title>Modeling polyglutamine pathogenesis in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Methods Enzymol</source>. <year>2006</year>;<volume>412</volume>:<fpage>256</fpage>&#x02010;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1016/S0076-6879(06)12016-9</pub-id>
<pub-id pub-id-type="pmid">17046663</pub-id></mixed-citation></ref><ref id="prp2721-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="prp2721-cit-0158">
<string-name>
<surname>Lakso</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vartiainen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Moilanen</surname>
<given-names>AM</given-names>
</string-name>, et al. <article-title>Dopaminergic neuronal loss and motor deficits in <italic>Caenorhabditis elegans</italic> overexpressing human alpha&#x02010;synuclein</article-title>. <source xml:lang="en">J Neurochem</source>. <year>2003</year>;<volume>86</volume>(<issue>1</issue>):<fpage>165</fpage>&#x02010;<lpage>172</lpage>.<pub-id pub-id-type="pmid">12807436</pub-id></mixed-citation></ref><ref id="prp2721-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="prp2721-cit-0159">
<string-name>
<surname>Hamamichi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rivas</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Knight</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Caldwell</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Caldwell</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Hypothesis&#x02010;based RNAi screening identifies neuroprotective genes in a Parkinson's disease model</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2008</year>;<volume>105</volume>(<issue>2</issue>):<fpage>728</fpage>&#x02010;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0711018105</pub-id>
<pub-id pub-id-type="pmid">18182484</pub-id></mixed-citation></ref><ref id="prp2721-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="prp2721-cit-0160">
<string-name>
<surname>Saldi</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Ash</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>TDP&#x02010;1, the <italic>Caenorhabditis elegans</italic> ortholog of TDP&#x02010;43, limits the accumulation of double&#x02010;stranded RNA</article-title>. <source xml:lang="en">EMBO J</source>. <year>2014</year>;<volume>33</volume>(<issue>24</issue>):<fpage>2947</fpage>&#x02010;<lpage>2966</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201488740</pub-id>
<pub-id pub-id-type="pmid">25391662</pub-id></mixed-citation></ref><ref id="prp2721-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="prp2721-cit-0161">
<string-name>
<surname>Yao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>WM</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Kinase inhibitors arrest neurodegeneration in cell and <italic>C. elegans</italic> models of LRRK2 toxicity</article-title>. <source xml:lang="en">Hum Mol Genet</source>. <year>2013</year>;<volume>22</volume>(<issue>2</issue>):<fpage>328</fpage>&#x02010;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds431</pub-id>
<pub-id pub-id-type="pmid">23065705</pub-id></mixed-citation></ref><ref id="prp2721-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="prp2721-cit-0162">
<string-name>
<surname>Corsi</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Wightman</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Chalfie</surname>
<given-names>M</given-names>
</string-name>. <article-title>A transparent window into biology: A primer on <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Genetics</source>. <year>2015</year>;<volume>200</volume>(<issue>2</issue>):<fpage>387</fpage>&#x02010;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.115.176099</pub-id>
<pub-id pub-id-type="pmid">26088431</pub-id></mixed-citation></ref><ref id="prp2721-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="prp2721-cit-0163">
<string-name>
<surname>Samuelson</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Carr</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Ruvkun</surname>
<given-names>G</given-names>
</string-name>. <article-title>Gene activities that mediate increased life span of <italic>C. elegans</italic> insulin&#x02010;like signaling mutants</article-title>. <source xml:lang="en">Genes Dev</source>. <year>2007</year>;<volume>21</volume>(<issue>22</issue>):<fpage>2976</fpage>&#x02010;<lpage>2994</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1588907</pub-id>
<pub-id pub-id-type="pmid">18006689</pub-id></mixed-citation></ref><ref id="prp2721-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="prp2721-cit-0164">
<string-name>
<surname>Uno</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nishida</surname>
<given-names>E</given-names>
</string-name>. <article-title>Lifespan&#x02010;regulating genes in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">NPJ Aging Mech Dis</source>. <year>2016</year>;<volume>2</volume>:<fpage>16010</fpage>. <pub-id pub-id-type="doi">10.1038/npjamd.2016.10</pub-id>
<pub-id pub-id-type="pmid">28721266</pub-id></mixed-citation></ref><ref id="prp2721-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="prp2721-cit-0165">
<string-name>
<surname>Kenyon</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gensch</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rudner</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tabtiang</surname>
<given-names>RA</given-names>
</string-name>. <article-title>A <italic>C. elegans</italic> mutant that lives twice as long as wild type</article-title>. <source xml:lang="en">Nature</source>. <year>1993</year>;<volume>366</volume>(<issue>6454</issue>):<fpage>461</fpage>&#x02010;<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1038/366461a0</pub-id>
<pub-id pub-id-type="pmid">8247153</pub-id></mixed-citation></ref><ref id="prp2721-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="prp2721-cit-0166">
<string-name>
<surname>Apfeld</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kenyon</surname>
<given-names>C</given-names>
</string-name>. <article-title>Regulation of lifespan by sensory perception in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Nature</source>. <year>1999</year>;<volume>402</volume>(<issue>6763</issue>):<fpage>804</fpage>&#x02010;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1038/45544</pub-id>
<pub-id pub-id-type="pmid">10617200</pub-id></mixed-citation></ref><ref id="prp2721-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="prp2721-cit-0167">
<string-name>
<surname>Kinser</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Pincus</surname>
<given-names>Z</given-names>
</string-name>. <article-title>High&#x02010;throughput screening in the <italic>C. elegans</italic> nervous system</article-title>. <source xml:lang="en">Mol Cell Neurosci</source>. <year>2017</year>;<volume>80</volume>:<fpage>192</fpage>&#x02010;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2016.06.001</pub-id>
<pub-id pub-id-type="pmid">27265309</pub-id></mixed-citation></ref><ref id="prp2721-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="prp2721-cit-0168">
<string-name>
<surname>O'Reilly</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Luke</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Perlmutter</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Silverman</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Pak</surname>
<given-names>SC</given-names>
</string-name>. <article-title>
<italic>C. elegans</italic> in high&#x02010;throughput drug discovery</article-title>. <source xml:lang="en">Adv Drug Del Rev</source>. <year>2014</year>;<volume>70</volume>:<fpage>247</fpage>&#x02010;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2013.12.001</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="prp2721-cit-0169">
<string-name>
<surname>Conery</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Larkins&#x02010;Ford</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ausubel</surname>
<given-names>FM</given-names>
</string-name>, <string-name>
<surname>Kirienko</surname>
<given-names>NV</given-names>
</string-name>. <article-title>High&#x02010;throughput screening for novel anti&#x02010;infectives using a <italic>C. elegans</italic> pathogenesis model</article-title>. <source xml:lang="en">Curr Protoc Chem Biol</source>. <year>2014</year>;<volume>6</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02010;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1002/9780470559277.ch130160</pub-id>
<pub-id pub-id-type="pmid">24652621</pub-id></mixed-citation></ref><ref id="prp2721-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="prp2721-cit-0170">
<string-name>
<surname>Leung</surname>
<given-names>CK</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Malany</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>An ultra high&#x02010;throughput, whole&#x02010;animal screen for small molecule modulators of a specific genetic pathway in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<elocation-id>e62166</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0062166</pub-id>
<pub-id pub-id-type="pmid">23637990</pub-id></mixed-citation></ref><ref id="prp2721-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="prp2721-cit-0171">
<string-name>
<surname>Petrascheck</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ye</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Buck</surname>
<given-names>LB</given-names>
</string-name>. <article-title>An antidepressant that extends lifespan in adult <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Nature</source>. <year>2007</year>;<volume>450</volume>(<issue>7169</issue>):<fpage>553</fpage>&#x02010;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1038/nature05991</pub-id>
<pub-id pub-id-type="pmid">18033297</pub-id></mixed-citation></ref><ref id="prp2721-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="prp2721-cit-0172">
<string-name>
<surname>Perni</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Casford</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aprile</surname>
<given-names>FA</given-names>
</string-name>, et al. <article-title>Automated behavioral analysis of large <italic>C. elegans</italic> populations using a wide field&#x02010;of&#x02010;view tracking platform</article-title>. <source xml:lang="en">J Vis Exp</source>. <year>2018</year>;(<issue>141</issue>):<elocation-id>e58643</elocation-id>. <pub-id pub-id-type="doi">10.3791/58643</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="prp2721-cit-0173">
<string-name>
<surname>Perni</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Challa</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Kirkegaard</surname>
<given-names>JB</given-names>
</string-name>, et al. <article-title>Massively parallel <italic>C. elegans</italic> tracking provides multi&#x02010;dimensional fingerprints for phenotypic discovery</article-title>. <source xml:lang="en">J Neurosci Methods</source>. <year>2018</year>;<volume>306</volume>:<fpage>57</fpage>&#x02010;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2018.02.005</pub-id>
<pub-id pub-id-type="pmid">29452179</pub-id></mixed-citation></ref><ref id="prp2721-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="prp2721-cit-0174">
<string-name>
<surname>Bargmann</surname>
<given-names>CI</given-names>
</string-name>. <article-title>Neurobiology of the <italic>Caenorhabditis elegans</italic> genome</article-title>. <source xml:lang="en">Science</source>. <year>1998</year>;<volume>282</volume>(<issue>5396</issue>):<fpage>2028</fpage>&#x02010;<lpage>2033</lpage>. <pub-id pub-id-type="doi">10.1126/science.282.5396.2028</pub-id>
<pub-id pub-id-type="pmid">9851919</pub-id></mixed-citation></ref><ref id="prp2721-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="prp2721-cit-0175">
<string-name>
<surname>Liu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Kidd</surname>
<given-names>PB</given-names>
</string-name>, <string-name>
<surname>Dobosiewicz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bargmann</surname>
<given-names>CI</given-names>
</string-name>. <article-title>
<italic>C. elegans</italic> AWA olfactory neurons fire calcium&#x02010;mediated all&#x02010;or&#x02010;none action potentials</article-title>. <source xml:lang="en">Cell</source>. <year>2018</year>;<volume>175</volume>(<issue>1</issue>):<fpage>57</fpage>&#x02010;<lpage>70 e17</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.08.018</pub-id>
<pub-id pub-id-type="pmid">30220455</pub-id></mixed-citation></ref><ref id="prp2721-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="prp2721-cit-0176">
<string-name>
<surname>Liu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ge</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Salkoff</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kotlikoff</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>ZW</given-names>
</string-name>. <article-title>Genetic dissection of ion currents underlying all&#x02010;or&#x02010;none action potentials in <italic>C. elegans</italic> body&#x02010;wall muscle cells</article-title>. <source xml:lang="en">J Physiol</source>. <year>2011</year>;<volume>589</volume>(<issue>Pt 1</issue>):<fpage>101</fpage>&#x02010;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2010.200683</pub-id>
<pub-id pub-id-type="pmid">21059759</pub-id></mixed-citation></ref><ref id="prp2721-bib-0177"><label>177</label><mixed-citation publication-type="journal" id="prp2721-cit-0177">
<string-name>
<surname>Shtonda</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Avery</surname>
<given-names>L</given-names>
</string-name>. <article-title>CCA&#x02010;1, EGL&#x02010;19 and EXP&#x02010;2 currents shape action potentials in the <italic>Caenorhabditis elegans</italic> pharynx</article-title>. <source xml:lang="en">J Exp Biol</source>. <year>2005</year>;<volume>208</volume>(<issue>11</issue>):<fpage>2177</fpage>&#x02010;<lpage>2190</lpage>. <pub-id pub-id-type="doi">10.1242/jeb.01615</pub-id>
<pub-id pub-id-type="pmid">15914661</pub-id></mixed-citation></ref><ref id="prp2721-bib-0178"><label>178</label><mixed-citation publication-type="journal" id="prp2721-cit-0178">
<string-name>
<surname>Link</surname>
<given-names>CD</given-names>
</string-name>. <article-title>Expression of human beta&#x02010;amyloid peptide in transgenic <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>1995</year>;<volume>92</volume>(<issue>20</issue>):<fpage>9368</fpage>&#x02010;<lpage>9372</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.92.20.9368</pub-id>
<pub-id pub-id-type="pmid">7568134</pub-id></mixed-citation></ref><ref id="prp2721-bib-0179"><label>179</label><mixed-citation publication-type="journal" id="prp2721-cit-0179">
<string-name>
<surname>Dickinson</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Ward</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Reiner</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>B</given-names>
</string-name>. <article-title>Engineering the <italic>Caenorhabditis elegans</italic> genome using Cas9&#x02010;triggered homologous recombination</article-title>. <source xml:lang="en">Nat Methods</source>. <year>2013</year>;<volume>10</volume>(<issue>10</issue>):<fpage>1028</fpage>&#x02010;<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2641</pub-id>
<pub-id pub-id-type="pmid">23995389</pub-id></mixed-citation></ref><ref id="prp2721-bib-0180"><label>180</label><mixed-citation publication-type="journal" id="prp2721-cit-0180">
<string-name>
<surname>Baskoylu</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Yersak</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>O'Hern</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Single copy/knock&#x02010;in models of ALS SOD1 in <italic>C. elegans</italic> suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegeneration</article-title>. <source xml:lang="en">PLOS Genet</source>. <year>2018</year>;<volume>14</volume>(<issue>10</issue>):<elocation-id>e1007682</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1007682</pub-id>
<pub-id pub-id-type="pmid">30296255</pub-id></mixed-citation></ref><ref id="prp2721-bib-0181"><label>181</label><mixed-citation publication-type="journal" id="prp2721-cit-0181">
<string-name>
<surname>Baskoylu</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Chapkis</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Unsal</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Disrupted autophagy and neuronal dysfunction in <italic>C. elegans</italic> knock&#x02010;in models of FUS amyotrophic lateral sclerosis</article-title>. <source xml:lang="en">bioRxiv</source>. <year>2019</year>:<fpage>799932</fpage>. <pub-id pub-id-type="doi">10.1101/799932</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0182"><label>182</label><mixed-citation publication-type="journal" id="prp2721-cit-0182">
<string-name>
<surname>Guha</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>GVW</given-names>
</string-name>, <string-name>
<surname>Nehrke</surname>
<given-names>K</given-names>
</string-name>. <article-title>Tauopathy&#x02010;associated tau modifications selectively impact neurodegeneration and mitophagy in a novel <italic>C. elegans</italic> single&#x02010;copy transgenic model</article-title>. <source xml:lang="en">Mol Neurodegeneration</source>. <year>2020</year>;<volume>15</volume>:<fpage>65</fpage>. <pub-id pub-id-type="doi">10.1186/s13024-02000410-7</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0183"><label>183</label><mixed-citation publication-type="journal" id="prp2721-cit-0183">
<string-name>
<surname>Lee</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Ung</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Sands</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Kikis</surname>
<given-names>EA</given-names>
</string-name>. <article-title>A new <italic>Caenorhabditis elegans</italic> model of human huntingtin 513 aggregation and toxicity in body wall muscles</article-title>. <source xml:lang="en">PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>3</issue>):<elocation-id>e0173644</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0173644</pub-id>
<pub-id pub-id-type="pmid">28282438</pub-id></mixed-citation></ref><ref id="prp2721-bib-0184"><label>184</label><mixed-citation publication-type="journal" id="prp2721-cit-0184">
<string-name>
<surname>Faber</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Alter</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>MacDonald</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Hart</surname>
<given-names>AC</given-names>
</string-name>. <article-title>Polyglutamine&#x02010;mediated dysfunction and apoptotic death of a <italic>Caenorhabditis elegans</italic> sensory neuron</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>1999</year>;<volume>96</volume>(<issue>1</issue>):<fpage>179</fpage>&#x02010;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.1.179</pub-id>
<pub-id pub-id-type="pmid">9874792</pub-id></mixed-citation></ref><ref id="prp2721-bib-0185"><label>185</label><mixed-citation publication-type="journal" id="prp2721-cit-0185">
<string-name>
<surname>Parker</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Connolly</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Wellington</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hayden</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dausset</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Neri</surname>
<given-names>C</given-names>
</string-name>. <article-title>Expanded polyglutamines in <italic>Caenorhabditis elegans</italic> cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2001</year>;<volume>98</volume>(<issue>23</issue>):<fpage>13318</fpage>&#x02010;<lpage>13323</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.231476398</pub-id>
<pub-id pub-id-type="pmid">11687635</pub-id></mixed-citation></ref><ref id="prp2721-bib-0186"><label>186</label><mixed-citation publication-type="journal" id="prp2721-cit-0186">
<string-name>
<surname>Drake</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Link</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Butterfield</surname>
<given-names>DA</given-names>
</string-name>. <article-title>Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta&#x02010;peptide (1&#x02013;42) in a transgenic <italic>Caenorhabditis elegans</italic> model</article-title>. <source xml:lang="en">Neurobiol Aging</source>. <year>2003</year>;<volume>24</volume>(<issue>3</issue>):<fpage>415</fpage>&#x02010;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(02)00225-7</pub-id>
<pub-id pub-id-type="pmid">12600717</pub-id></mixed-citation></ref><ref id="prp2721-bib-0187"><label>187</label><mixed-citation publication-type="journal" id="prp2721-cit-0187">
<string-name>
<surname>Fong</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Teo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>LF</given-names>
</string-name>, et al. <article-title>Energy crisis precedes global metabolic failure in a novel <italic>Caenorhabditis elegans</italic> Alzheimer disease model</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2016</year>;<volume>6</volume>(<issue>1</issue>):<fpage>33781</fpage>. <pub-id pub-id-type="doi">10.1038/srep33781</pub-id>
<pub-id pub-id-type="pmid">27653553</pub-id></mixed-citation></ref><ref id="prp2721-bib-0188"><label>188</label><mixed-citation publication-type="journal" id="prp2721-cit-0188">
<string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Butko</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Amyloid&#x02010;beta&#x02010;induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">J Neurosci</source>. <year>2006</year>;<volume>26</volume>(<issue>50</issue>):<fpage>13102</fpage>&#x02010;<lpage>13113</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3448-06.2006</pub-id>
<pub-id pub-id-type="pmid">17167099</pub-id></mixed-citation></ref><ref id="prp2721-bib-0189"><label>189</label><mixed-citation publication-type="journal" id="prp2721-cit-0189">
<string-name>
<surname>Kraemer</surname>
<given-names>BC</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Leverenz</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</string-name>. <article-title>Neurodegeneration and defective neurotransmission in a <italic>Caenorhabditis elegans</italic> model of tauopathy</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2003</year>;<volume>100</volume>(<issue>17</issue>):<fpage>9980</fpage>&#x02010;<lpage>9985</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1533448100</pub-id>
<pub-id pub-id-type="pmid">12872001</pub-id></mixed-citation></ref><ref id="prp2721-bib-0190"><label>190</label><mixed-citation publication-type="journal" id="prp2721-cit-0190">
<string-name>
<surname>Guha</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>GVW</given-names>
</string-name>, <string-name>
<surname>Nehrke</surname>
<given-names>K</given-names>
</string-name>. <article-title>Tauopathy&#x02010;associated tau modifications selectively impact neurodegeneration and mitophagy in a novel <italic>C. elegans</italic> single&#x02010;copy transgenic model</article-title>. <source xml:lang="en">Mol Neurodegener</source>. <year>2020</year>;<volume>15</volume>(<issue>1</issue>):<fpage>65</fpage>. <pub-id pub-id-type="doi">10.1186/s13024-020-00410-7</pub-id>
<pub-id pub-id-type="pmid">33168053</pub-id></mixed-citation></ref><ref id="prp2721-bib-0191"><label>191</label><mixed-citation publication-type="journal" id="prp2721-cit-0191">
<string-name>
<surname>Kuwahara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha&#x02010;synuclein transgenic C. elegans</article-title>. <source xml:lang="en">Hum Mol Genet</source>. <year>2008</year>;<volume>17</volume>(<issue>19</issue>):<fpage>2997</fpage>&#x02010;<lpage>3009</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn198</pub-id>
<pub-id pub-id-type="pmid">18617532</pub-id></mixed-citation></ref><ref id="prp2721-bib-0192"><label>192</label><mixed-citation publication-type="journal" id="prp2721-cit-0192">
<string-name>
<surname>Kuwahara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gengyo&#x02010;Ando</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Familial Parkinson mutant alpha&#x02010;synuclein causes dopamine neuron dysfunction in transgenic <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">J Biol Chem</source>. <year>2006</year>;<volume>281</volume>(<issue>1</issue>):<fpage>334</fpage>&#x02010;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M504860200</pub-id>
<pub-id pub-id-type="pmid">16260788</pub-id></mixed-citation></ref><ref id="prp2721-bib-0193"><label>193</label><mixed-citation publication-type="journal" id="prp2721-cit-0193">
<string-name>
<surname>Nass</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hall</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>DM</given-names>
<suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Blakely</surname>
<given-names>RD</given-names>
</string-name>. <article-title>Neurotoxin&#x02010;induced degeneration of dopamine neurons in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2002</year>;<volume>99</volume>(<issue>5</issue>):<fpage>3264</fpage>&#x02010;<lpage>3269</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.042497999</pub-id>
<pub-id pub-id-type="pmid">11867711</pub-id></mixed-citation></ref><ref id="prp2721-bib-0194"><label>194</label><mixed-citation publication-type="journal" id="prp2721-cit-0194">
<string-name>
<surname>Oeda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shimohama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kitagawa</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis&#x02010;related mutant SOD1 in transgenic <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Hum Mol Genet</source>. <year>2001</year>;<volume>10</volume>(<issue>19</issue>):<fpage>2013</fpage>&#x02010;<lpage>2023</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.19.2013</pub-id>
<pub-id pub-id-type="pmid">11590119</pub-id></mixed-citation></ref><ref id="prp2721-bib-0195"><label>195</label><mixed-citation publication-type="journal" id="prp2721-cit-0195">
<string-name>
<surname>Gidalevitz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Krupinski</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Garcia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Morimoto</surname>
<given-names>RI</given-names>
</string-name>. <article-title>Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2009</year>;<volume>5</volume>(<issue>3</issue>):<elocation-id>e1000399</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000399</pub-id>
<pub-id pub-id-type="pmid">19266020</pub-id></mixed-citation></ref><ref id="prp2721-bib-0196"><label>196</label><mixed-citation publication-type="journal" id="prp2721-cit-0196">
<string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Farr</surname>
<given-names>GW</given-names>
</string-name>, <string-name>
<surname>Hall</surname>
<given-names>DH</given-names>
</string-name>, et al. <article-title>An ALS&#x02010;linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2009</year>;<volume>5</volume>(<issue>1</issue>):<elocation-id>e1000350</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000350</pub-id>
<pub-id pub-id-type="pmid">19165329</pub-id></mixed-citation></ref><ref id="prp2721-bib-0197"><label>197</label><mixed-citation publication-type="journal" id="prp2721-cit-0197">
<string-name>
<surname>Liachko</surname>
<given-names>NF</given-names>
</string-name>, <string-name>
<surname>Guthrie</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Kraemer</surname>
<given-names>BC</given-names>
</string-name>. <article-title>Phosphorylation promotes neurotoxicity in a <italic>Caenorhabditis elegans</italic> model of TDP&#x02010;43 proteinopathy</article-title>. <source xml:lang="en">J Neurosci</source>. <year>2010</year>;<volume>30</volume>(<issue>48</issue>):<fpage>16208</fpage>&#x02010;<lpage>16219</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2911-10.2010</pub-id>
<pub-id pub-id-type="pmid">21123567</pub-id></mixed-citation></ref><ref id="prp2721-bib-0198"><label>198</label><mixed-citation publication-type="journal" id="prp2721-cit-0198">
<string-name>
<surname>Ash</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>CM</given-names>
</string-name>, et al. <article-title>Neurotoxic effects of TDP&#x02010;43 overexpression in <italic>C. elegans</italic>
</article-title>. <source xml:lang="en">Hum Mol Genet</source>. <year>2010</year>;<volume>19</volume>(<issue>16</issue>):<fpage>3206</fpage>&#x02010;<lpage>3218</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq230</pub-id>
<pub-id pub-id-type="pmid">20530643</pub-id></mixed-citation></ref><ref id="prp2721-bib-0199"><label>199</label><mixed-citation publication-type="journal" id="prp2721-cit-0199">
<string-name>
<surname>Vaccaro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tauffenberger</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ash</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Carlomagno</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>JA</given-names>
</string-name>. <article-title>TDP&#x02010;1/TDP&#x02010;43 regulates stress signaling and age&#x02010;dependent proteotoxicity in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2012</year>;<volume>8</volume>(<issue>7</issue>):<elocation-id>e1002806</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002806</pub-id>
<pub-id pub-id-type="pmid">22792076</pub-id></mixed-citation></ref><ref id="prp2721-bib-0200"><label>200</label><mixed-citation publication-type="journal" id="prp2721-cit-0200">
<string-name>
<surname>Murakami</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>ALS mutations in FUS cause neuronal dysfunction and death in <italic>Caenorhabditis elegans</italic> by a dominant gain&#x02010;of&#x02010;function mechanism</article-title>. <source xml:lang="en">Hum Mol Genet</source>. <year>2012</year>;<volume>21</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr417</pub-id>
<pub-id pub-id-type="pmid">21949354</pub-id></mixed-citation></ref><ref id="prp2721-bib-0201"><label>201</label><mixed-citation publication-type="journal" id="prp2721-cit-0201">
<string-name>
<surname>Witan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kern</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Koziollek&#x02010;Drechsler</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Wade</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Behl</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Clement</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Heterodimer formation of wild&#x02010;type and amyotrophic lateral sclerosis&#x02010;causing mutant Cu/Zn&#x02010;superoxide dismutase induces toxicity independent of protein aggregation</article-title>. <source xml:lang="en">Hum Mol Genet</source>. <year>2008</year>;<volume>17</volume>(<issue>10</issue>):<fpage>1373</fpage>&#x02010;<lpage>1385</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn025</pub-id>
<pub-id pub-id-type="pmid">18211954</pub-id></mixed-citation></ref><ref id="prp2721-bib-0202"><label>202</label><mixed-citation publication-type="journal" id="prp2721-cit-0202">
<string-name>
<surname>van der Goot</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Vazquez&#x02010;Manrique</surname>
<given-names>RP</given-names>
</string-name>, et al. <article-title>Delaying aging and the aging&#x02010;associated decline in protein homeostasis by inhibition of tryptophan degradation</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>. <year>2012</year>;<volume>109</volume>(<issue>37</issue>):<fpage>14912</fpage>&#x02010;<lpage>14917</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1203083109</pub-id>
<pub-id pub-id-type="pmid">22927396</pub-id></mixed-citation></ref><ref id="prp2721-bib-0203"><label>203</label><mixed-citation publication-type="journal" id="prp2721-cit-0203">
<string-name>
<surname>Jadiya</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fatima</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Baghel</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mir</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Nazir</surname>
<given-names>A</given-names>
</string-name>. <article-title>A systematic RNAi screen of neuroprotective genes identifies novel modulators of alpha&#x02010;synuclein&#x02010;associated effects in transgenic <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Mol Neurobiol</source>. <year>2016</year>;<volume>53</volume>(<issue>9</issue>):<fpage>6288</fpage>&#x02010;<lpage>6300</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-015-9517-3</pub-id>
<pub-id pub-id-type="pmid">26567108</pub-id></mixed-citation></ref><ref id="prp2721-bib-0204"><label>204</label><mixed-citation publication-type="journal" id="prp2721-cit-0204">
<string-name>
<surname>Knight Adam</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Hamamichi</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>The glycolytic enzyme, GPI, Is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson&#x02019;s models</article-title>. <source xml:lang="en">Cell Metab</source>. <year>2014</year>;<volume>20</volume>(<issue>1</issue>):<fpage>145</fpage>&#x02010;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.04.017</pub-id>
<pub-id pub-id-type="pmid">24882066</pub-id></mixed-citation></ref><ref id="prp2721-bib-0205"><label>205</label><mixed-citation publication-type="journal" id="prp2721-cit-0205">
<string-name>
<surname>Silva</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Fox</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Beam</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Thakkar</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Amaral</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Morimoto</surname>
<given-names>RI</given-names>
</string-name>. <article-title>A genetic screening strategy identifies novel regulators of the proteostasis network</article-title>. <source xml:lang="en">PLoS Genet</source>. <year>2011</year>;<volume>7</volume>(<issue>12</issue>):<elocation-id>e1002438</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002438</pub-id>
<pub-id pub-id-type="pmid">22242008</pub-id></mixed-citation></ref><ref id="prp2721-bib-0206"><label>206</label><mixed-citation publication-type="journal" id="prp2721-cit-0206">
<string-name>
<surname>van Ham</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Holmberg</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>van der Goot</surname>
<given-names>AT</given-names>
</string-name>, et al. <article-title>Identification of MOAG&#x02010;4/SERF as a regulator of age&#x02010;related proteotoxicity</article-title>. <source xml:lang="en">Cell</source>. <year>2010</year>;<volume>142</volume>(<issue>4</issue>):<fpage>601</fpage>&#x02010;<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.07.020</pub-id>
<pub-id pub-id-type="pmid">20723760</pub-id></mixed-citation></ref><ref id="prp2721-bib-0207"><label>207</label><mixed-citation publication-type="journal" id="prp2721-cit-0207">
<string-name>
<surname>Holden&#x02010;Dye</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Anthelmintic drugs and nematicides: Studies in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">WormBook</source>. <year>2014</year>;<fpage>1</fpage>&#x02010;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1895/wormbook.1.143.2</pub-id>
</mixed-citation></ref><ref id="prp2721-bib-0208"><label>208</label><mixed-citation publication-type="journal" id="prp2721-cit-0208">
<string-name>
<surname>Weng</surname>
<given-names>HB</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>HX</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>MW</given-names>
</string-name>. <article-title>Innovation in neglected tropical disease drug discovery and development</article-title>. <source xml:lang="en">Infect Dis Poverty</source>. <year>2018</year>;<volume>7</volume>(<issue>1</issue>):<fpage>67</fpage>. <pub-id pub-id-type="doi">10.1186/s40249-018-0444-1</pub-id>
<pub-id pub-id-type="pmid">29950174</pub-id></mixed-citation></ref><ref id="prp2721-bib-0209"><label>209</label><mixed-citation publication-type="journal" id="prp2721-cit-0209">
<string-name>
<surname>Wolstenholme</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Fairweather</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Prichard</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>von Samson&#x02010;Himmelstjerna</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Sangster</surname>
<given-names>NC</given-names>
</string-name>. <article-title>Drug resistance in veterinary helminths</article-title>. <source xml:lang="en">Trends Parasitol</source>. <year>2004</year>;<volume>20</volume>(<issue>10</issue>):<fpage>469</fpage>&#x02010;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2004.07.010</pub-id>
<pub-id pub-id-type="pmid">15363440</pub-id></mixed-citation></ref><ref id="prp2721-bib-0210"><label>210</label><mixed-citation publication-type="journal" id="prp2721-cit-0210">
<string-name>
<surname>Osei&#x02010;Atweneboana</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Eng</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Boakye</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Gyapong</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Prichard</surname>
<given-names>RK</given-names>
</string-name>. <article-title>Prevalence and intensity of <italic>Onchocerca volvulus</italic> infection and efficacy of ivermectin in endemic communities in Ghana: A two&#x02010;phase epidemiological study</article-title>. <source xml:lang="en">Lancet</source>. <year>2007</year>;<volume>369</volume>(<issue>9578</issue>):<fpage>2021</fpage>&#x02010;<lpage>2029</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60942-8</pub-id>
<pub-id pub-id-type="pmid">17574093</pub-id></mixed-citation></ref><ref id="prp2721-bib-0211"><label>211</label><mixed-citation publication-type="journal" id="prp2721-cit-0211">
<string-name>
<surname>Kaminsky</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bapst</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Stein</surname>
<given-names>PA</given-names>
</string-name>, et al. <article-title>Differences in efficacy of monepantel, derquantel and abamectin against multi&#x02010;resistant nematodes of sheep</article-title>. <source xml:lang="en">Parasitol Res</source>. <year>2011</year>;<volume>109</volume>(<issue>1</issue>):<fpage>19</fpage>&#x02010;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-010-2216-0</pub-id>
<pub-id pub-id-type="pmid">21161271</pub-id></mixed-citation></ref><ref id="prp2721-bib-0212"><label>212</label><mixed-citation publication-type="journal" id="prp2721-cit-0212">
<string-name>
<surname>Geurden</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hoste</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jacquiet</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Anthelmintic resistance and multidrug resistance in sheep gastro&#x02010;intestinal nematodes in France, Greece and Italy</article-title>. <source xml:lang="en">Vet Parasitol</source>. <year>2014</year>;<volume>201</volume>(<issue>1&#x02010;2</issue>):<fpage>59</fpage>&#x02010;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetpar.2014.01.016</pub-id>
<pub-id pub-id-type="pmid">24560365</pub-id></mixed-citation></ref><ref id="prp2721-bib-0213"><label>213</label><mixed-citation publication-type="journal" id="prp2721-cit-0213">
<string-name>
<surname>Krucken</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fraundorfer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mugisha</surname>
<given-names>JC</given-names>
</string-name>, et al. <article-title>Reduced efficacy of albendazole against Ascaris lumbricoides in Rwandan schoolchildren</article-title>. <source xml:lang="en">Int J Parasitol Drugs Drug Resist</source>. <year>2017</year>;<volume>7</volume>(<issue>3</issue>):<fpage>262</fpage>&#x02010;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2017.06.001</pub-id>
<pub-id pub-id-type="pmid">28697451</pub-id></mixed-citation></ref><ref id="prp2721-bib-0214"><label>214</label><mixed-citation publication-type="journal" id="prp2721-cit-0214">
<string-name>
<surname>Ward</surname>
<given-names>JD</given-names>
</string-name>. <article-title>Rendering the intractable more tractable: tools from <italic>caenorhabditis elegans</italic> ripe for import into parasitic nematodes</article-title>. <source xml:lang="en">Genetics</source>. <year>2015</year>;<volume>201</volume>(<issue>4</issue>):<fpage>1279</fpage>&#x02010;<lpage>1294</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.115.182717</pub-id>
<pub-id pub-id-type="pmid">26644478</pub-id></mixed-citation></ref><ref id="prp2721-bib-0215"><label>215</label><mixed-citation publication-type="journal" id="prp2721-cit-0215">
<string-name>
<surname>Katiki</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Ferreira</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Zajac</surname>
<given-names>AM</given-names>
</string-name>, et al. <article-title>
<italic>Caenorhabditis elegans</italic> as a model to screen plant extracts and compounds as natural anthelmintics for veterinary use</article-title>. <source xml:lang="en">Vet Parasitol</source>. <year>2011</year>;<volume>182</volume>(<issue>2&#x02010;4</issue>):<fpage>264</fpage>&#x02010;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetpar.2011.05.020</pub-id>
<pub-id pub-id-type="pmid">21680095</pub-id></mixed-citation></ref><ref id="prp2721-bib-0216"><label>216</label><mixed-citation publication-type="journal" id="prp2721-cit-0216">
<string-name>
<surname>Kumarasingha</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Palombo</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Bhave</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Enhancing a search for traditional medicinal plants with anthelmintic action by using wild type and stress reporter <italic>Caenorhabditis elegans</italic> strains as screening tools</article-title>. <source xml:lang="en">Int J Parasitol</source>. <year>2014</year>;<volume>44</volume>(<issue>5</issue>):<fpage>291</fpage>&#x02010;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpara.2014.01.008</pub-id>
<pub-id pub-id-type="pmid">24583111</pub-id></mixed-citation></ref><ref id="prp2721-bib-0217"><label>217</label><mixed-citation publication-type="journal" id="prp2721-cit-0217">
<string-name>
<surname>Richmond</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Jorgensen</surname>
<given-names>EM</given-names>
</string-name>. <article-title>One GABA and two acetylcholine receptors function at the <italic>C. elegans</italic> neuromuscular junction</article-title>. <source xml:lang="en">Nat Neurosci</source>. <year>1999</year>;<volume>2</volume>(<issue>9</issue>):<fpage>791</fpage>&#x02010;<lpage>797</lpage>. <pub-id pub-id-type="doi">10.1038/12160</pub-id>
<pub-id pub-id-type="pmid">10461217</pub-id></mixed-citation></ref><ref id="prp2721-bib-0218"><label>218</label><mixed-citation publication-type="journal" id="prp2721-cit-0218">
<string-name>
<surname>Rayes</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Flamini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hernando</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bouzat</surname>
<given-names>C</given-names>
</string-name>. <article-title>Activation of single nicotinic receptor channels from <italic>Caenorhabditis elegans</italic> muscle</article-title>. <source xml:lang="en">Mol Pharmacol</source>. <year>2007</year>;<volume>71</volume>(<issue>5</issue>):<fpage>1407</fpage>&#x02010;<lpage>1415</lpage>. <pub-id pub-id-type="doi">10.1124/mol.106.033514</pub-id>
<pub-id pub-id-type="pmid">17314321</pub-id></mixed-citation></ref><ref id="prp2721-bib-0219"><label>219</label><mixed-citation publication-type="journal" id="prp2721-cit-0219">
<string-name>
<surname>Fonseca&#x02010;Salamanca</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Martinez&#x02010;Grueiro</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Martinez&#x02010;Fernandez</surname>
<given-names>AR</given-names>
</string-name>. <article-title>Nematocidal activity of nitazoxanide in laboratory models</article-title>. <source xml:lang="en">Parasitol Res</source>. <year>2003</year>;<volume>91</volume>(<issue>4</issue>):<fpage>321</fpage>&#x02010;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-003-0974-7</pub-id>
<pub-id pub-id-type="pmid">14574563</pub-id></mixed-citation></ref><ref id="prp2721-bib-0220"><label>220</label><mixed-citation publication-type="journal" id="prp2721-cit-0220">
<string-name>
<surname>Weeks</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Lockery</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>WM</given-names>
</string-name>. <article-title>Anthelmintic drug actions in resistant and susceptible <italic>C. elegans</italic> revealed by electrophysiological recordings in a multichannel microfluidic device</article-title>. <source xml:lang="en">Int J Parasitol Drugs Drug Resist</source>. <year>2018</year>;<volume>8</volume>(<issue>3</issue>):<fpage>607</fpage>&#x02010;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpddr.2018.10.003</pub-id>
<pub-id pub-id-type="pmid">30503202</pub-id></mixed-citation></ref><ref id="prp2721-bib-0221"><label>221</label><mixed-citation publication-type="journal" id="prp2721-cit-0221">
<string-name>
<surname>Geary</surname>
<given-names>TG</given-names>
</string-name>, <string-name>
<surname>Woo</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>McCarthy</surname>
<given-names>JS</given-names>
</string-name>, et al. <article-title>Unresolved issues in anthelmintic pharmacology for helminthiases of humans</article-title>. <source xml:lang="en">Int J Parasitol</source>. <year>2010</year>;<volume>40</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpara.2009.11.001</pub-id>
<pub-id pub-id-type="pmid">19932111</pub-id></mixed-citation></ref><ref id="prp2721-bib-0222"><label>222</label><mixed-citation publication-type="journal" id="prp2721-cit-0222">
<string-name>
<surname>Atchison</surname>
<given-names>WD</given-names>
</string-name>, <string-name>
<surname>Geary</surname>
<given-names>TG</given-names>
</string-name>, <string-name>
<surname>Manning</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>VandeWaa</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>DP</given-names>
</string-name>. <article-title>Comparative neuromuscular blocking actions of levamisole and pyrantel&#x02010;type anthelmintics on rat and gastrointestinal nematode somatic muscle</article-title>. <source xml:lang="en">Toxicol Appl Pharmacol</source>. <year>1992</year>;<volume>112</volume>(<issue>1</issue>):<fpage>133</fpage>&#x02010;<lpage>143</lpage>.<pub-id pub-id-type="pmid">1310165</pub-id></mixed-citation></ref><ref id="prp2721-bib-0223"><label>223</label><mixed-citation publication-type="journal" id="prp2721-cit-0223">
<string-name>
<surname>Martin</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Verma</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Levandoski</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Drug resistance and neurotransmitter receptors of nematodes: Recent studies on the mode of action of levamisole</article-title>. <source xml:lang="en">Parasitology</source>. <year>2005</year>;<volume>131</volume>(<issue>Suppl</issue>):<fpage>S71</fpage>&#x02010;<lpage>S84</lpage>. <pub-id pub-id-type="doi">10.1017/S0031182005008668</pub-id>
<pub-id pub-id-type="pmid">16569294</pub-id></mixed-citation></ref><ref id="prp2721-bib-0224"><label>224</label><mixed-citation publication-type="journal" id="prp2721-cit-0224">
<string-name>
<surname>Qian</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>
<given-names>AP</given-names>
</string-name>. <article-title>Pharmacology of N&#x02010;, L&#x02010;, and B&#x02010;subtypes of nematode nAChR resolved at the single&#x02010;channel level in Ascaris suum</article-title>. <source xml:lang="en">FASEB J</source>. <year>2006</year>;<volume>20</volume>(<issue>14</issue>):<fpage>2606</fpage>&#x02010;<lpage>2608</lpage>. <pub-id pub-id-type="doi">10.1096/fj.06-6264fje</pub-id>
<pub-id pub-id-type="pmid">17056760</pub-id></mixed-citation></ref><ref id="prp2721-bib-0225"><label>225</label><mixed-citation publication-type="journal" id="prp2721-cit-0225">
<string-name>
<surname>Sloan</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Reaves</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Maclean</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Storey</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Wolstenholme</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Expression of nicotinic acetylcholine receptor subunits from parasitic nematodes in <italic>Caenorhabditis elegans</italic>
</article-title>. <source xml:lang="en">Mol Biochem Parasitol</source>. <year>2015</year>;<volume>204</volume>(<issue>1</issue>):<fpage>44</fpage>&#x02010;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbiopara.2015.12.006</pub-id>
<pub-id pub-id-type="pmid">26747395</pub-id></mixed-citation></ref><ref id="prp2721-bib-0226"><label>226</label><mixed-citation publication-type="journal" id="prp2721-cit-0226">
<string-name>
<surname>Weeks</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>WM</given-names>
</string-name>, <string-name>
<surname>Leasure</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Sertraline, paroxetine, and chlorpromazine are rapidly acting anthelmintic drugs capable of clinical repurposing</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>975</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-18457-w</pub-id>.<pub-id pub-id-type="pmid">29343694</pub-id></mixed-citation></ref></ref-list></back></article>